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CHAPTER I
INTRODUCTION
DNA replication is a fundamental process for all life. With few exceptions, each of
the trillions of cell  divisions that occur in a human lifetime requires the accurate and
complete duplication of all 6 billion base pairs of the human genome. Errors in replication
can lead to mutations that contribute to cancer development. As if this alone were not
enough of a challenge, replication takes place in the context of DNA damage. To counter
this challenge to genome integrity, cells contain an innate machinery known as the DNA
Damage Response (DDR), which coordinates cell cycle checkpoints, DNA repair activity,
and  replicative  senescence  or  apoptosis  to  ensure  that  either  the  genetic  material
remains intact or the cell is removed from the actively cycling population.
Highlighting  the  importance  of  the  DDR  machinery,  several  proteins  in  this
pathway, such as ATR (ATM- [Ataxia Telangiectasia Mutated]  and Rad3-related) and
CHK1, are essential  for life  (Brown and Baltimore 2000;  de Klein et al.  2000), while
mutations  in  others,  such  as  MRE11  (Meiotic  recombination  11  homolog),  NBS1
(Nijmegen  breakage  syndrome  protein  1),  and  CHK2  (Checkpoint  kinase  2),  cause
disease syndromes associated with cancer (Hartlerode and Scully 2009). Many cancers
have inactivated one or more DDR pathways, which allows mutations to accumulate and
drive cancer progression  (Hanahan and Weinberg 2011);  however, these same cells
may be more sensitive to inhibition of other DDR pathways – an example of synthetic
lethality.  The  classic  example  of  this  is  that  BRCA1/2  (Breast  cancer  type  1/2
susceptibility  protein)  mutations  sensitize  cancer  cells  to  PARP  (Poly-ADP  ribose
polymerase) inhibitors  (Bryant et al. 2005; Farmer et al. 2005). PARP inhibitors block
single-strand break (SSB) repair. When the cell attempts to replicate these SSBs, they
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are converted to double strand breaks (DSBs), which require homology directed repair
(HDR). While normal cells have little problem with this, BRCA1 and BRCA2 are required
for HDR; thus cells deficient for these genes accumulate unrepaired DSBs and die in the
presence of  PARP inhibitors  (Helleday 2011).  Alternatively, PARP inhibition may trap
PARP on DNA repair intermediates which require BRCA1/2 to repair stalled replication
forks that encounter these sites (Helleday 2011).
Replication stress arises any time a cell encounters difficulty replicating its DNA.
UV light, alkylating agents, oxidative metabolic products, difficult to replicate sequences,
and nucleotide imbalances can all cause replication stress (Cimprich and Cortez 2008;
Zeman and Cimprich 2013). The oncogene-induced replication stress model posits that
the genome instability that characterizes many cancer cells arises from replication stress
(Halazonetis  et  al.  2008).  As  such,  these  same  cells  may  have  an  increased
dependence on replication stress response genes such as ATR and CHK1 (Charrier et
al. 2011; López-Contreras et al. 2012; Reaper et al. 2011). For this reason, inhibitors of
ATR and CHK1 may prove valuable  anti-cancer  agents  and are currently  in  various
stages of development (Chen et al. 2012; Fokas et al. 2014; Toledo et al. 2011a).
In this thesis, I will describe our studies of how ATR and SMARCAL1 function in
the DNA damage response. In Chapter III, I will describe work done in collaboration with
Bianca Sirbu to study the protein composition of stalled and collapsed replication forks
using the iPOND technology. In Chapter IV, I  will  describe work done using an ATR
inhibitor to probe the changes that occur during acute replication stress when ATR is
absent.  I  also  collaborated  with  Carol  Bansbach-Robbins,  who  demonstrated  that
SMARCAL1  is  regulated  by  phosphorylation.  Together,  we  demonstrated  that
SMARCAL1 is regulated by ATR after DNA damage to prevent excess fork remodeling.
Finally, in Chapter V, I will describe how I have built upon previous work described here
and  work  by  Rémy  Bétous  to  understand  at  a  deeper  level  the  biochemistry  of
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SMARCAL1 and what the function of SMARCAL1 might be in cells. Finally, in Chapter
VI, I will discuss what these results mean in the context of the literature and outline some
future  experiments.  First,  however,  I  will  introduce  several  key  concepts  in  DNA
replication, the DNA damage response, and replication stress.
DNA Replication
Origin Firing
The  process  of  duplicating  the  genome,  known  as  DNA replication,  involves
several  enzymatic  activities and the coordinated action of  several  proteins,  including
helicases, polymerases, single-stranded binding proteins, topoisomerases, and various
accessory factors. Bacterial replication is relatively simple, as bacteria contain a single
circular  chromosome  with  a  single,  well-defined  origin  of  replication.  In  contrast,
eukaryotes have multiple large linear chromosomes that initiate replication from multiple
origins (O’Donnell et al. 2013).
The process of DNA replication actually begins in the G1 phase of the cell cycle.
In eukaryotes, origins of replication are bound by the origin recognition complex (ORC),
which consists of ORC1-6. These origins are controlled such that only a single round of
replication occurs during each cell cycle. To accomplish this, the prereplicative complex
(pre-RC), consisting of the ORC complex, CDC6 (cell division cycle 6 homolog), CDT1
(chromatin licensing and DNA replication factor 1), and two molecules of the MCM2-6
(minichromosome maintenance  complex  components  2-6)  heterohexameric  helicase,
only  assembles  during  G1.  Once  the  cell  enters  S-phase,  CDK  (cyclin-dependent
kinase) activity prevents further formation of the pre-RC through subcellular localization
and degradation of pre-RC components CDC6 and CDT1 (Siddiqui et al. 2013). 
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At the onset of S-phase, CDKs and the DBF4/CDC7 kinase (or DBF4-dependent
kinase,  DDK)  phosphorylate  the  pre-RC  to  allow  recruitment  of  accessory  factors
CDC45 (cell  division cycle 45) and the GINS complex (Go-ichi-ni-san complex).  The
origin can then 'fire', or unwind the DNA duplex to allow the MCM helicase to shift from
its dsDNA-encircling mode to the active ssDNA-encircling mode and begin processive
unwinding of the DNA duplex (Siddiqui et al. 2013).
Replication Elongation
The replicative helicases, DNA polymerase delta (POLD) and DNA polymerase
epsilon (POLE), cannot initiate de-novo DNA synthesis, but must extend an existing DNA
primer. To create these primers, DNA primase synthesizes an RNA primer, which DNA
polymerase alpha (POLA) extends. After synthesis of a short DNA tract, the replicative
polymerases can then take over DNA synthesis. On the leading strand, DNA synthesis is
highly processive, aided by the proliferating cell nuclear antigen (PCNA) sliding clamp,
which encircles the DNA and acts as a processivity factor for the polymerase. Because
DNA  synthesis  occurs  only  in  the  5'  →  3'  direction,  lagging  strand  synthesis  is
discontinuous. Thus, the activity of POLA/Primase is required throughout the process of
DNA synthesis to create primers for Okazaki fragments on the lagging strand (O’Donnell
et al. 2013).
Intriguingly, PrimPol  was recently  identified as a second DNA priming activity
capable  of  synthesizing  DNA primers.  Evidence  so  far  suggests  that  PrimPol  acts
primarily at damaged replication forks to mediate repriming and tolerance of DNA lesions
such as those induced by UV light (Mourón et al. 2013).
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Replication through chromatin
Eukaryotic DNA is packaged into nucleosomes that contain the eight core histone
proteins  around which  the DNA wraps.  These  nucleosomes  are  then  packaged into
higher order structures. As such, DNA replication takes place in the context of chromatin.
Nucleosomes on the parental DNA must be removed and replaced on the daughter DNA
strands  (Fig  1.1).  Additionally,  half  of  the  newly  deposited  histones  will  be  newly
synthesized,  and  thus  will  not  contain  the  correct  pattern  of  post-translational
modifications (PTMs) that  define the region of  chromatin undergoing replication.  The
process through which these histones acquire the proper  PTMs is called “chromatin
maturation” (MacAlpine and Almouzni 2013).
The DNA Damage Response
The parts of the DDR that I will focus on here are the responses to double-strand
breaks (DSBs) and replication stress (RSR). Both of these responses involve signaling
from sensor kinases of the phosphoinositide-3-kinase-like kinase (PIKK) family: DNA-PK
(DNA-dependent protein kinase) and ATM respond to DSBs, while ATR responds to both
DSBs  and  replication  stress.  These  PIKK  family  members  share  several  important
features.  Structurally,  the  PIKKs  consist  of  a  large  N-terminal  domain  of  HEAT
(Huntingen, Elongation factor 3, Protein phosphatase 2A, yeast TOR1) repeats followed
by a FAT (FRAP-ATM-TRRAP) domain, kinase domain, PIKK regulatory domain (PRD),
and FATC (FAT-C-terminal) domain (Lovejoy and Cortez 2009).
HEAT  repeat  domains  typically  mediate  protein-protein  or  protein-DNA
interactions, which is likely the case for ATM, ATR, and DNA-PK. Each of these proteins
interacts  with  a  protein  activator:  DNA-PK  with  KU70/80,  ATM  with  the  MRN
(MRE11-RAD50-NBS1) complex,  and ATR with ATRIP (ATR Interacting  Protein)  (Fig
1.2).  While  DNA-PK and ATM exist  without  their  activators  in  solution,  ATRIP is  an
5
6Figure 1.1 DNA replication through chromatin.  As the MCM2-6 replicative helicase
unwinds the DNA duplex, nucleosomes ahead of the replication fork are destabilized.
RPA  coats  the  unwound  ssDNA  on  the  lagging  strand  during  Okazaki  fragment
synthesis. The PCNA sliding clamp serves as a processivity factor for DNA polymerases
delta  and  epsilon.  Following  replication,  histones  are  deposited  to  form  nascent
nucleosomes. Half of these deposited histones are newly synthesized and must be post
translationally  modified  to  reproduce  the original  chromatin  state.  This  also  includes
removal of deposition marks H4K5 and H4K12 acetylation.
7Figure 1.2 DSBs activate DNA-PK, ATM, and ATR.  At a DSB, the KU heterodimer
binds the DNA end and activates DNA-PK which coordinates NHEJ. If the ends cannot
be directly ligated, the MRN complex displaces KU and leads to ATM activation. Minimal
processing may lead to ligatable ends, allowing NHEJ to occur. Alternatively, the MRN
complex initiates end resection to yield a 3' ssDNA tail. RPA bound to this tail activates
ATR,  which  curbs  end  resection  by  phosphorylation  of  EXO1  and  promotes
homology-directed repair.
obligatory  subunit  of  ATR:  ATR  and  ATRIP  purify  as  a  stoichiometric  complex  and
mutually depend on one another for protein stability (Cortez et al. 2001).
These proteins also require interactions in the PRD for maximal activation. While
the KU heterodimer likely provides this interaction for DNA-PK, the situation is more
complex for ATM and ATR. ATM requires acetylation by Tip60 in this region, while ATR
requires  interaction  with  the  ATR  activation  domain  (AAD)  of  TopBP1  (DNA
Topoisomerase II-Binding Protein 1) (Lovejoy and Cortez 2009).
Finally,  ATM  and  DNA-PK  are  regulated  by  auto-phosphorylation.  DNA-PK
extensively auto-phosphorylates, including several sites in the PQR cluster, which leads
to increased activity, and the ABCDE cluster, which allows dissociation of the protein
from DNA (Cui et al. 2005; Meek et al. 2008). ATM S1981 is an auto-phosphorylation site
required  for  activation  of  ATM  (Bakkenist  and  Kastan  2003).  The  Cortez  lab  has
identified  and  characterized  several  potential  auto-phosphorylation  sites  in  ATR;
however, it has not yet been demonstrated that these sites are phosphorylated by ATR in
cells.  One phosphorylation  site,  T1989,  is  damage-inducible  and dependent  on ATR
activity. However, T1989 is followed by proline, not the PIKK consensus glutamine, and
cannot  be  phosphorylated  by  ATR  in  vitro, and  is  thus  unlikely  to  be  an
autophosphorylation site. Unlike ATM S1981, ATR T1989 is not critical for ATR activity,
but marks an activated kinase and will likely prove a more direct and robust marker for
ATR activation than CHK1 phosphorylation (Nam et al. 2011a).
DSB Repair
At genomic DSBs, meaning those not associated with a replication fork, there are
two  major  pathways  of  repair,  non-homologous  end  joining  (NHEJ)  and
homology-directed repair  (HDR;  also  known as:  homologous recombination,  HR;  HR
repair, HRR). I will not provide an extensive treatment of these pathways as, especially
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in the case of HDR, these are complex pathways and not the primary concern of this
dissertation (reviewed in  Hartlerode and Scully 2009; Kakarougkas and Jeggo 2013).
However, I do want to give a general overview and point out important details as we
often gain insight  into replication stress response pathways through comparison with
DSB repair.
Non-homologous end joining (NHEJ)
The current  model  in  the literature is  that  upon DSB formation,  the KU70/80
heterodimer rapidly binds the DNA ends due to its high abundance and affinity. The KU
heterodimer recruits and activates DNA-PK, which then coordinates rapid joining of the
two DNA ends through recruitment of XRCC4, XLF, and DNA ligase IV (Fig. 1.3 and
Kakarougkas and Jeggo 2013). In mammalian cells,  most DSBs are repaired rapidly
using this pathway; however, in S and G2 phases, when CDKs are active, this pathway
can be passed over for HDR when the DSB occurs in a heterochromatic region or the
DNA  damage  is  too  complex  for  simple  ligation  (Hartlerode  and  Scully  2009;
Kakarougkas and Jeggo 2013).
Homology directed repair (HDR)
At DSBs which cannot  be joined by NHEJ, DNA-PK is phosphorylated in the
ABCDE (T2609) cluster, which allows DNA-PK to dissociate from DNA, a step required
for HDR (Kakarougkas and Jeggo 2013; Shibata et al. 2011). Recruitment of the MRN
complex activates ATM, which begins accumulation of a large number of proteins at the
site  of  damage  including  MDC1,  53BP1,  and  BRCA1.  Interestingly,  ATM  activity  is
required for DNA-PK T2609 phosphorylation, suggesting that ATM activation itself is the
signal for the switch from DNA-PK to ATM signaling (Chen et al. 2007).
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Figure  1.3  Pathways  of  DSB Repair.  The  KU heterodimer  can  bind  and  stabilize
dsDNA ends. Rapid ligation through non-homologous end joining requires DNA ligase IV
and XRCC4/XLF. Alternatively, the MRN complex can displace KU and promote 5' end
resection.  Extensive  resection  allows  loading  of  RAD51  which  can  mediate  strand
invasion.  If  both  strands  are  captured,  the  “DSB  Repair”  model  predicts  that  DNA
synthesis and ligation will form a double holliday junction, which can be dissolved by
BLM-TOPOIII (not shown; non-crossover) or cleaved by Holliday junction resolvases to
form crossover or non-crossover products. If only one strand is captured, the “Synthesis
Dependent Strand Annealing” model predicts that after extension of the invading strand,
the strand will be displaced and re-anneal to the exposed 3' tail of the other DSB end.
Gap filling and ligation can then complete repair.
Of note, MDC1 binds to γH2AX on the chromatin and serves as an additional
binding site for the MRN complex (Chapman and Jackson 2008; Goldberg et al. 2003;
Lukas et al. 2004; Spycher et al. 2008; Wu et al. 2008). ATM then binds this additional
MRN and  phosphorylates  more  H2AX molecules,  which  in  turn  allows  more  MDC1
binding.  In  this  way, γH2AX spreads from the site  of  damage throughout  the entire
surrounding region of chromatin,  up to several megabases (Fig. 1.4 and  Savic et al.
2009).
The critical decision point for the switch from NHEJ to HDR is resection initiation.
This is a highly regulated process which requires CtIP and MRE11 (Kakarougkas and
Jeggo 2013; You and Bailis  2010). CtIP is a highly modified protein that coordinates
most  cellular  resection. CtIP requires phosphorylation by CDKs and deacetylation by
SIRT6 to initiate resection  (Huertas and Jackson 2009; Kaidi et al. 2010). At blocked
ends, such as SPO11 cleavage sites in yeast,  the MRE11 endonuclease incises the
blocked  strand  internally  to  generate  a  free  5'  end  for  resection.  CtIP  then  directs
extensive 5' resection that involves the EXO1, DNA2, and BLM proteins  (Huertas and
Jackson 2009;  Kakarougkas and Jeggo 2013;  Sartori  et  al.  2007).  This  extended 5'
resection produces a 3'-ssDNA tail, which is rapidly bound by RPA. RPA coated ssDNA
adjacent  to  a  5'-dsDNA junction  is  the  activating  structure  for  ATR.  ATR  activation
restricts resection, likely through phosphorylation of EXO1, and promotes the completion
of HDR. ATM and ATR phosphorylate BRCA2, and CHK1 phosphorylation of RAD51 is
required for RAD51 recruitment to sites of damage (Ciccia and Elledge 2010). RAD51
displaces RPA, potentially through a SUMOylation regulated process, to form a filament
on the  3'  ssDNA tail  in  a  BRCA2-dependent  process.  RAD51 then mediates  strand
exchange to form a D-loop (Ciccia and Elledge 2010).
Completion  of  HDR requires  the  activity  of  DNA polymerases  to  extend  the
invading strand. Finally, branch migration of the D-loop can displace the invading strand
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Figure 1.4 ATM and MDC1 mediate spreading of γH2AX from site of DSB. MRN
binds the DSB end and stimulates ATM phosphorylation of neighboring H2AX molecules
(red flag represents phosphorylation; light oval represents H2AX containing H2A/H2B
dimer). γH2AX serves as a docking site for MDC1, which recruits additional MRN/ATM.
This  recruited  ATM then  phosphorylates  additional  H2AX molecules.  This  cycle  can
continue to spread γH2AX throughout megabase regions of chromatin.
and allow completion of HDR by synthesis-dependent strand annealing – the extended
3' tail anneals to the 3' tail of the other DSB end – or annealing of the other 3' ssDNA tail
to the displaced strand, which then forms a double Holliday junction (Ciccia and Elledge
2010; Hartlerode and Scully 2009). These double Holliday junctions can be resolved by
the BLM/TOPOIII resolvase complex or several structure-specific nucleases in the cell
such as SLX1/SLX4, GEN1, or MUS81/EME1 (Fig. 1.3 and  Ciccia and Elledge 2010;
Hartlerode and Scully 2009).
DNA Damage Responsive Histone Modifications
One area of interest is the interplay between histone PTMs and the DNA damage
response. The use of chromatin immunoprecipitation (ChIP) and site-specific nucleases
has allowed researchers to define several chromatin changes that occur near double
strand breaks (DSBs)  (Berkovich et al. 2008; Rodrigue et al. 2006; Rudin and Haber
1988; Soutoglou et al. 2007). The most obvious change in PTMs is phosphorylation of
H2A variant H2AX on S139, known as γH2AX, which occurs at DSBs and spreads into
the entire chromatin domain surrounding the DSB (Berkovich et al. 2007; Savic et al.
2009).
A  second  chromatin  modification  that  frequently  occurs  near  DSBs  is
ubiquitination  of  H2A.  This  ubiquitination  is  catalyzed  by  RNF8 and  RNF168,  which
require  MDC1 for  recruitment  to  break sites.  Ub-H2A,  in  turn,  allows recruitment  of
RAP80 and 53BP1 (Ciccia and Elledge 2010; Kakarougkas and Jeggo 2013).
Chromatin,  especially  compacted heterochromatin,  presents  a  barrier  to  DSB
repair. As such, it makes sense that in at least some cases, loosening of the chromatin
must occur to allow repair. Indeed, this is the case, as MOF acetylates H4K16 and CBP
and p300 catalyze acetylation of H3 and H4 to relax chromatin (Li et al. 2010; Sharma et
al. 2010). It is unclear how these changes mimic those at a stalled replication fork, where
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the  situation  is  vastly  different.  The  region  of  DNA  immediately  surrounding  the
replication fork is free of nucleosomes, while the daughter strands contain nucleosomes
in  various  states  of  maturation.  Our  investigation  into  the  link  between  chromatin
maturation and the DDR will be described in Chapter III.
The Replication Stress Response
Replication  stress  arises  from  a  variety  of  sources,  both  endogenous  and
exogenous. DNA lesions, insufficient nucleotides, difficult to replicate sequences, and
collisions between replication and transcription machineries all cause replication stress.
In many cases, replication stress results in stalling of replication forks. If these stalled
forks remain unresolved, chromosomal rearrangements or cell death can occur when the
cell attempts to enter mitosis (Cimprich and Cortez 2008; Zeman and Cimprich 2013).
Stalled Replication Fork Repair Pathways
Replication  fork  repair  pathways  have  been  extensively  studied  in  lower
organisms including bacteria and yeast. Technical limitations make studying replication
fork repair difficult in higher eukaryotes, and so limits our knowledge of these pathways.
Bacteria contain a single circular chromosome that initiates DNA replication at the oriC
site. Two replication forks then proceed in opposite directions through the chromosome
and meet in the terminator region. The Tus protein prevents passage of replication forks
out of the terminator region (Duggin et al. 2008; Mulcair et al. 2006). Thus, replication
fork restart is a critical process in bacteria because there is no possibility of rescue by
the opposite replication fork. There are several possible fork restart  mechanisms: (1)
stabilization and restart or rescue; (2) repriming and post-replicative repair; (3) template
switching or fork regression; and (4) DSB-mediated restart (Jones and Petermann 2012;
Petermann and Helleday 2010; Yeeles et al. 2013). Note that these pathways are for a
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'generic' lesion that blocks the polymerase but not the helicase. Interstrand crosslinks,
which block the helicase, have a specialized repair pathway (that falls into category 4
listed above; reviewed in Deans and West 2011).
1. Stabilization and restart or rescue
The simplest replication fork restart pathway is simply to stabilize the replication
machinery  and  await  repair  of  the  lesion  or  removal  of  the  stressor  (Fig.  1.5).  For
example, some alkylated bases can be directly repaired by ALKB or MGMT (Fu et al.
2012). REV1 is a translesion polymerase implicated in replication fork progression on
damaged templates, possibly by performing translesion synthesis (TLS) directly at the
stalled  fork  (Jones  and  Petermann  2012).  In  the  case  of  nucleotide  deprivation  by
hydroxyurea (HU) or polymerase inhibition with aphidicolin (APH), a stabilized stalled
fork  can  directly  restart  after  removal  of  the  drug.  Eukaryotes  contain  linear
chromosomes with multiple origins of replication. As such, stalled replication forks can
be  rescued  by  replication  from  a  nearby  origin,  possibly  leaving  a  small  patch  of
unreplicated DNA that can be filled in by TLS (Fig. 1.5).
2. Repriming and post-replicative repair
For some lesions, the replication fork machinery may simply skip over the lesion
and continue on its  way. For  lagging strand lesions,  this  is  accomplished simply  by
continuing normal DNA synthesis – the DNA priming activity is active on the lagging
strand, and completion of one Okazaki fragment is not required to begin the next. A
lesion on the leading strand, where DNA replication is more processive, would require
repriming on the leading strand for bypass. This is indeed the case in  E. coli,  where
DnaG repriming of the leading strand is the rate-limiting step for bypass of leading strand
lesions (Yeeles and Marians 2013).
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Figure 1.5 Stabilization and restart or rescue.  The simplest method to deal with a
stalled fork is to stabilize the replisome and wait for repair to occur or removal of a drug,
then resume synthesis.  In many cases,  stabilization of a replication fork can allow a
neighboring origin to fire and “rescue” the stalled fork by replicating up to the point where
the fork stalled.
In  mammals,  PrimPol  may provide  this  functionality. PrimPol-depleted  human
cells  and  PrimPol-/- MEFs showed slower  replication fork progression and decreased
replication fork restart after UV irradiation (Mourón et al. 2013). Moreover, while PrimPol
has  both  TLS  and  DNA  primase  activities,  ablation  of  only  the  primase  activity
recapitulated the phenotypes of PrimPol deficiency (Mourón et al. 2013). This suggests
that, indeed, repriming allows bypass of UV-induced lesions (Fig. 1.6). 
Ubiquitination of the PCNA molecule adjacent to the lesion marks the lesion for
post-replicative repair. Subsequent  translesion synthesis can handle several types of
lesions including alkylation damage induced by methyl methanesulfonate (MMS) and
photo-crosslinked bases induced by UV (Ulrich and Walden 2010; Yeeles et al. 2013).
3. Template switching or fork regression
Template switching, using the opposite nascent strand as a template for DNA
synthesis,  is  a  potential  error-free  pathway  to  bypass  template  damage.  The  S.
cerevisiae Rad5  and  human  orthologue  HLTF  may  be  involved  in  such  a  process
through their helicase activity  (Lin et al. 2011; Motegi et al. 2008; Ulrich and Walden
2010).  If  this  occurs  post-replicatively, such as at  a bypassed UV- or  MMS-induced
lesion, there are few conceptual problems to overcome, as unwinding by HLTF could
expose 3'-ssDNA, which could participate in strand exchange with the sister chromatid.
A short  patch  of  DNA synthesis  could  replicate  past  the  lesion  followed  by  D-loop
dissolution and flap cleavage or gap filling as necessary (Fig. 1.7).
Template  switching  that  occurs  at  the  replication  fork  would  involve  fork
regression, a more challenging biochemical problem. Fork regression has been a topic
of  interest  in  the DNA damage field  for  some time.  This  structure  appears to occur
frequently  in  E.  coli  in  response  to  replication  fork  stalling  and  is  invoked  in  many
pathways  of  replication  fork  restart  (Atkinson  and  McGlynn  2009).  Single  molecule
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Figure 1.6 Repriming and post-replicative repair. After a lesion stalls the replication
fork,  functional  uncoupling  of  the  polymerase  and  helicase  leads  to  excess  ssDNA.
Repriming activity on this ssDNA can allow the replisome to bypass the lesion. PCNA
ubiquitination  can then  serve  as  a  marker  fork  translesion  synthesis  at  the  skipped
region.
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Figure 1.7 Fork regression and template switching. Nascent-nascent strand pairing,
or  template  switching,  can  occur  either  at  the  replication  fork,  in  the  case  of  fork
regression,  or  behind  the  replication  fork  if  the  stalled  nascent  strand  invades  the
opposite  nascent  strand.  Then,  branch  migration  –  either  D-loop  dissolution  or  fork
restoration – restores the replication fork to its normal state, having synthesized past the
lesion using the opposite nascent strand as a template.
studies of the T4 phage replication system demonstrated that the UvsW helicase allows
the replisome to  bypass a  polymerase-blocking lesion using such a pathway. UvsW
regresses the stalled replication fork, polymerization occurs using the opposite nascent
strand as a template. UvsW subsequently restores the reversed fork  (Manosas et al.
2012). 
The situation in eukaryotes is less clear. In S. cerevisiae, fork regression occurs
in  checkpoint  deficient  cells  and  is  associated with  nucleolytic  degradation  of  newly
synthesized DNA and cell lethality (Cobb et al. 2003, 2005; Cotta-Ramusino et al. 2005;
Sogo et al. 2002). However, the idea that this structure represents a repair intermediate
rather than a pathogenic structure is bolstered by recent observations in mammalian
cells. Both low-dose camptothecin (CPT) treatment and overexpression of oncogenes
Cyclin E and CDC25A cause fork regression (Neelsen et al. 2013; Ray Chaudhuri et al.
2012). This suggests that fork regression is a frequent outcome of fork stalling, since
these cells have otherwise intact checkpoint signaling.
Fork regression requires some combination of helicase or annealing activity that
results in reannealing of the template DNA strands and annealing of the nascent strands
to  one  another.  This  forms  a  Holliday  junction-like  structure.  Several  enzymes  can
perform this reaction  in vitro including HLTF, BLM, WRN, SMARCAL1, ZRANB3, and
FANCM  (Achar et al.  2011;  Bétous et  al.  2012, 2013;  Ciccia et al.  2012;  Gari  et  al.
2008a, 2008b; Machwe et al. 2006, 2007; Ralf et al. 2006). Fork regression still presents
a  biochemical  problem:  what  happens  to  the  replisome  during  fork  regression?  It
remains unclear whether the MCM helicase remains bound to the DNA, and if  other
replisome components, such as PCNA and the polymerases, also remain bound. 
The T4 phage UvsW protein is a SWI/SNF family ATPase that supports template
switching  (Manosas  et  al.  2012).  Beyond  both  belonging  to  the  SWI/SNF  family,
SMARCAL1  and  UvsW  also  share  structural  similarities:  the  HARP  domains  of
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SMARCAL1 can substitute for the N-terminal MotA-like domain of UvsW (Aaron Mason
and Brandt Eichman, unpublished observations). Both proteins have annealing helicase
activity and can catalyze the regression of replication forks – annealing the two nascent
strands – and the restoration of regressed forks – annealing the nascent strands back to
their cognate template strands (Bétous et al. 2013).
In  E.  coli,  replisomes  at  stalled  forks  have  short  half  lives,  and  PriA-  and
PriC-dependent activities facilitate reloading of the replisome (Yeeles and Marians 2013;
Yeeles et al. 2013). It is unclear whether the MCM helicase can be reloaded in such a
mechanism.  However, one recent  report  implies  that  this  may be the case:  FANCM
promotes  replication  traversal  across  interstrand  crosslinks  (Huang  et  al.  2013).  An
interstrand crosslink cannot be bypassed by the MCM helicase – such a structure cannot
be unwound. This implies that cells have either a mechanism for reloading the MCM
helicase,  can  substitute  an  alternative  helicase,  or  the  MCM  helicase  has  an
unappreciated ability to bypass crosslinks, presumably by ring-opening and -closing.
4. DSB-mediated restart
Single cell organisms such as E. coli and S. cerevisiae have pathways known as
break induced replication, which allow replication to initiate or resume from a DSB (Fig.
1.8 and Anand et al. 2013). In S. cerevisiae, this pathway can replicate long patches of
DNA, up to the length of a chromosome arm (Anand et al. 2013). The best evidence for
such a pathway in vertebrates comes from experiments in  Xenopus egg extracts.  In
these  experiments,  replicating  extracts  were  treated  with  nucleases  to  collapse
replication  forks  into  DSBs.  Rad51  facilitated  origin-independent  replication  restart
(Hashimoto et al. 2011).
Several  structure specific  nucleases exist  in  cells  which might  facilitate break
induced replication. MUS81 is most commonly linked to replication-associated DSBs,
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Figure 1.8 DSB-mediated recovery of stalled replication forks. A persistently stalled
fork is cleaved by a structure-specific nuclease such as MUS81. After resection of the
leading template strand, the leading nascent strand can invade the sister chromatid to
form a new replication fork.
especially after depletion of SMARCAL1, WRN, and CHK1 (Bétous et al. 2012; Forment
et al. 2011; Franchitto et al. 2008). MUS81 is the catalytic subunit of the MUS81-EME1/2
heterodimer.  Unlike  other  structure-specific  nucleases  which  cleave  intact  Holliday
junctions  efficiently,  MUS81  prefers  Holliday  junction-like  structures  that  resemble
replication  forks,  especially  those  that  have  a  free  5'-hydroxyl  at  the  junction
(Bastin-Shanower et al. 2003; Fricke et al. 2005; Osman and Whitby 2007). 
MUS81 is  also  linked  to  DSB formation  after  treatment  with  camptothecin,  a
Topoisomerase  I  inhibitor,  or  extended  (18-24h)  treatments  with  hydroxyurea  (HU)
(Regairaz et al. 2011). MUS81-dependent DSBs occur in situations associated with fork
collapse.  Therefore,  it  is  possible  that  these  MUS81  DSBs  are  the  cause  of  fork
collapse,  which  is  defined  as  the  inability  to  resume  replication  at  a  stalled  fork.
However, co-depletion  of  WRN and MUS81 does not  relieve the fork restart  defect,
suggesting that these DSBs are not the cause (Franchitto et al. 2008; Petermann et al.
2010).  Furthermore,  MUS81-deficient  cells  display  hypersensitivity  to  cross-linking
agents such as Mitomycin C (MMC) and cisplatin and impaired recovery of replication
forks from HU, suggesting that DSB formation may be a critical step in at least some
forms of repair (Hanada et al. 2007).
In the special case of interstrand crosslinks (ICLs), replication forks on either side
of the ICL converge. Nucleolytic processing then “unhooks” the ICL and generates a
two-ended DSB. Homology directed repair then completes repair past the lesion (Deans
and West 2011). Likewise after a DSB occurs at a stalled replication fork, a combination
of endo- and exonucleases, such as MRE11 and EXO1, could generate a 3' overhang to
allow RAD51 loading and strand invasion. Branch migration and annealing of the leading
template  strand to  the lagging template  strand would  then allow re-formation of  the
replication fork. In this case, further processing by endonucleases or BLM-TOPOIII is
required to resolve the remaining Holliday junction (Fig. 1.8).
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Of  course,  fork  regression  and  DSB-mediated  fork  repair  are  by  no  means
mutually exclusive ideas. In fact, it is entirely possible that regressed replication forks
serve as substrates for structure-specific nucleases such as MUS81 or SLX1/SLX4 in
order to generate DSBs. This is the case in E. coli where RecG-mediated fork regression
allows cleavage by the RuvABC nuclease (McGlynn and Lloyd 2002).
Ataxia telangiectasia mutated and rad3-related (ATR)
ATR is  the master  regulator  of  the replication stress response  (Cimprich and
Cortez  2008).  Upon  replication  fork  stalling,  ATR  is  activated  and  phosphorylates
hundreds of substrates to effect the various functions of ATR, including replication fork
stabilization, repression of dormant origins, and cell cycle arrest  (Cimprich and Cortez
2008; Matsuoka et al. 2007). While many ATR substrates have been defined, and this
signaling pathway is well  studied,  little is known about  what  happens to the DNA at
stalled replication forks and how ATR regulates these changes.
Essential Function of ATR
ATR is an essential gene in replicating cells, but the essential function of ATR is a
matter  of  some debate.  It  is  possible  that  ATR is  essential  simply  because all  cells
undergo some level  of  replication  stress  during each cell  division  cycle  and  ATR is
required to handle this  stress.  Evidence from  S. cerevisiae suggests that  at  least  in
yeast,  regulation  of  origin  firing  is  not  the  essential  function.  This  is  based  on  the
observation  that  strains  containing  the  mec1-100  allele  (Mec1  is  the  S.  cerevisiae
ortholog of ATR) are viable, yet unable to repress dormant origins (Paciotti et al. 2001;
Zhong et al. 2013).
Edward Nam, a former graduate student in our lab,  identified a separation of
function mutant ATR (ATR-3A), which could perform the G2 checkpoint, but not S phase
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functions of ATR. ATR-3A could prevent progression into mitosis following IR treatment,
but  the  ATR-3A protein  could  not  support  viability  in  clonogenic  survival  assays  or
support  resumption  of  DNA synthesis  after  release  from  HU  treatment  (Nam  et  al.
2011b). Taken together, these data suggest that the essential function of ATR is likely at
the level  of  replication  fork  stability  rather  than  regulation  of  origin  firing  or  the  G2
checkpoint.
Because ATR is essential, it is difficult to study the effects of ATR deletion at the
replication fork level – the cells die over time as ATR levels decrease. However, the
synthetic lethality concept has garnered support in recent years and several companies
are directing efforts at developing inhibitors of ATR and ATR-pathway genes, such as
CHK1. As such, we were able to obtain two such ATR inhibitor compounds, one from
AstraZeneca  called  AZ20  (unpublished)  and  another  published  by  Vertex,  VE-821
(Reaper et al. 2011). In Chapter IV, I will describe how we utilized ATR inhibitors as tools
to probe how ATR prevents replication fork collapse.
The S-phase checkpoint
ATR activation at stalled replication forks leads to a phenomenon known as the
“S-phase checkpoint,” although this checkpoint differs from other cell cycle checkpoints
in that the activities described do not directly prevent cell cycle transitions (Friedel et al.
2009). At any rate, the S-phase checkpoint activities of ATR are to promote replication
fork stability, repress global origin firing, and promote local origin firing. While the latter
goals may seem somewhat contradictory, it is important to note that some replication
factors may be limiting, so firing random origins throughout the genome is not likely to
resolve a fork stalling problem, but rather exacerbate it. In contrast, firing origins only
locally may also titrate essential replication factors away from the stalled fork, but this
stalled fork can then be rescued by replication from a nearby dormant origin. As such,
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ATR only  needs to prevent  the replication fork from collapsing,  rather  than promote
resumption of DNA synthesis.
Indeed, in CHK1 deficient cells,  S-phase is shortened due to derepression of
global origin firing.  However, the replication rate of  each individual  replication fork is
significantly slower due to titration of essential replication factors, such as dNTPs (Seiler
et  al.  2007).  Origin  firing  requires  phosphorylation  of  the  MCM  proteins  by  the
DBF4-dependent  kinase  (DDK,  consists  of  DBF4  and  CDC7).  DDK phosphorylation
requires a 'priming' phosphorylation – normally administered by CDKs  (Siddiqui et al.
2013). ATR activity inhibits CDK activity, so this priming activity is not available to global
origins. However, ATR activity promotes PLK1 (Polo-like kinase 1) activity locally, which
may override ATR signaling and allow replication initiation near the stalled fork (Cimprich
and Cortez 2008).
ATR activation and the G2/M checkpoint
While DSBs require resection to expose ssDNA and activate ATR, the situation at
replication forks is somewhat different. At an ongoing replication fork, ssDNA is produced
constantly on the lagging DNA strand due to the discontinuous nature of DNA synthesis.
When  replication  forks  stall,  which  for  our  purposes  means  when  the  polymerase
encounters  a problem and stops inserting  nucleotides,  the polymerase and helicase
become functionally uncoupled, and excess ssDNA is generated (Byun et al. 2005). The
RPA coated ssDNA serves as an activating structure for  ATR,  which phosphorylates
numerous  substrates  at  the  replication  fork,  including  H2AX  and  the  downstream
checkpoint kinase CHK1 (Cimprich and Cortez 2008; Nam and Cortez 2011; Zeman and
Cimprich 2013).
CHK1 phosphorylates CDC25, which targets CDC25 for degradation  (Cimprich
and Cortez 2008). CDC25 is a protein phosphatase that promotes cell cycle progression
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by  removing  inhibitory  phosphates  on  CDK1/2  (Boutros  et  al.  2006).  ATR  also
phosphorylates  and  stabilizes  p53,  which  in  turn  executes  its  transcription  program,
including expression of p21, an inhibitor of CDK activity, and leads to further inhibition of
cell  cycle progression  (Tibbetts et al.  1999; Wang et al. 2008). This is known as the
G2/M checkpoint, as CDK activity is required to proceed from G2 to M phase, which
does not occur in wild type cells with DNA damage (Fig. 1.9 and Cimprich and Cortez
2008; Wang et al. 2009).
Function of MRE11 in ATR activation
Recent work has proposed a function for MRE11 in activation of ATR at stalled
replication  forks.  At  DSBs,  MRE11  is  required  for  ATR  activation  because
MRE11-dependent resection is necessary to expose the ATR-activating ssDNA (Myers
and Cortez 2006). However, the function of MRE11 in ATR activation at stalled forks is
less  clear.  Functional  uncoupling  of  the  MCM  helicase  and  DNA polymerase  at  a
replication fork seems sufficient to form ssDNA, so why is MRE11 necessary?
Experiments in X. laevis egg extracts suggest that depletion of MRN or xMRE11
prevents  maximal  activation  of  ATR,  and  that  depletion  of  xMRE11 also  resulted  in
decreased xTOPBP1 recruitment to damaged chromatin. This suggests that MRE11 is
required  for  full  recruitment  of  TOPBP1  to  damaged  replication  forks.  Interestingly,
xMRE11 recruitment of xTOPBP1 was independent of the 9-1-1 complex, and artificial
targeting  of  the  TOPBP1-AAD to  ssDNA was  sufficient  to  rescue  ATR activation  in
MRE11-depleted extracts (Duursma et al. 2013). Another report also demonstrated in X.
laevis egg extracts that MRE11 depletion prevented ATR activation via recruitment of
TopBP1, and that this function of MRE11 required its nuclease activity (Lee and Dunphy
2013).
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Figure  1.9  G2/M  Checkpoint.  At  DSBs,  ATM  phosphorylates  CHK2,  which  in  turn
phosphorylates  CDC25.  Alternatively,  RPA  coated  ssDNA  activates  ATR,  which
phosphorylates CHK1. CHK1 can also phosphorylate CDC25. CDC25 phosphorylation
by  CHK1/2  targets  it  for  degradation,  which  prevents  CDC25-mediated
dephosphorylation of CDKs. ATR and ATM also phosphorylate and stabilize p53, which
triggers transcription of the p21 CKI, which inhibits CDK activity.
ATR Stabilization of Replication Forks
Mechanistically, it  remains unclear how ATR stabilizes stalled replication forks.
However, clues from lower organisms provide some insight. Unlike mammalian cells, S.
cerevisiae have defined, sequence specific origins such that replisomes can be tracked
as they progress along DNA by chromatin immunoprecipitation (ChIP). These studies
revealed that in a rad53Δ background, replisome components dissociated from stalled
forks (Lucca et al. 2004). These cells also accumulated regressed fork structures (Lucca
et  al.  2004;  Sogo  et  al.  2002),  and  this  phenotype  was  exacerbated  in  an  exo1Δ
background (Cotta-Ramusino et al. 2005). Deletion of the S. cerevisiae RecQ helicase,
Sgs1, was synthetic lethal with the mec1-100 allele, and these mutants had synergistic
defects in maintenance of replisome components at stalled replication forks (Cobb et al.
2005).  Taken together, these observations suggest  that  in  S. cerevisiae,  mec1p and
rad53p stabilize replication forks to prevent dissociation of replication factors and fork
regression.
X. laevis egg extracts depleted of ATR and ATM do not maintain POLE on chromatin
during and after  treatment  with camptothecin  (CPT)  or  mitomycin  C (MMC),  but  not
aphidicolin  (Trenz et al. 2006). Moreover, recovery of DNA synthesis after removal of
CPT or MMC required both MRE11 and ATM/ATR (Trenz et al. 2006). This suggests that
the function of checkpoint signaling to maintain replisome integrity is conserved. Indeed,
our lab and others demonstrated that  one function of  ATR is to prevent  cleavage of
replication forks by SLX4. Fork collapse in ATR-deficient cells involves replication fork
remodeling by SMARCAL1 and degradation of replisome components by the PLK1 and
RNF4 pathways (Couch et al. 2013; Ragland et al. 2013).
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SMARCAL1
Carol  Bansbach-Robbins,  a  former  student  in  the  Cortez  lab, identified
SMARCAL1 in a functional genomic screen for DDR proteins  (Bansbach et al. 2009),
and several other groups also identified SMARCAL1 as a genome maintenance protein
(Ciccia  et  al.  2009;  Yuan  et  al.  2009;  Yusufzai  and  Kadonaga  2008).  Depletion  of
SMARCAL1  from  human  cells  produced  increased  γH2AX  and  HU  sensitivity.
Intriguingly, over-expression of SMARCAL1 also produced γH2AX, though depletion and
over-expression  present  two  different  staining  patterns:  foci  in  the  former  case  and
pan-nuclear in the latter (Bansbach et al. 2009). 
The  γH2AX  produced  in  SMARCAL1-deficient  cells  is  MUS81-dependent
(Bansbach  et  al.  2009).  While  there  is  no  direct  physical  evidence,  one  possible
explanation is that in the absence of SMARCAL1 activity, cells accumulate regressed
replication  forks  that  serve  as  a  substrate  for  nucleases  such  as  MUS81.  Another
possibility is that SMARCAL1 is required to perform fork regression in some cases, and,
absent this, MUS81 cleaves these forks. In fact, this may be the likely explanation, as
MUS81  prefers  to  cleave  substrates  with  a  5'-DNA  end  at  the  junction  point
(Bastin-Shanower  et  al.  2003;  Fricke  et  al.  2005),  which  would  occur  at  a  “stalled”
replication fork with ssDNA only on the leading strand. Regression of this replication fork
would effectively hide the 5'-DNA end from MUS81 and prevent cleavage. Elucidating
this  will  require  DNA  structural  evidence  to  determine  whether  regressed  forks
accumulate in SMARCAL1- or MUS81-deficient cells.
SMARCAL1 Biochemistry
Biochemically,  SMARCAL1  has  several  interesting  properties.  SMARCAL1
belongs to the SWI/SNF family of ATPases in helicase superfamily 2 (SF2) (Flaus et al.
2006). While these proteins share structural similarity with other helicases, such as the
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RecQ  family,  they  primarily  have  DNA  translocase  activity  –  sliding  along  double
stranded  DNA –  and  use  accessory  factors  or  other  protein  domains  to  determine
substrate specificity and activity (Singleton et al. 2007). 
For  example,  SNF2H exists  in  a  complex  with  accessory  factors  that  confer
chromatin  remodeling  activity  and  allow  SNF2H  to  couple  ATP  hydrolysis  with
nucleosome  sliding  (Gangaraju  and  Barthmolomew  2007).  Similarly,  the  N-terminal
region  of  SMARCAL1 contains  an  RPA binding  motif  and  two  HARP (HepA-related
protein)  domains.  The  RPA binding  motif  is  required  for  SMARCAL1  localization  to
replication foci in cells, and the HARP domains are required for DNA binding and ATP
hydrolysis.  In  fact,  the  ATPase core  and  adjacent  HARP domain  (HARP2)  form the
enzymatic core of the protein and are sufficient for enzymatic activity in vitro (Bétous et
al. 2012).
Unlike many other SWI/SNF family members which bind dsDNA, SMARCAL1
binds to DNA that contains dsDNA and ssDNA regions. These structures include dsDNA
with ssDNA gaps, ssDNA extensions, or more complex structures such as 3- and 4-way
junctions that do not have overt  ssDNA. In the latter case, SMARCAL1 may bind to
ssDNA at the junction that results from breathing of the structure (Bétous et al. 2012).
A talented biochemist  in  the Cortez  lab,  Rémy Bétous,  set  out  to  define  the
substrate specificity of SMARCAL1. To do this,  he utilized substrates that resembled
“normal” and “stalled” replication forks, which contain an ssDNA gap at the fork on either
the lagging or leading strand,  respectively (Fig. 1.10A). Rémy determined that in the
absence of RPA, SMARCAL1 preferred to perform fork regression on the “normal” fork
substrate; however, RPA stimulated SMARCAL1 activity on the “stalled” fork substrate
and  inhibited  SMARCAL1  activity  on  the  “normal”  fork  substrate,  inverting  the
preference. This suggests that in a cell, one function of SMARCAL1 may be to regress
stalled replication forks (Bétous et al. 2013).
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Figure  1.10  SMARCAL1  substrate  preferences.  (A) In  the  absence  of  RPA,
SMARCAL1 prefers a fork regression substrate that resembles a “normal” replication
fork – lagging strand ssDNA. However, in the presence of RPA, SMARCAL1 prefers a
substrate that resembles a “stalled” replication fork – ssDNA on the leading strand. (B)
SMARCAL1 prefers to restore model regressed forks with a longer leading strand than
lagging strand, such that when restored, the fork resembles a “normal” fork – lagging
strand ssDNA. RPA enforces this preference by inhibiting SMARCAL1 on the stalled fork
substrate and strongly stimulating SMARCAL1 on the normal fork substrate.
Conversely, Rémy also determined that using substrates that mimic regressed
normal and stalled forks, SMARCAL1 preferred to restore a “normal” fork compared to a
“stalled”  fork,  and  that  RPA strongly  stimulated  SMARCAL1  fork  restoration  on  a
regressed “normal” fork substrate (Fig. 1.10B). This suggests a cycle of regression and
restoration wherein SMARCAL1 may regress a stalled fork, repair occurs through some
mechanism that produces a “normal” regressed fork, which SMARCAL1 then restores
(Fig. 1.11 and Bétous et al. 2013). Such a mechanism is not unprecedented, as UvsW
can perform such activities in an in vitro T4 replication assay (Manosas et al. 2012).
Annealing Helicases and Replication
Human cells contain at least two annealing helicases: SMARCAL1 and ZRANB3
(Bansbach et al. 2010; Ciccia et al. 2009, 2012; Postow et al. 2009; Yuan et al. 2009,
2012; Yusufzai and Kadonaga 2008, 2010). Both of these are DNA-stimulated ATPases
that catalyze strand annealing and RPA displacement  in vitro. Cells depleted of either
enzyme have increased γH2AX foci, and mutations in SMARCAL1 are associated with
the human disease Schimke Immunoosseous Dysplasia (SIOD) (Bansbach et al. 2010;
Boerkoel et  al.  2002). The biological function of these proteins in the cell  remains a
mystery. However, annealing  helicase activity  is  highly  conserved,  as  the T4 phage
UvsW and E. coli RecG proteins perform similar in vitro activities.
The question remains, however, why more than one annealing helicase? While
these  enzymes  have  a  similar  biochemical  activity,  some  biochemical  and  genetic
evidence suggests that they have at least some distinct functions in cells. Depletion of
either protein alone results in γH2AX foci and sensitivity to replication stress. However,
simultaneous  depletion  of  both  proteins  results  in  further  sensitivity  to  camptothecin
(Ciccia et al. 2012). Genetically, this suggests that these proteins function in separate
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Figure 1.11 Model for SMARCAL1 function in repair of stalled replication forks. (i)
A leading strand DNA lesion stalls the replication fork. (ii)  RPA bound to the leading
strand stimulates SMARCAL1 fork regression activity. (iii)  SMARCAL1 further branch
migrates the initially regressed fork. (iv) DNA replication and/or repair can occur on the
regressed fork and exonuclease activity may digest the regressed lagging strand. (v)
SMARCAL1 branch migrates the replication fork until only the ssDNA overhang remains
(vi) RPA stimulates SMARCAL1 restoration of a regressed fork with the leading strand
overhang exposed. Figure is from (Bétous et al. 2013).
pathways. Unfortunately, due to the inherent limitations of siRNA, we cannot make a
definitive statement based on this evidence alone. 
SMARCAL1 and ZRANB3 also have distinct modes of recruitment. SMARCAL1
contains an RPA32 binding domain at the N-terminus of the protein which is required for
localization to replication foci and to complement the γH2AX phenotype (Bansbach et al.
2009). In contrast, ZRANB3 contains both a PIP box and an APIM motif, which interact
with PCNA, and its NZF domain interacts with ubiquitin  (Ciccia et al. 2012). As such,
ZRANB3 is  recruited  to  replication  foci  through  its  interaction  with  poly-ubiquitinated
PCNA.
One possibility is that ZRANB3 participates in template switching, which makes
sense  given  that  it  binds  to  poly-ubiquitinated  PCNA,  which  is  thought  to  regulate
template switching  (Motegi et al.  2008; Unk et al.  2010; Zeman and Cimprich 2012).
ZRANB3 can perform D-loop dissolution and branch migration in vitro, and depletion of
ZRANB3 leads to  increased sister  chromatid  exchanges (Ciccia  et  al.  2012).  These
activities suggest an anti-recombinase function for ZRANB3. One component of which
could  be  dissolving  template-switching  intermediates.  SMARCAL1  is  recruited  and
stimulated  by  RPA on  certain  substrates,  which  could  reflect  a  cellular  function  in
regressing and restoring damaged replication forks (Bétous et al. 2013).
Mechanism of Fork Remodeling
One important open question for these enzymes is the biochemical mechanism
by which they translocate on DNA to remodel substrates. Unfortunately, there is little
structural data on either SMARCAL1 or ZRANB3. However, structural studies of RecG in
complex with forked DNA are illustrative (Singleton et al. 2001). While this structure does
not show the contacts that the ATPase domain makes with the template DNA strands,
clearly the so-called wedge domain of RecG inserts into the fork junction. This suggests
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that RecG translocates along the parental duplex toward the fork junction and uses the
wedge domain to displace the nascent strands and produce annealing (Singleton et al.
2001). The DNA protection footprint of RecG indicates that RecG protects the template
duplex in the region near the junction (Tanaka and Masai 2006).
Rad54 is another member of the SWI/SNF family involved in D-loop migration
during HR. A structure of the ATPase domain of S. solfataricus Rad54 bound to dsDNA
shows that the ATPase A lobe of Rad54 binds to the 3' → 5' strand, while the ATPase B
lobe makes contacts with the opposite strand. The protein itself spans the minor groove.
Given the 3' → 5' translocase polarity of Rad54 and DNA binding activity of only the
ATPase A domain, Rad54 likely translocates along the 3' → 5' strand (Dürr et al. 2005).
NS3 is a herpes virus helicase of the SWI/SNF family. Crystal structures with
various ATP-analogues that mimic transition states allowed structural insight into how
these enzymes couple ATP hydrolysis to translocation. This study revealed that the NS3
ATPase A domain makes contact with the nucleic acid and that conformational changes
induced during the ATPase cycle shift one nucleotide from one binding site to another,
allowing the protein to move along the backbone (Gu and Rice 2010).
What is known for SMARCAL1 is that it has opposite substrate preferences to
RecG in the absence of RPA, and Rémy Bétous's footprinting studies demonstrated that
SMARCAL1 primarily protects the leading template strand immediately upstream of the
fork  junction  (Bétous  et  al.  2013).  This  suggests  that  SMARCAL1  may  bind  and
translocate along the leading template strand in the 5' → 3' direction. We hypothesize,
therefore, that SMARCAL1 would be more sensitive to lesions on the leading template
strand and tolerant of those on the lagging template strand. I will explore this hypothesis
in Chapter V.
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Crosstalk between ATR and SMARCAL1
ATR phosphorylates and regulates a number of replication stress proteins, and
Carol Bansbach determined that this includes SMARCAL1. She identified several ATR
consensus phosphorylation sites ([S/T]Q) in SMARCAL1 and found that S173, S652,
and  S919  are  damage-inducible.  SMARCAL1  purified  from  HU-treated  cells  is  less
active as an ATPase, and the phosphomimetic S652D mutant is less active in vitro and
is  less  able  to  produce  the  pan-nuclear  γH2AX  overexpression  phenotype  of
SMARCAL1 in cells (Couch et al. 2013). The link between SMARCAL1 and ATR will be
further explored in Chapter IV.
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CHAPTER II
MATERIALS AND METHODS
Antibodies (Western Blotting)
Antibody Sp. Dilution Company Cat. No. Notes
ATRIP 403 Rbt 1:3000 Cortez
ATRIP C Rbt 1:1000 Cortez
ATRIP N Rbt 1:1000 Cortez
BrdU Ms 1:1000 BD 555627
CAF1/p60 Rbt 1:2000 Bethyl A301-085A
CDK9 Rbt 1:1000 Cell Signaling C12F7
Chk1 (G-4) Ms 1:1000 Santa Cruz sc-8408
Chk1pS317 Rbt 1:1000 Cell Signaling 2344S
Chk2 Rbt 1:2000 Cortez
Chk2pT68 Rbt 1:1000 Cell Signaling 2661S
CtIP Rbt 1:500 Abcam ab70163
Cyclin K Rbt 1:500 Bethyl A301-939A-1 Not great
DNA-PK Ms 1:200 Santa Cruz SC-5282
DNA-PKpS2056 Rbt 1:2000 Abcam ab18192
DNA-PKpT2609 Ms 1:1000 Abcam ab18356
GAPDH Ms 1:50,000 Millipore MAB374
H1 (AE-4) Ms 1:200 Millipore 05-457 5% Milk, 
overnight
H2AX (non-phospho) Rbt 1:5000 Bethyl A300-082A
γH2AX (JBW301) Ms 1:1000 Millipore 05-636
H2B Rbt 1:5000 Abcam ab1790
H3 Rbt 1:5000 Abcam ab46765
H3 “pan acetyl” Rbt 1:2500 Millipore 06-599
H3K9me1 Rbt 1:2500 Millipore 07-450
H3K56ac Rbt 1:1000 Abcam ab76307
H4 Ms 1:5000 Abcam ab31830
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H4K5ac Rbt 1:1000 Abcam ab51997
H4K12ac Rbt 1:2000 Active Motif 39166
H4K20me1 Rbt 1:1000 Active Motif 39727
HA Ms 1:3000 Covance MMS-101P
HP1α Rbt 1:1000 Active Motif 39296 Didn't work
HP1β Goat 1:1000 Bethyl A300-019A Didn't work
Ku80 Rbt 1:1000 Abcam ab33242
MCM2 Ms 1:10,000 BD 39289
MDC1 Rbt 1:500 Bethyl
MDC1 Rbt 1:1000 From J. Chen MC879
MRE11 Ms 1:1000 Gene Tex GTX30294
MUS81 Ms 1:1000 Novus NBP1-00609
ORC2 Rbt 1:5000 BD 559266
PCNA Rbt 1:200 Santa Cruz SC-7907
RAD51 Ms 1:250 Abcam ab213
RAD51 (H-92) Rbt 1:200 Santa Cruz sc-8349
RPA32 Rbt 1:1000 Bethyl A300-244A
RPA32pS4S8 Rbt 1:1000 Bethyl A300-245A
RPA32pS33 Rbt 1:1000 Bethyl A300-246A
RPA70 Rbt 1:1000 Cell Signaling 2267
SLX4 Rbt 1:1000 Bethyl A302-269A-1
SMARCAL1 Rbt 1:5000 Bethyl A301-616A
SMARCAL1 909 Rbt 1:1000 Open
SMARCAL1 pS652 Rbt 1:1000 + 
1:500 
non-phospho 
peptide (5 
mg/mL stock)
Bethyl Preincubate 
antibody and 
peptide 1h; 
only works 
after IP
WRN Rbt 1:1000 Bethyl A300-239
ZRANB3 Rbt 1:1000 From J. Chen
Antibodies (Immunofluorescence)
Antibody Species Dilution Company Cat. No. Notes
53BP1 Rbt 1:500 Bethyl A300-272A
BrdU Ms 1:50 BD 555627 3% BSA-PBS, 
1h at 37°
“CldU” (BrdU) Rbt 1:100 Abcam ab6326
“IdU” (BrdU) Ms 1:100 BD 347580
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RAD51 (H-92) Rbt 1:500 Santa Cruz sc-8349 3% BSA + 
0.1% 
Tween-20 / 
PBS
RAD51 Rbt 1:400 Calbiochem PC130
γH2AX 
(JBW301)
Ms 1:10000 Millipore 05-636 5% BSA-PBS
γH2AX Rbt 1:9000 Cortez
ATR inhibitor
The  VE-821  ATR-selective  inhibitor  (Reaper  et  al.  2011) was  synthesized  by  the
Vanderbilt Institute for Chemical Biology Chemical Synthesis facility and used in most
experiments.  ATR  inhibition  in  Xenopus  extracts  was  achieved  with  64  μM
4-{4-[(3R)-3-methylmorpholin-4-yl]-6-[4-(methylsulfonyl)piperidin-4-yl]pyrimidin-2-yl}-1H-i
ndole  (Foote et al. 2010, Patent no. WO2010073034), synthesized by CheminPharma.
The minimum concentration needed to achieve a near-complete block of ATR-dependent
CHK1 phosphorylation was determined and used in all experiments. This concentration
did not inhibit ATM, DNA-PKcs, or mTOR kinases ((Reaper et al. 2011); data not shown).
Cell culture
Name Media Source Notes
U2OS DMEM + 7.5% FBS
RPE-hTERT DMEM/F12 + 10% 
FBS, 0.348% 
sodium bicarbonate, 
2mM L-glutamine
293T DMEM + 7.5% FBS
HCT116 McCoy's + 10% FBS
MUS81-/- HCT116 McCoy's 5A + 10% 
FBS
(Shimura et al. 
2008)
HLTF-/- and +/+ 
MEFs
DMEM + 15% FBS +
2mM L-glutamine + 
55μM 
(Motegi et al. 2008)
40
β-mercaptoethanol +
pen/strep
Werner syndrome 
cells (hTERT)
DMEM + 7.5% FBS 
+ pen/strep
(Oshima et al. 2002)
FANCM-/- HCT116 McCoy's + 7.5% 
FBS + pen/strep
(Wang et al. 2013b)
BSC40 DMEM + 7.5% FBS Ellen Fanning Monkey cells for 
permissive SV40 
infection
Clonogenic survival
U2OS cells were seeded onto 60-mm cell culture plates at 200–5000 cells per plate in
triplicate. The following day, cells were treated with drug,  washed, and released into
fresh growth medium for 10–14 days prior to staining with methylene blue.
Fiber labeling
The day before, split cells onto a 6 well plate so that they will be 60-70% confluent on
the day of the experiment (~200,000 RPE-hTERT cells per well). Label with 20 μM IdU
for 20 minutes, rinse twice with equilibrated HEPES buffered saline, treat with 2 mM HU
or 3 μM ATRi, then label with 100 μM CldU (Sigma) for 20 minutes. Harvest cells by
trypsinizing  in  300μL/well  trypsin  at  room temperature.  Resuspend  in  500μL media,
transfer  to  eppendorf  tube,  and  pellet  by  centrifuging  at  2000  rcf  for  2-3  minutes.
Aspirate and resuspend cells in ice cold PBS to about 1,000,000 cells/mL (200-300μL
typically). Dilute labeled cells 1:3 with non-labeled cells. Spot 2μL of cell suspension on
a microscope slide and add 10μL of spreading buffer (200 mM Tris-HCl, pH 7.4, 0.5%
SDS, 50 mM EDTA) to the cells on the slide for 6 minutes. Then, tilt the slides to 15
degrees to stretch the DNA fibers. (Note: mark in pencil where you deposited the cells.
You can put at least 2 spots on one slide, I typically do 3 slides per sample). Air dry for at
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least 40 minutes. Fix for 2 minutes in 3:1 methanol:acetic acid in coplin jars. Do this in
the hood. Air dry the lides in the hood for about 20 minutes. Slides can be stored up to 5
days at 4°. 
Denature the DNA with 2.5N HCl for 30 minutes in coplin jars. Rinse 3 times with
PBS in the coplin jars. Block for 1 hour with 10% goat serum in PBS + 0.1% Triton X-100
(Serum solution should be sterile filtered. Can be reused if you add sodium azide and
keep at  4°).  Stain  for  1  hour  with  rat  anti-CldU (Abcam, ab6326;  1:00 dilution)  and
mouse anti-IdU (Becton Dickinson,  347580;  1:100 dilution) diluted in  PBS containing
10% goat serum and 0.1% triton X-100. Do this by placing 200μL drops of antibody on
parafilm. Invert the slide and place atop, taking care to eliminate bubbles. Rinse 3 times
in PBS in a coplin jar. Stain with secondary antibodies (Alexa-594 goat anti-rat IgG and
Alexa-488 goat anti-mouse (Invitrogen); 1:350 dilutions). Rinse 3 times in PBS. Air dry,
dark. Mount whole slide coverslips with 110μL Prolong gold (no DAPI!). Dry overnight.
To find the spots with DNA, start with the 100X objective over the pencil marks.
Move over  to  the slide  area,  zoom out  fully, then focus on the speckles,  which are
typically in the same plane as the DNA. Search around for the DNA. Take at least 10
pictures per condition, really 5-10 pictures per drop, so that you have plenty. You can
only measure tracks that are straight and do not overlap. Measure at least 100 tracks
per condition. 
Fork regression assays
Fork regression assays were completed with 3nM of gel purified, labeled fork regression
DNA substrate  containing  a  leading  strand  gap  and  3nM  of  SMARCAL1  protein  in
reaction buffer (40mM Tris (pH=7.5),  100mM KCl, 5mM MgCl2,  100µg/ml BSA, 2mM
ATP and 2mM DTT). Reactions were terminated by the addition of 3X stop buffer (0.9%
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SDS, 50mM EDTA, 40% glycerol, 0.1% bromophenol blue, and 0.1% xylene cyanol).
Samples were separated on 8% polyacrylamide (19:1) 1X TBE gels. The gels were dried
and quantified using a Molecular Imager FX (Bio Rad). Sequences of olignoucleotides
used to make substrates are listed in Tables 4.1 and 5.1.
Flow Cytometry
Seed ~300,000 cells in a 6-well dish the previous day. Label cells for 40 minutes with
10μM BrdU. Trypsinize and collect. Spin for 5 minutes at 1000rpm to pellet. Transfer to a
1.5mL microcentrifuge tube with cold PBS. Spin 5 minutes at 300 rcf. Resuspend in 1mL
cold 70% ethanol. Leave on ice 60 minutes or at -20° indefinitely. Spin 5 minutes at 1800
rcf. Aspirate supernatant. Add 1mL 0.5% BSA/PBS (BSA needs to be in all the washes
from now on  or  the  ethanol  fixed  cells  will  not  pellet  and  resuspend  properly)  and
resuspend. Spin 5 minutes at 1800 rcf. Aspirate supernatant. Add 1mL 2N HCl + 0.5%
Triton X-100 in PBS. Incubate 30 minutes at room temperature. Spin and aspirate (5
minutes  at  1800  rcf  from  now  on).  Add  1mL  0.1M  sodium  borate  and  resuspend.
Incubate  2  minutes.  Spin  and  aspirate.  Wash  with  1mL 0.5%  BSA/PBS.  Spin  and
aspirate.  Add  100μL  BrdU  antibody  solution  (1:50  Alexa-488  conjugated  mouse
anti-BrdU [MoBu-1]  in  0.5% BSA/PBS  +  0.5% Tween-20).  Resuspend.  Incubate  30
minutes  at  room temperature  in  the  dark.  Spin  and  aspirate.  Wash with  1mL 0.5%
BSA/PBS. Spin and aspirate.  Resuspend in 0.5-1mL of  PBS with 5μg/mL propidium
iodide and 1:200 RNAse A from Sigma. Incubate 2 hours at 37° or overnight at room
temperature,  dark.  Pass  through  fine  nylon  mesh  (Sefar  Nitex  90μm  mesh).  If  not
staining BrdU, after wash following 70% ethanol fixation, resuspend in PBS containing
25μg/ml propidium iodide and 1:200 RNAse A. Pro tip: use P1000 with a yellow tip on
top of the blue tip to aspirate, this gives greater control so that you don't aspirate your
pellets. Also, when resuspending, always rake the tubes across a test tube rack before
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adding the next solution to break up the pellet. Also, getting good separation of your
BrdU positive  and  negative  cells  requires  some  finagling  with  the  FL1  voltage  and
compensation settings. It's also probably a good idea to optimize the amount of antibody
for your specific cell line/numbers.
In vitro kinase assay
GST-S652 protein contains amino acids 645-661 of SMARCAL1 inserted into pBG101.
GST-His’ protein is produced from the pBG101 vector without insertion of SMARCAL1
amino  acids.  It  is  larger  than  GST-S652  since  there  is  no  stop  codon  to  prevent
translation  through  the  polylinker.  Both  proteins  were  purified  from  E.  coli using
glutathione  sepharose.  Kinase  reactions  were  performed  with  hyperactive
ATR(S1333A)-ATRIP purified from human cells and incubated with the TOPBP1 AAD
protein as previously described (Mordes et al. 2008). 
Isolation of Proteins on Nascent DNA (iPOND)
The iPOND procedure was carried out as described previously (Sirbu et al. 2011, 2012): 
EdU-labeled  sample  preparation:  HEK  293T  cells  (approximately  1.5  x  108)
cells/sample  –  3-4  15cm  dishes)  were  incubated  with  10-12   M  EdU  (Vanderbilt
Synthesis Core). For pulse chase experiments with thymidine (Sigma), EdU-labeled cells
were  washed  once  with  temperature  and  pH-equilibrated  media  containing  10   M
thymidine to remove the EdU, then chased into 10   M  thymidine. Other chemicals were
added  to  the  cell  cultures  at  the  following  concentrations:  HU (Sigma,  3mM),  HAT
inhibitor anacardic acid (Enzo, 30   M), HDAC inhibitor FK228 (kindly provided by Dineo
Khabele,  100nM),  Mre11  inhibitor  Mirin  (Sigma,  100   M),  ATM  inhibitor  (KU55933,
10   M,  AstraZeneca),  DNA-PK inhibitor  (KU57788, 1   M,  AstraZeneca),  caffeine (ICN
Biomedicals,  10mM), AZ20 ATR inhibitor  (3   M,  AstraZeneca),  ATR inhibitor  (VE821,
5   M, Reaper et al. 2011). DMSO was used as a vehicle control where appropriate.
44
After labeling, cells were crosslinked in 1% formaldehyde/PBS for 20 min (10
minutes works fine) at room temperature, quenched using 0.125M glycine, and washed
three times in PBS. Collected cell  pellets were frozen at -80°C, then resuspended in
0.25% Triton X/PBS to permeabilize. Pellets were washed once with 0.5% BSA/PBS and
once with PBS prior to the click reaction.
Cells were incubated in click reaction buffer for 1-2h at a concentration of 2 x 107
cells/ml of click reaction buffer (2h is better when using these reagents instead of the
Invitrogen kit). The click reaction buffer is PBS containing 2mg/mL sodium ascorbate, 2
mM copper (II) sulfate (CuSO4), and 1   M  photocleavable biotin-azide (Kim et al. 2009)
(kindly  provided  by  Ned  Porter).  DMSO  was  added  instead  of  biotin-azide  to  the
negative control samples (no clk in all figures). Cell pellets were washed once with 0.5%
BSA/PBS and once with PBS.
Cells were then resuspended in lysis buffer containing 1% SDS, 50mM Tris (pH
8.0),  1  g/mL  leupeptin  and  1  g/mL  aprotinin.  Samples  were  sonicated  (Micro-tip,
Misonix 4000) using the following settings: 13-16 Watts (~30% amplitude), 20 s constant
pulse, 40-59 sec pause for a total of 4-5 min. (Note: this is the official protocol. What I
actually do is two 40 second pulses, and rotate through each sample so that I don't have
any down time. I wipe off the tip between each sample). Samples were centrifuged at
13,200rpm for 10 min, filtered through a 90 micron nylon mesh, and diluted 1:1 (v/v) with
PBS containing 1  g/mL leupeptin and 1  g/mL aprotinin prior to purification.
Streptavidin-agarose beads (Novagen) were washed 1:1 (v/v) two times in lysis
buffer and one time in PBS (The protocol calls for 100   L  beads per 10 million cells. I use
about  one-fourth  of  that  with good results).  Washed beads were incubated with  the
samples at 4°C in the dark for 14-20 hours (Huzefa Dungrawala showed that 1h at room
temperature also works well). The beads were washed one time with lysis buffer, once
with 1M NaCl, then twice with lysis buffer. Captured proteins were eluted and crosslinks
reversed in SDS sample buffer (add 1:1 to the beads) by incubating for 25 min at 95°C.
Collect lysate by poking a hole in the bottom of the tube with a hypodermic needle, then
45
spin at low speed into another tube (you recover ~1.5x volume this way). Proteins were
resolved on SDS-PAGE and detected by immunoblotting. In most cases, quantitative
immunoblotting was performed using the Odyssey infrared imaging system.
Native iPOND
Native iPOND is performed the same as normal iPOND with the following modifications:
samples are lysed with in Cell Lysis buffer (10mM Tris [pH 8.0], 2mM MgCl2, 1% NP-40)
and vortexing 5 times for 5 seconds with 5 seconds between pulses. Nuclei are then
collected by centrifugation at 100 rcf for 5 minutes at 4°. The nuclei are washed twice in
5mL Cell Lysis buffer without NP-40 and resuspended in ice cold Nuclei buffer (15mM
Tris  [pH 8],  0.125M Sucrose,  15mM NaCl,  40mM KCl,  0.5mM Spermidine,  0.15mM
Spermine) at 2,500,000 cells/mL then added to Click reactions (formula is the same).
After Click reactions, nuclei are again collected by centrifugation at 100 rcf for 5 minutes
at 4° and resuspended at 2,000,000 cells/mL. Add EDTA to 1mM and CaCl2 to 2mM.
Warm to 37° in a water bath and add Micrococcal Nuclease (NEB) to 20 Kurntz units per
1,000,000 cells. Incubate at 37° for 3.5 minutes. Add EDTA to 2mM to quench reactions.
Collect by centrifugation. Extract chromatin by resuspending nuclei in ice cold Extraction
Buffer  (1X  PBS  containing  350mM  NacL,  2mM  EDTA,  and  0.1%  Triton  X-100)  at
5,000,000 cells per 3mL. Rock for 2h to overnight at 4°. Centrifuge at 16,000 rcf for 5
minutes at 4° to remove insoluble material. Wash and add 20   L  Streptavidin Agarose
beads (Novagen).  Pulldown is the same as the normal iPOND – incubate overnight,
wash the beads, and elute by boiling in 2X sample buffer.
Neutral COMET assay
The neutral  COMET assays  were performed in  accordance  with  the  manufacturer’s
(Trevigen) instructions:
The day before, plate 150,000 U2OS cells/well in 6-well dishes. Make sure to
plate cells for 30 minutes of 1μM CPT and untreated as positive and negative controls,
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respectively.  Treat  cells  as  necessary  then  harvest  by  trypsinization,  pellet,  and
resuspend at 200,000 cells/mL in cold PBS. Pre-warm low melting temperature agarose
(LM Agarose, Trevigen) on 95° heat block until thawed, then place in 42° water bath. Mix
10μL cells + 100μL agarose, pipette 50μL into one well of  a Trevigen COMET slide.
Spread around to make sure agarose is completely covering the well using the pipette
tip. Plate 2 wells per condition. Allow to polymerize for 20 minutes at 4°. Immerse slides
in  pre-chilled  lysis  buffer  (Trevigen)  at  4°  for  1  hour.  Wash  by  immersion  in  50mL
pre-chilled TAE for 30 minutes at 4°. Place in large horizontal electrophoresis tank and
fill with TAE until buffer is at least 0.5cm above the slides. Electrophorese for 1 hour at 1
V/cm (20V) at 4°. Rinse with deionized water. Immerse in DNA precipitation solution (1M
ammonium acetate in  ethanol;  this  stuff  is  quite pungent,  use it  in  the hood)  for  30
minutes  at  room  temperature.  Immerse  in  70%  ethanol  for  30  minutes  at  room
temperature. Dry at 45° for 10-15 minutes in the hybridization oven. Store overnight if
desired before staining.  Stain with 100μL SYBR Green for 30 minutes. Remove and
allow to dry for 30 minutes. View the slides with the 10X objective on our Zeiss scope
and take pictures. I usually try for ~5 cells per picture, 20 pictures per well so that you
can measure at  least  100 cells per condition with CometScore software (look in  my
folder on our backup drive to find the free version).
Plasmid constructs
POLE2-HA  and  POLE3-HA  retroviral  vectors  were  generated  by  gateway  cloning.
pENTR  POLE2  and  pENTR  POLE3  were  recombined  with  pLPCX-GW-HA3X
(pDC1127) to generate a C-terminal HA-tagged POLE2 and POLE3 retroviral vectors.
pDC1127 was created by subcloning a 3XHA epitope into pLPCX between the Not1 and
Cla1  restriction  sites,  then  subcloning  the  gateway  cassette  containing  attR1,  ccdB
gene, and attR2 as an EcoRV fragment between EcoR1 and Not1 sites.
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Preparation of Fork Regression Substrates
Oligo labeling: I usually label the lagging nascent strand (LagN42 in this case). Each
10μL labeling reaction should contain 10μM oligo, 1x T4 polynucleotide kinase buffer,
0.5μL T4 PNK, 0.5μL-2μL γ-[32P]-ATP. Incubate for 1 hour at 37°, then purify on a G25
column (GE). To use the G25 columns, mix the resin well before opening and removing
the cap. Spin at 2,800 rpm in an Eppendorf tabletop centrifuge for 1 minute. Add up to
50μL of sample. Spin another 2 minutes at 2,800 rpm.
Annealing forks: Anneal each arm of the replication fork separately. In 20μL total,
mix 7μL of LagP62 at 10μM with 9μL LagN42* (labeled) in 1x SSC. Separately, in 20μL
total, mix 7μL LeadP62 at 20μM and 7μL LeadN42 at 20μM, also in 1X SSC. Also create
the product at this step: 2.5μL LagN42* and 7.5μL LeadN42 at 5μM in 1X SSC. Use the
RBanneal PCR program to anneal these (RBanneal is designed to prevent secondary
structure formation; see program below). Next, add 20μL of the leading strand and 20μL
of the lagging strand to 4.5μL of  10X annealing buffer  (400mM Tris [pH 7.5],  50mM
MgCl2, 20mM DTT, 1mg/mL BSA, 200mM KCl). Incubate 20-30 minutes on a 37° heat
block. Turn off the heat block at the beginning of the incubation. It will cool to about 30°
by the end of the incubation.
Gel purification: Add 6x loading dye to the annealed substrate and load into 2
wells of a pre run 5% acrylamide (37.5:1) 0.25X TBE gel (pre-run 100V, 60 minutes).
Run for 60 minutes at 100V. Place gel in saran wrap, expose to film for 1 minute, and cut
out the band. Place in 3500 MWCO dialysis bag with 1mL 0.25X TBE. Electroelute in
ethidium bromide-free gel box in 0.25X TBE for 80 minutes at 80V. Massage the bag and
transfer the liquid to 1.5mL eppendorf tubes. Concentrate using Amicon Ultra 4 (10,000
MWCO) columns (add 0.5mL, spin for 5 minutes at 14,000 rcf, discard flowthrough and
repeat until only ~50μL remain, invert column in fresh collection tube and spin 2 minutes
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at 1,000 rcf). Then G25 column purify and add Tris pH 7.5 to 40mM and MgCl2 to 5mM.
Aliquot and store at -80°.
Preparation of Fork Restoration Substrates
This is similar to preparation of fork regression substrates except that the first annealing
mixture should contain RD62-P, RG62-P, and ResG30. After RBanneal, add RD62-N2.6
and anneal in annealing buffer before gel purification. Note: this is the lagging gap fork
restoration substrate. Use ResD30 and RG62-N2.6 for the leading gap fork restoration
substrate.
Pan-nuclear γH2AX immunofluorescent assay
U2OS  cells  were  transfected  with  GFP-SMARCAL1  encoding  vectors  (pLEGFP-C1,
Clontech)  using Fugene HD (Promega)  according to the manufacturer’s  instructions.
Twenty-four hours after transfection the cells were seeded into 96-well CellCarrier plates
(Perkin Elmer).  Forty-eight  hours after  transfection the cells  were washed once with
PBS, fixed with 3% paraformaldehyde solution and permeabilized with 0.5% triton X-100
for 10 minutes at 4 degrees. Fixed cells were then incubated with mouse anti-γH2AX
antibody followed by Cy5-conjugated secondary antibody. After washing, the cells were
incubated with DAPI then imaged on an Opera automated confocal microscope (Perkin
Elmer) using a 20X water immersion objective. Columbus software (Perkin Elmer) was
used to define nuclei and calculate the mean intensity per nucleus for GFP and γH2AX. 
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RBanneal PCR Program
1. 95° for 30 seconds.
2. 95° (-3° per cycle) for 40 seconds.
3. 97° (-3° per cycle) for 40 seconds.
4. 96° (-3° per cycle) for 40 seconds.
5. GOTO 2, 24X. (25 total cycles).
6. 12° forever.
RIPA Lysis for Western Blot
Resuspend cells in RIPA buffer (50mM Tris [pH 8.0], 150mM NaCl, 0.1% SDS, 0.5%
sodium deoxycholate, 1% Triton X-100, 1mM DTT, 1μg/mL aprotinin, 1μg/mL leupeptin)
about 2:1 v/v. Incubate 30 minutes, then pellet at 16,000 rcf for 5 minutes to remove
insoluble material. Move supernatant to a new tube, quantitate protein by Biorad DC
protein assay. Separate proteins by SDS-PAGE and detect by Western blot.
ssDNA immunofluorescent assays
To detect parental-strand ssDNA, the cells were labeled for 20 hours with 10 μM BrdU
then released into fresh growth media for 2 hours prior to addition of drugs. To detect
nascent-strand  ssDNA,  the  cells  were  labeled  for  10  minutes  with  10  μM  BrdU
immediately prior to addition of drugs. 3mM HU was added with 5 μM ATRi. Next, the
cells were washed once with PBS, permeabilized with 0.5% triton X-100 for 10 minutes
at 4 degrees, fixed with 3% paraformaldehyde/2% sucrose solution for 10 minutes, and
blocked for 15 minutes in 3% BSA-PBS. Fixed cells were then incubated with mouse
anti-BrdU  antibody  (BD  Pharmingen)  for  60  minutes  at  37  degrees  followed  by
Alexa-488  goat  anti-mouse  (Invitrogen)  secondary  antibody.  Images  were  collected
using a Zeiss camera at a constant exposure time and quantitated with Cell  Profiler
(http://www.cellprofiler.org).
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CellProfiler Pipeline: 
1. LoadImages:
File type to be loaded:individual images 
File selection method:Text-Exact match 
Number of images in each group?:3 
Type the text that the excluded images have in common:GFP+DAPI 
Analyze all subfolders within the selected folder?:None 
Input image file location:Default Input Folder\x7C. 
Check image sets for missing or duplicate files?:No 
Group images by metadata?:No 
Exclude certain files?:Yes 
Specify metadata fields to group by: 
Select subfolders to analyze: 
Image count:2 
Text that these images have in common (case-sensitive):DAPI 
Position of this image in each group:hoe 
Extract metadata from where?:None 
Regular expression that finds metadata in the file name:None 
Type the regular expression that finds metadata in the subfolder
path:None 
Channel count:1 
Group the movie frames?:No 
Grouping method:Interleaved 
Number of channels per group:2 
Load the input as images or objects?:Images 
Name this loaded image:OrigBlue 
Name this loaded object:Nuclei 
Retain outlines of loaded objects?:No 
Name the outline image:NucleiOutlines 
Channel number:1 
Rescale intensities?:Yes 
Text that these images have in common (case-sensitive):GFP 
Position of this image in each group:h2ax 
Extract metadata from where?:None 
Regular expression that finds metadata in the file name:None 
Type the regular expression that finds metadata in the subfolder
path:None 
Channel count:1 
Group the movie frames?:No 
Grouping method:Interleaved 
Number of channels per group:2 
Load the input as images or objects?:Images 
Name this loaded image:OrigGreen 
Name this loaded object:Nuclei 
Retain outlines of loaded objects?:No 
Name the outline image:NucleiOutlines 
Channel number:1 
Rescale intensities?:Yes
2. IdentifyPrimaryObjects:
Select the input image:OrigBlue 
Name the primary objects to be identified:Nuclei 
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Typical diameter of objects, in pixel units (Min,Max):60,150 
Discard objects outside the diameter range?:Yes 
Try to merge too small objects with nearby larger objects?:No 
Discard objects touching the border of the image?:Yes 
Select the thresholding method:Otsu PerObject 
Threshold correction factor:1 
Lower and upper bounds on threshold:0.0,1.0 
Approximate fraction of image covered by objects?:10% 
Method to distinguish clumped objects:Intensity 
Method to draw dividing lines between clumped objects:Intensity 
Size of smoothing filter:10 
Suppress local maxima that are closer than this minimum allowed
distance:5 
Speed up by using lower-resolution image to find local maxima?:Yes
Name the outline image:None 
Fill holes in identified objects?:Yes 
Automatically calculate size of smoothing filter?:Yes 
Automatically  calculate  minimum  allowed  distance  between  local
maxima?:Yes 
Manual threshold:0.0 
Select binary image:Otsu Global 
Retain outlines of the identified objects?:No 
Automatically calculate the threshold using the Otsu method?:Yes 
Enter Laplacian of Gaussian threshold:.5 
Two-class or three-class thresholding?:Two classes 
Minimize the weighted variance or the entropy?:Weighted variance 
Assign pixels in the middle intensity class to the foreground or
the background?:Foreground 
Automatically calculate the size of objects for the Laplacian of
Gaussian filter?:Yes 
Enter LoG filter diameter:5 
Handling  of  objects  if  excessive  number  of  objects
identified:Continue 
Maximum number of objects:500 
Select the measurement to threshold with:None
3. MeasureObjectIntensity:
Hidden:2 
Select an image to measure:OrigBlue 
Select an image to measure:OrigGreen 
Select objects to measure:Nuclei
4. ExportToSpreadsheet:
Select or enter the column delimiter:Comma (",") 
Prepend the output file name to the data file names?:Yes 
Add image metadata columns to your object data file?:No 
Limit output to a size that is allowed in Excel?:No 
Select the columns of measurements to export?:Yes 
Calculate the per-image mean values for object measurements?:Yes 
Calculate the per-image median values for object 
measurements?:Yes 
Calculate the per-image standard deviation values for object 
measurements?:Yes 
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Output file location:Default Output Folder\x7C. 
Create a GenePattern GCT file?:No 
Select source of sample row name:Metadata 
Select the image to use as the identifier:None 
Select the metadata to use as the identifier:None 
Export all measurements, using default file names?:No 
Press button to select measurements to 
export:Image\x7CCount_Nuclei,Image\x7CFileName_OrigGreen,Image\
x7CFileName_OrigBlue,Nuclei\x7CIntensity_MeanIntensity_OrigGree
n,Nuclei\x7CIntensity_MeanIntensity_OrigBlue,Nuclei\x7CIntensit
y_IntegratedIntensity_OrigGreen,Nuclei\x7CIntensity_IntegratedI
ntensity_OrigBlue,Nuclei\x7CLocation_Center_Y,Nuclei\x7CLocatio
n_Center_X,Nuclei\x7CNumber_Object_Number 
Data to export:Image 
Combine these object measurements with those of the previous 
object?:No 
File name:Image.csv 
Use the object name for the file name?:No 
Data to export:Nuclei 
Combine these object measurements with those of the previous 
object?:No 
File name:Nuclei.csv 
Use the object name for the file name?:No
SMARCAL1 Overexpression ssDNA Assay
Transfect  cells  with  SMARCAL1  cDNA  as  in  the  pan-nuclear  γH2AX
immunofluorescence assay. 24 hours after transfection, add 10μM BrdU. Harvest and
process for ssDNA detection 48 hours after transfection.
SMARCAL1 ATPase assay
ATPase  assays  were  performed  as  described  previously  with  a  splayed  arm  DNA
substrate  (Bétous et al. 2012). Make ATPase buffer (20mM HEPES [pH 7.6], 100mM
KCl,  5mM MgCl2,  3% glycerol,  0.25mg/mL BSA,  0.05M EDTA,  0.5mM DTT, 0.01%
NP-40).  Each ATPase reaction should contain 0.24μL γ-[32P]-ATP, 100nM cold ATP,
SMARCAL1  (around  8nM),  splayed  arm  substrate  (RBanneal  [see  program  above]
GTCGCTGCCCTAATCTGGCTTGCTAGGACATCTTTGCCGAGGTAGACCCG  and
CGGGTCTACCTCGGCAAAGATGTCCTAGCAATGTAATCGTCTATGTCGTG) and buffer
up to 10μL total. Incubate at 30° for 1 hour, place on ice, then spot 1μL on a TLC plate.
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Migrate 45 minutes with 1M formic acid/0.5M LiCl buffer in equilibrated chromatography
tank. Dry overnight, then expose to a K-screen and quantitate on the Phosphorimager.
SMARCAL1 purification
Flag-SMARCAL1 was purified from HEK293T cells  following transient  transfection or
from insect cells after baculovirus infection as described previously (Bétous et al. 2012).
Insect cell purification: Thaw pellets on ice for 1 hour. While thawing, prepare
lysis buffer (20mM Tris [pH 7.5],  150mM NaCl, 0.1mM EDTA, 0.2mM PMSF, 1μg/mL
aprotinin, 1μg/mL leupeptin, 0.1% Triton X-100) and add 20 mL to each pellet. Once
thawed, pipette up and down to resuspend the pellets. Transfer to high speed centrifuge
tubes (ensure the weight of each is within 10% of one another). Centrifuge 25000 rcf for
10 minutes at 4°. Decant supernatant into another centrifuge tube. Centrifuge 25000 rcf
for 10 minutes at 4°. Decant supernatant into a 50mL conical (“cleared lysate”). Wash
250μL anti-FLAG M2 beads (Sigma; use the red ones so you can see them) with lysis
buffer twice. Add the beads to the cleared lysate and incubate on the rotator in the cold
room for at least 2 hours. Centrifuge at 1200 rcf for 1 minute at 4° to pellet the beads.
Transfer the beads to a microcentrifuge tube. Wash once with lysis buffer, once with
0.1M KCl solution (10mM HEPES [pH 7.6], 100mM Kcl, 20% Glycerol, 0.2mM EDTA,
0.01% NP40, 1mM DTT, 0.2mM PMSF, 1.5mM MgCl2), once with 0.1M KCl solution +
0.5M LiCl, and twice more with 0.1M KCl solution. After washes, elute with 250μg/mL
FLAG peptide in 0.1M KCl solution by rotating 15 minutes in the cold room (probably just
do  2x  200μL elutions).  Centrifuge  eluates  at  1200  rcf  for  1  minute  to  remove  any
remaining  beads.  Use  a  gradient  gel  to  check  that  you  got  protein.  If  desired,
concentrate and rinse on a 50,000Da MWCO concentrating column. Aliquot and flash
freeze. Store at -80°.
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Flag-SMARCAL1 from HEK293T: Harvest 2 15cm dishes per condition. Rinse
cell pellet with PBS, then lyse in 2mL NETN buffer (100mM NaCl, 20mM Tris [pH 8],
0.5mM EDTA, 0.5% NP-40, 1mM DTT, 10mM Sodium Fluoride, 0.2mM PMSF, 25mM
β-glycerophosphate, 1μg/mL aprotinin, 1μg/mL leupeptin). Centrifuge at 16,000 rcf for 15
minutes at 4°. Immunoprecipitate 16μg protein with 30μL anti-FLAG M2 beads (Sigma)
equilibrated with NETN. Incubate 3 hours at 4° on rotator. Wash 3 times with NETN
buffer, once with NETN buffer + 0.5M LiCl, and twice with SMARCAL1 buffer  (20mM
HEPES [pH 7.6], 20% glycerol, 100mM KCl, 1.5mM MgCl2, 1mM DTT, 0.2mM EDTA,
0.2mM  PMSF, 0.01%  NP-40).  Elute  in  30μL  SMARCAL1  buffer  +  300μg/mL FLAG
peptide  for  1  hour  on  ice.  Endogenous  SMARCAL1  was  purified  using  the  same
procedure with SMARCAL1 909 antibody and Protein A beads.
Transfections
siRNA  transfections  were  performed  using  either  RNAiMax  (Invitrogen),  HiPerfect
(Qiagen) or Dharmafect 1 (Dharmacon) at a final siRNA concentration of 10 μM. siRNAs
were purchased from Dharmacon or Ambion.
RNAiMax
• W/S cells: 3.2μL lipid for 210,000 cells.
• U2OS cells: 4.8μL lipid for 210,000 cells.
• RPE cells: 3.2μL lipid for 128,000 cells.
HiPerfect
• U2OS cells: 12μL lipid for 300,000 cells.
Dharmafect 1
• U2OS cells: 3.2μL lipid for 127,500 cells.
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Xenopus cell free replication experiments
Xenopus low  speed  extract  was  prepared  as  described  (Lebofsky  et  al.  2009).
Immunodepletion of xSMARCAL1 was carried out by incubation of serum with Protein
A-Sepharose Fast Flow beads (GE Healthcare) at a 1:1 ratio for 1.5 h at 4°C, and the
resulting beads were mixed with extract at a 3:1 extract/bead ratio for 1 h at 4°C. 10
mg/ml  rabbit  IgG  (Sigma-Aldrich)  was  incubated  with  Protein  A-beads  for  mock
depletions at a 1:10 ratio. For nuclei spindowns, extracts (20 μl) were transferred to 1 ml
dilution buffer (30% glycerol, 150 mM KCl, 0.5% Triton X-100, 80 mM PIPES pH 6.8, 1
mM MgCl2, 1 mM EGTA) and 1 ml of fixation buffer (30% glycerol, 0.5% Triton X-100, 80
mM PIPES pH 6.8,  1 mM MgCl2,  1  mM EGTA, 4% formaldehyde)  was added.  The
resulting 2 mL was then layered on top of a glycerol  cushion (40% glycerol,  80 mM
PIPES pH 6.8, 1 mM MgCl2, 1 mM EGTA) and spun at 3500 rpm for 15 min in a JS-4.2
rotor.  Nuclei  were  washed  with  TBS and  blocked  in  TBS+1% BSA overnight.  BrdU
antibody (Santa Cruz, IIB5) was added for 5 h, followed by alexa-594 goat anti-mouse
(Invitrogen). Mean BrdU signal intensity was quantitated using ImageJ.
Extra Methods
[3H]Thymidine Incorporation Assay
Adapted from  (Coward et  al.  1998).  Plate about  500,000 cells  in  a 12-well  dish the
previous day. Add 10μL of 0.1μCi/μL [3H]Thymidine in PBS (1 μCi/mL final) to the media.
Incubate for at least 10 minutes. Carefully remove the media with 1mL pipette. Wash
with 1mL PBS. Aspirate. Add 1mL ice cold 5% Trichloroacetic acid. Place at 4° or on ice
for  30  minutes.  (Note:  It's  okay  to  leave  cells  at  37°  in  the  incubator  if  you  aren't
harvesting all the wells at the same time). Remove the TCA and wash with 1mL PBS.
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Add 500μL freshly prepared 0.5N NaOH/0.5% SDS at room temperature. Pipette up and
down  and  add  to  scintillation  vials.  Add  3mL EcoScint  fluid.  Shake  vigorously  until
phases are mixed (not cloudy). Allow to sit a few hours or overnight before counting. I
used the scintillation counter in the Wagner lab. Note: make sure to keep blue pads
under everything while you're working. You can't detect [3H] with a Geiger counter, so
this will prevent you from accidentally spreading it everywhere.
BrdU Dot-Blot
Cut two pieces of Whatman paper to the size of the dot-blot manifold. Cut one piece of
Nytran membrane to the same size. Pour 6x SSC to a depth of 0.5cm and place the
Nytran membrane on top. Allow it  to sit  for 10 minutes before submerging. Wet one
piece of Whatman paper with 6x SSC and place on the manifold. Place the membrane
on top of the Whatman paper. Adjust all samples to 200-400μL in 6x SSC using 20x SSC
and deionized water. (Note: I usually load 150-200ng of DNA). Apply 500μL 6x SSC to
all wells of the manifold. Apply vacuum such that it takes about 5 minutes for the liquid to
be sucked through. Apply the samples. Remove membrane from the manifold and dry on
a  fresh  piece  of  Whatman  paper  overnight.  Crosslink  using  on  the  Stratalinker
auto-crosslink setting (120,000 μJ) with 265nm light. Block for 30 minutes with 5% milk
in TBST. Incubate on the rocker in 1% milk/TBST containing 1:1000 mouse anti-BrdU
from BD for 1 hour. Wash four times with TBST. Incubate on the rocker in 1% milk/TBST
containing the Licor anti-mouse 800 secondary at 1:10,000 for 1 hour. Wash four times
with TBST. Then rinse with TBS. Scan on the Odyssey scanner.
Chromatin Fractionation
Adapted from: (Wysocka et al. 2001). Harvest 10,000,000-20,000,000 cells using a cell
scraper. Spin down at 300 rcf for 2 minutes. Wash pellet with PBS, spin again at 300 rcf
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for 2 minutes. Repeat wash. Resuspend cell pellet in 200μL Buffer A (10mM HEPES [pH
7.9],  10mM KCl,  1.5mM MgCl2,  0.34M sucrose,  10% glycerol,  1mM DTT, protease
inhibitors).  Add Triton  X-100  to  a  final  concentration  of  0.1%.  Incubate  on ice  for  8
minutes. Centrifuge at 1,300 rcf for 5 minutes at 4°. Separate supernatant (fraction S1)
from pellet  (nuclei;  P1).  Clarify  S1  by  high  speed  centrifugation  at  20,000  rcf  for  5
minutes at 4° (I usually just do 16,000 rcf). Separate the supernatant (fraction S2) and
discard the pellet. Wash P1 once with Buffer A and lyse for 30 minutes in 100μL Buffer B
(3mM EDTA, 0.2mM EGTA, 1mM DTT, protease inhibitors). Centrifuge at 1,700 rcf for 5
minutes at 4°. Separate supernatant (S3) from pellet (chromatin; P3). Wash P3 once
with  Buffer  B  and  resuspend  in  SDS  sample  buffer,  boil  for  10  minutes.  Separate
proteins by SDS-PAGE and analyze by Western blot.
Plasmid-based Fork Regression Substrate Preparation
Prepare pG46 and pG68 plasmid DNAs. Digest 150μg of pG46 with Nt.BbvCI and 150μg
of pG68 with Nb.BbvCI (use 50μg DNA and 25μL enzyme in 500μL reactions). Incubate
for 1 hour at 37° then add 2μL calf intestinal phosphatase to the pG46 reactions for 20
minutes at 37°. Heat at 80° for 10 minutes then immediately add buffer PBI (from Qiagen
kit). Purify each reaction (3 each) on a Qiagen PCR purification kit and calculate the
molar concentration (1μg of each is 0.57pmol). Digest 2uL of pG46/pG68 products with
1μL SpeI to check gap (SpeI will not cleave gapped plasmid). Digest pG68 product with
XhoI (10μL in each of 2 reactions) for 1 hour at 37° then use Qiagen PCR kit again –
elute each reaction in 30μL. Ensure linearity on agarose gel. Label pG46 product with
γ-[32P]-ATP (use 12μL [32P]ATP and 4μL T4 polynucleotide kinase) for 2 hours at 37°.
Purify on G25 columns (GE). Prepare 10x annealing buffer (500mM Tris-HCl [pH 7.5],
100mM MgCl2, 50mM DTT). Anneal labeled pG46 product and XhoI-digested pG68 in
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1X  annealing  buffer:  30  seconds  at  80°  then  20  minute  cooldown  to  53°  in  the
hybridization oven. Turn the oven off and allow to cool for 20 minutes. Store at -80°.
Thaw the annealed substrate,  add 6x loading dye (7.5% ficoll,  15% glycerol,
xylene cyanol, bromophenol blue). Prepare 0.6% agarose gel in 0.25X TBE (22mM Tris,
22mM Boric acid, 500μM EDTA). Load ~45μL per well (about 14 wells total). Run until
the dye bands are well separated. Expose to film, then excise the band and place in two
dialysis bags (3500 MWCO) with 3mL 0.25X TBE each. Electroelute in 0.25X TBE for
60-70 minutes at 90V. Massage the bag then add Tris (pH 7.5) to 10mM. Transfer to (4)
1.5mL tubes and add 1μL MgCl2 to each. Speedvac (2.0 mmHg, no heat) until about
50μL remains in each tube (about 200μL total). Split  into 10μL aliquots and freeze at
-80°.
To quantitate the substrate, pour a 5% acrylamide (37.5:1) gel in 1X TBE (89mM
Tris, 89mM Boric acid, 2mM EDTA). Load 2uL of 1.185-15nM dilution series of labelled
pG46 and 2uL of substrate. Run at 100V for 90 minutes. Dry overnight and quantitate on
Phosphorimager. 
Plasmid Based Fork Regression Assay
Dilute SMARCAL1 to desired concentrations (150nM works well) and substrate (1.6nM
final) in replication fork buffer (20mM Tris-Hcl [pH 7.5], 50mM KCl, 5mM MgCl2, 1mM
DTT, 130μg/mL  BSA,  2.5mM  ATP  or  ATPγS).  Add  5μL  of  10X  substrate  and  10X
SMARCAL1 stock to 40μL replication fork buffer and incubate 20 minutes at 37°. Add
5μL of 60mM MgCl2 + 110mM ATPγS to stop reactions. Mix 9μL of reaction with 1μL of
50% glycerol or AvrII, EcoRI, SapI, or AlwNI and further incubate 30 minutes at 37°. Add
5μL STOP buffer  (0.9% SDS,  50mM EDTA,  30% glycerol,  dye).  Load  10μL on  6%
acrylamide (37.5:1) gel in 1X TBE. Run for 100 minutes at 80V. Dry overnight. AlwNI
product is 836bp; SapI, 329bp; EcoRI, 86bp; AvrII, 36bp.
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Replication Intermediate Purification for Electron Microscopy
Plate 5,000,000 cells per dish in 10 centimeter dishes the previous day. Label cells for
10 minutes with 10μM BrdU then treat as necessary. Harvest by trypsinization. Wash
once with cold PBS and resuspend in 10mL cold PBS. 
Transfer  to  a  6cm dish  on ice.  Add  0.5mL of  200μg/mL Trioxsalen  (TMP)  in
ethanol. Mix and incubate 5 minutes on ice. Irradiate in Stratalinker for 5 minutes with
365nm light for 5 minutes. Add TMP and crosslink 4 times total. Purify genomic DNA
using the Qiagen Blood & Tissue kit. The DNA can be stored overnight at 4°. Digest
16μg of DNA for each sample with 5μL NdeI in 450μL total volume for 3 to 5 hours.
Adjust volume to 600μL with 5M NaCl and TBS-300 (10mM Tris [pH 8.0], 300mM NaCl)
to yield a final NaCl concentration of 300μM. 
BND-Cellulose stock should be prepared ahead of time at 0.1g/mL in TBS-300.
This will require lots of vortexing and pipetting up and down with a cut pipette tip to yield
a mostly homogeneous solution. Using a cut pipette tip, add 1mL BND-Cellulose solution
to an empty Bio-rad Poly-Prep Chromatography column. Allow the liquid to drain through
completely.  Pre-wash  the  column  6  times  with  1mL TBS-800  (10mM  Tris  [pH  8.0],
800mM NaCl). Add the liquid rapidly so that the BND-cellulose gets resuspended in it.
Equilibrate  the  column  6  times  with  1mL TBS-300,  again  adding  rapidly.  Allow  the
column to drain completely, but don't let it dry out.
Bind digested DNA to the column by adding it to the column and gently tapping
the column to resuspend the BND-cellulose. Incubate 30 minutes at room temperature
with agitation every 10 minutes. Collect and save the flow-through. Elute the dsDNA by
adding 1 mL TBS-800. Collect the flow through and repeat once. Elute the replication
intermediates by adding 600μL TBSC-1000 (10mM Tris [pH 8.0], 1M NaCl, 1.8% w/v
caffeine). Incubate 10 minutes with agitation every 5 minutes. Collect the eluate, which
should contain replication intermediates.
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Load  the  eluate  onto  a  Microcon  YM-100  column (100,000  kDa MW cutoff).
Centrifuge at 2400 rcf for 5 minutes. Add 200μL TE. Centrifuge at 850 rcf for 3 minutes.
Repeat. Continue to spin until only 10-30μL remain. Turn column upside down in a fresh
collection tube. Quick spin twice up to 9500 rcf (hold down the button until ~9500rcf,
then release). Load 1-2μL onto an agarose gel to quantitate DNA. Residual caffeine in
the prep precludes A260 quantification. Proceed to dot blot to confirm the presence of
BrdU.
Yeast iPOND
Inoculate  a  25mL overnight  culture  the  previous  day.  Use  this  culture  to  inoculate
50-100mL  0.1OD  culture.  Grow  to  0.56OD,  add  200μg/μL  EdU  1:500  to  a  final
concentration  of  400μg/mL.  Grow for  60  minutes  at  30°  with  shaking  (target  is  0.8
OD600 at the end of the labeling). Add 37% formaldehyde to a final concentration of 1%.
Incubate  on  rotator  for  20  minutes  at  room temperature.  Quench  by  adding  1.25M
glycine  to  a  final  concentration  of  125mM.  Incubate  10  minutes  on  rotator  at  room
temperature. Split  as necessary. Pellet (3000rpm for 2 minutes) and wash twice with
equal volume water. Resuspend in 1mL water, transfer to a 2mL microcentrifuge tube,
pellet, discard supernatant, and store at -80°.
Resuspend in 1600μL lysis buffer (1% Triton X-10, 50mM Tris [pH 8.0]). Divide
into four 2-mL tubes and add acid washed beads until only a tiny amount of volume
remains atop the beads. Bead beat six times, 30 seconds per step. Incubate on ice 1
minute between steps. Poke a hole in the bottom of the tube and spin into 15mL tube at
2000  rpm.  Resuspend  lysate  and  transfer  to  a  microcentrifuge  tube.  Check  lysis
efficiency by looking at 5μL under the microscope. Broken cells appear as “ghosts” - very
light and faint compared to unbroken cells. Save 1% for gel (“pre-click”).
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Resuspend in click reactions – 500μL per 2 OD (1x Click buffer, xx Biotin-azide,
1x Click additive, 2mM CuSO4). Rotate for 2 hours in dark at room temperature. Add
20% SDS to a final concentration of 0.5%. Save 1% for gel (“post-click”). Sonicate until
clear – 30% amplitude, 20 second pulses, 1 minute on ice between pulses). Save 1% for
gel  (“post-sonication”).  Spin  at  16000 rcf  for  5 minutes.  Collect  the supernatant  and
transfer to a fresh tube. Centrifuge again at 16000 rcf for 15 minutes. Pass through a
FACS membrane into a fresh tube. Wash 10uL Novagen Streptavidin agarose beads per
OD. Wash two times with 1mL lysis buffer then once with 1mL PBS. Resuspend 1:1 in
PBS. Save 1% of the lysate as “input” before adding beads. Add beads and incubate
overnight at 4°, dark. Spin at 1800 rcf for 5 minutes, transfer supernatant to another
tube. Transfer beads to fresh tubes using 1mL lysis buffer. Incubate beads for 5 minutes
on rotator, then discard supernatant.  Wash three times with 1mL lysis buffer. Add 2x
sample buffer 1:1 to the beads and boil for 25 minutes. Resolve proteins by SDS-PAGE
and detect by Western blotting.
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CHAPTER III
ANALYSIS OF THE DNA DAMAGE RESPONSE AT STALLED REPLICATION FORKS†
Preamble
I joined the Cortez laboratory in  May 2010 just  after  Bianca Sirbu developed
iPOND (isolation of proteins on nascent DNA) and was fortunate enough to collaborate
on two of her publications (Sirbu et al. 2011, 2012). As such, this chapter draws primarily
from the first  of  these publications,  and I  have borrowed heavily  from this work and
focused the discussion here on areas where I made primary contributions. I have also
included several unpublished experiments where I have adapted the protocol to specific
applications, such as native iPOND and damaging agents other than HU.
Introduction
Human cells replicate billions of base pairs of DNA during each cell cycle. While
much of the cellular machinery involved in this process has been identified, much still
remains unknown. DNA replication must be faithful and complete. Insufficient nucleotide
precursors,  difficult  to replicate sequences,  and DNA lesions challenge the fidelity of
replication. Failure to overcome these challenges can lead to mutations that contribute to
the development of cancer. To deal with challenges to genome integrity, the cell contains
machinery known as the DNA damage response (DDR). The DDR activities that respond
to  replication  stress,  appropriately  termed  the  replication  stress  response  (RSR),
coordinate replication fork stabilization, cell cycle progression, and completion of DNA
synthesis (Cimprich and Cortez 2008; Harper and Elledge 2007).
† Parts of this chapter were published in (Sirbu et al. 2011).
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In comparison to the cellular response to DSBs, we know relatively little about
the replication  stress  response.  Numerous proteins  accumulate  at  stalled  replication
forks and these forks can be repaired in a number of ways, likely dependent on the
context,  type,  and  severity  of  damage.  However,  we  know little  about  the  interplay
between these pathways and how they are regulated.
At  a  DSB,  there  are  extensive  modifications  to  the  surrounding  chromatin
including  destabilization  of  nucleosomes,  chromatin  remodeling,  and  histone
post-translational modifications (van Attikum and Gasser 2009; Morrison and Shen 2009;
Rossetto et al. 2010; Venkitaraman 2010). These changes increase access to the repair
machinery and recruit proteins involved in repair and DDR signaling. The extent to which
chromatin changes at a stalled fork mimic those at a double-strand break is unknown.
Replication provides a unique landscape and set of challenges compared to a
DSB.  The  immediate  vicinity  of  the  replisome  lacks  nucleosomes.  Also,  half  of  the
histones  on  the  nascent  DNA  are  newly  synthesized  and  require  changes  in
post-translational modifications to restore the proper chromatin structure (MacAlpine and
Almouzni 2013). Finally, several mechanisms exist to recover stalled replication forks,
which necessitate the recruitment of multiple enzymatic activities and perhaps different
chromatin changes (Yeeles et al. 2013). 
Our lack of knowledge is in part due to the unique challenges of studying the
replication  stress  response  in  the  mammalian  system.  Engineering  site-specific
nucleases with unique cleavage sites into the mammalian genome allows researchers to
use chromatin immunoprecipitation (ChIP) to monitor changes in protein dynamics at a
single  DSB  (Berkovich  et  al.  2008;  Rodrigue  et  al.  2006;  Rudin  and  Haber  1988;
Soutoglou et al. 2007).
Thus  far,  the  only  site-specific  analysis  of  active  and  stalled  replisomes  in
mammalian cells was achieved using an episome containing an interstrand crosslink
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(Shen  et  al.  2009).  Unlike  lower  organisms,  mammalian  cells  lack  efficient,
sequence-specific origins which makes tracking the location of any single replisome in a
mammalian cell impossible and limits the utility of ChIP-based technologies.  We have
addressed this technical limitation by developing the iPOND methodology. Briefly, we
utilized the thymidine analog 5-ethynyl-2’-deoxyuridine (EdU) (Salic and Mitchison 2008)
which contains an alkyne functional group. Covalent linkage to a biotin-azide using click
chemistry  (Moses  and  Moorhouse  2007) facilitates  single-step  purification  of  the
EdU-labeled nascent DNA and associated proteins at  replication forks (Fig. 3.1).  We
demonstrated previously that iPOND can detect replication proteins with as little as 2.5
minutes of EdU labeling, which suggests resolution on the order of 2-6kb  (Sirbu et al.
2011).  iPOND  permits  the  isolation  and  analysis  of  proteins  at  active,  stalled,  and
collapsed replication forks.
The development of iPOND allows us to ask new questions about the DDR at
replication forks. While previous analyses were sufficient to demonstrate much of the
protein recruitment and phosphorylation events that occur at stalled replication forks,
iPOND  allows  us  to  investigate  these  events  with  a  higher  degree  of  spatial  and
temporal  resolution.  Therefore,  we  endeavored  to  describe  in  detail  the  protein
recruitment and PTM changes that occur over time at stalled and collapsed replication
forks.
Results
Analysis of chromatin maturation using iPOND
Maturation  of  the  new  chromatin  requires  addition  and  removal  of  histone
post-translational  modifications.  Newly  synthesized  histone  H4  is  acetylated  on  two
lysines  (5  and  12),  and  these  evolutionarily  conserved  marks  are  removed  after
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Figure 3.1 Isolation of Proteins on Nascent DNA (iPOND). (1) Cells are incubated
with  Thymidine  analogue 5'-Ethynyl-3'-deoxyuridine (EdU)  to  label  nascent  DNA.  (2)
Formaldehyde  crosslinks  protein-DNA complexes.  (3)  Cells  are  permeabilized  using
Triton X-100. (4) Click chemistry covalently links EdU and Biotin-azide. (5)  Cells are
sonicated to release small fragments of DNA bound to proteins. (6) Streptavidin resin
allows single-step, high-affinity purification of biotin tagged protein-DNA complexes. (7)
Reverse formaldehyde crosslinks to elute and detect by Western blotting.
deposition (Sobel et al. 1995; Taddei et al. 1999). Therefore, we monitored removal of
these marks  as  a  surrogate  for  chromatin  maturation.  Our  time course experiments
indicate that H4K5ac is removed rapidly and H4K12ac deacetylation is slightly delayed
(Fig.  3.2A).  The  delay  in  K12  deacetylation  could  be  due  to  the  activity  of
chromatin-associated histone acetyl transferases (HATs) that promote the acetylation of
this site in some chromatin domains. Indeed, in the presence of the non-selective HAT
inhibitor anacardic acid the rate of H4K12 deacetylation became identical to H4K5 with a
half-life  of  less  than  20  minutes  (Fig.  3.2B).  We also  observed  that  replication  fork
stalling with HU did not alter the rate of H4 deacetylation. Therefore, replication fork
progression can be uncoupled from chromatin maturation (Sirbu et al. 2011).
Development of Native iPOND (n-iPOND)
Another application of iPOND is to study the chromatin context of the replication
fork  under  a  variety  of  conditions.  One  limitation  in  this  regard  is  the  use  of  a
formaldehyde crosslinking step. Incomplete removal of this crosslinker interferes with
these analyses by destroying antibody epitopes and altering the m/z ratio of proteins,
making detection of PTMs difficult. Therefore, we developed an alternative methodology
called Native iPOND (n-iPOND) to address these limitations.
Native iPOND differs from iPOND in that we omitted the cross-linking step and
used micrococcal nuclease (MNase) in lieu of sonication to solubilize the chromatin after
the  Click  chemistry  step.  Proteins  bound  to  these  fragments  can  be  purified  and
detected by Western blot (Fig. 3.3). We successfully purified histones using the n-iPOND
technology, and we envision that  future studies will  use n-IPOND to catalog histone
modifications  at  replication  forks  under  a  variety  of  conditions.  While  the  n-iPOND
protocol reported in (Sirbu et al. 2012) is unoptimized and has a low experimental yield,
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Figure  3.2  H4K5ac  and  H4K12ac  are  deacetylated  with  different  kinetics  after
deposition due to reacetylation by HATs. (A)  Cells  were labeled with EdU for  10
minutes followed by a chase into thymidine containing media for the indicated times prior
to performing iPOND. (B) Quantitation of H4 acetylation levels compared to total H4 in
the  click  reaction  samples  from  three  independent  experiments.  Error  bars  indicate
standard deviation. (C) Cells were labeled with EdU for 10 minutes followed by a chase
into thymidine containing media in the presence or absence of 30μM anacardic acid for
the indicated times prior to performing iPOND. (D) Quantitation of H4 acetylation levels
compared to total H4 in the click reaction samples from three independent experiments.
Error bars indicate standard deviation. Data for panels A and B were produced by Bianca
M. Sirbu and Frank B. Couch.
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Figure 3.3 Native isolation of proteins on nascent DNA (n-iPOND).  (1) Cells were
labeled with EdU for 60 minutes, (2) permeabilized with Triton X-100, then (3) biotin
conjugated  using  click  chemistry.  (4)  Chromatin  fragments  were  solubilized  using
Mnase,  followed by  (5)  purification  with  streptavidin  agarose.  Purified  proteins  were
separated by SDS-PAGE and visualized by Western blotting with antibodies to H2B and
H4.
another  group  has  since  improved  the  n-iPOND protocol  (Leung  et  al.  2013).  This
improved protocol will likely enable further studies of chromatin modifications.
Analysis of Replisome Stability During Prolonged Replication Stress
Unfortunately,  iPOND  coupled  to  SDS-PAGE  and  Western  blot  requires
highly-specific,  high-affinity  antibodies,  especially  for  proteins  of  low  abundance.  To
detect such proteins, for example polymerase subunits,  we engineered cell  lines that
stably express tagged versions of these proteins. Using these cell lines, we detected two
subunits of polymerase epsilon: POLE2 and POLE3 (Fig. 3.4A).
In  lower  organisms  such  as  S.  cerevisiae and  X.  laevis,  certain  types  of
replication stress lead to disassembly of the replisome as measured by dissociation of
polymerases from DNA  (Cobb et  al.  2003; Trenz et al.  2006). We hypothesized that
replisome disassembly also occurs in human cells in response to prolonged replication
stress induced by HU. To test this hypothesis, we labeled cells expressing POLE3-HA for
10 minutes with EdU then added HU for 0, 1, or 8 hours before purifying replication fork
associated proteins using iPOND. We observed a modest decrease in POLE3 captured
at both timepoints. This suggests that while some replisome disassembly may occur, this
is not a major event during HU treatments of 8 hours or less (Fig. 3.4B), and this result
can be explained by replication termination events that occur during this time. Further
experimentation can elucidate whether the replisome is destabilized under other damage
conditions and if and how ATR regulates this process.
DDR response at stalled replication forks
HU treatment causes DDR activation to stabilize the stalled fork and induce a cell
cycle  checkpoint.  Previous  studies  suggest  that  HU-stalled  forks  remain  stable  and
competent to resume DNA synthesis for several hours; however, eventually the stalled
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Figure 3.4  Detection of  polymerase subunits  using iPOND. (A)  Cells  expressing
HA-tagged versions of POLE2 or POLE3 were labeled with EdU for 10 minutes prior to
performing  iPOND.  (B)  Cells  expressing  POLE2-HA were  labeled  with  EdU  for  10
mintues then HU was added to 3mM for the indicated times prior to performing iPOND.
Data were produced by Jordan T. Feigerle under the direction of Frank B. Couch.
fork collapses and double-strand breaks form  (Hanada et al.  2007;  Petermann et  al.
2010).  Using  iPOND,  we  demonstrated  that  PCNA and  CAF-1  decrease  after  HU
addition to a steady state level of 20-30% of that found at elongating forks, likely due to
unloading of PCNA from completed Okazaki fragments (Sirbu et al. 2011). Moreover, we
detected rapid phosphorylation of RPA on S33 followed by S4-S8 at later timepoints (Fig.
3.5A), consistent with phosphorylation of S33 by ATR and S4-S8 by DNA-PK (Anantha
et al.  2007;  Sirbu et al.  2011). We detected phosphorylation of H2AX at the earliest
timepoints of HU tested, 10 minutes  (Sirbu et al. 2011), well before evidence of DSB
formation (Petermann et al. 2010). Finally, we monitored accumulation of DSB proteins
and detected MRE11, RAD51, and KU80 (Fig 3.5A). While we observed low levels of
these proteins at early timepoints, we detected a shift in the DDR between 2 and 4 hours
of HU treatment that resulted in hyperaccumulation of these proteins, suggesting the
formation of DSBs (Fig. 3.5A and Sirbu et al. 2011).
RAD51 accumulation at stalled replication forks
With similar  kinetics to the shift  from ATR- to ATM/DNA-PK-dependent  H2AX
phosphorylation,  we  observed  increased  accumulation  of  the  DSB proteins  MRE11,
RAD51, and KU70/80 at stalled replication forks (Fig. 3.5A and  Sirbu et al. 2011). At
DSBs,  MRE11-dependent  end-resection  is  required  to  load  RAD51  (Mimitou  and
Symington  2009).  At  collapsed  forks,  RAD51  may  function  to  promote
recombination-based methods to re-establish the replication fork  (Anand et  al.  2013;
Errico and Costanzo 2010). To test whether the loading of RAD51 at stalled forks also
requires MRE11, we treated cells with the MRE11 nuclease inhibitor mirin (Dupré et al.
2008). Although the early recruitment of RAD51 occurred independently of MRE11, the
late accumulation required MRE11 activity (Fig. 3.5B), suggesting that end-resection of
the parental DNA strand promotes this loading. The timing of MRE11 recruitment also
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Figure 3.5 RAD51 accumulation during extended HU treatments is dependent on
MRE11 nuclease activity. (A) Cells were labeled with EdU for 10 minutes then HU was
added to 3mM for the indicated times prior to performing iPOND. (B) Cells were labeled
with EdU for 10 minutes then HU was added to 3mM in the presence or absence of
100μM mirin for the indicated times prior to performing iPOND. (C)  Cells labeled with
EdU for 10 minutes were treated with 3mM HU for 8 hours. Mirin (100μM), ATRi (AZ20,
3μM), ATMi (KU55933, 10μM), and DNA-PKi (NU7441, 1μM) were added at the same
time as HU. Data for panel A were produced by Bianca M. Sirbu.
correlated with a large increase in RPA S4/S8 phosphorylation (Sirbu et al. 2011), which
was previously  linked to end-resection at  camptothecin-damaged forks  (Sartori  et  al.
2007).
ATR Regulation of Stalled Replication Forks 
ATR is the master regulator of the response to replication fork stalling. While ATR
phosphorylates hundreds of substrates at stalled replication forks, how ATR regulates
the  DDR  at  stalled  replication  forks  to  preserve  genome  integrity  remains  unclear
(Cimprich and Cortez 2008;  Nam and Cortez 2011). Therefore,  we next  investigated
whether  RAD51 accumulation  is  ATR-dependent.  Using the ATR inhibitor  AZ20 from
AstraZeneca, we observed that RAD51 accumulation remains unchanged regardless of
ATR signaling after 8 hours of HU treatment (Fig. 3.5C). This suggests that the observed
shift in the DNA damage response that results in increased RAD51 accumulation does
not require ATR signaling. Inhibition of ATM or DNA-PK also had no effect on RAD51
accumulation (Fig. 3.5C).
Interestingly, we noticed an increase in the RPA and γH2AX purified at the stalled
replication  forks  when  ATR was  inhibited.  iPOND likely  only  purifies  RPA molecules
immediately adjacent to the newly synthesized DNA strand (Sirbu et al. 2011); therefore,
the increase in RPA purification indicates that the nascent strand likely became single
stranded and bound by RPA. Since we also observed increased γH2AX, this may occur
though DSB formation and resection of the template strand to expose ssDNA on the
newly synthesized strand. This topic will be revisited in Chapter IV.
γH2AX spreading from stalled forks before and after fork collapse
We noticed that the rapid phosphorylation of H2AX near the fork saturates within
30 minutes; however, global levels continue to increase  (Sirbu et al. 2011). Therefore,
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we hypothesized that the global increase stems from γH2AX spreading from the stalled
fork as is observed near double-strand breaks (Berkovich et al. 2007; Savic et al. 2009).
To test this hypothesis we first labeled cells with EdU, then chased with thymidine for
various lengths of time to extend the distance between the EdU-labeled fragment and
the fork, and finally added HU to stall  the fork. A detailed analysis revealed that the
density of γH2AX gradually declined as a function of distance from the stalled fork (Fig.
3.6).  Compared  to  the  saturated  density  at  the  fork,  the  γH2AX density  decreased
approximately two-fold for every 15 minutes of thymidine chase time when cells were
treated with HU for one hour. By two hours, we observed increased γH2AX density in all
chromatin segments analyzed suggesting that γH2AX spreading contributes significantly
to the global change in γH2AX levels.
To examine the chromatin at a single location distant from the fork, we repeated
this experiment holding the thymidine chase time constant at 30 minutes and treated
with HU for varying times. We observe a steady increase in γH2AX at this distance from
the fork with increasing times of  HU treatment (Fig.  3.6B).  Importantly, these results
indicate considerable  spreading of  the  γH2AX signal  even shortly  after  fork  stalling.
Assuming a conservative rate of fork elongation of 1kb/min, these data imply that within
one hour of fork stalling γH2AX spreads to include a large domain containing tens of
thousands of base pairs of DNA. 
To identify the kinase(s) that phosphorylate H2AX adjacent to the stalled fork and
that  promote  spreading,  we  utilized  small  molecule  kinase  inhibitors.  The  selective
DNA-PK and ATM inhibitors NU7441 (Leahy et al. 2004) and KU55933 (Hickson et al.
2004) had minimal effects on the spreading or total levels of γH2AX induced by a short
(30-60min) HU treatment  (Sirbu et al. 2011). However, these inhibitors did significantly
reduce γH2AX levels  in  cells  treated with HU for  4 hours (Fig.  3.7A).  These results
indicate  that  DNA-PK/ATM  contributes  to  maintenance  and  spreading  of  γH2AX  at
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Figure 3.6 γH2AX spreads along chromatin behind stalled replication forks. (A-B)
Cells were labeled with EdU for 10 minutes then chased into thymidine containing media
for  the  indicated  times  before  addition  of  3mM HU for  the  indicated  times  prior  to
performing iPOND. (A) Graphed values are the mean and standard deviation of fold
change in the ratio of γH2AX to H2B compared to the 0 minute thymidine chase from 3
independent experiments for the 2h HU timepoints and 2 independent experiments at
the 1h HU timepoints.
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Figure  3.7  γH2AX  spreading  is  ATM/DNA-PK-dependent  during  extended  HU
treatments, but ATR-dependent during short HU treatments. Cells labeled with EdU
for 10 minutes were chased into thymidine followed by treatment with HU. The length of
thymidine  and  HU treatments  are  indicated.  (A)  DNA-PK  (NU7441,  1μM)  and  ATM
(KU55933,  10μM)  inhibitors  were  added  at  the  same  time  as  HU  in  the  indicated
samples.  (B)  Caffeine (10mM) was added at  the same time as HU in the indicated
samples.
persistently stalled forks. In contrast, treatment with caffeine, which preferentially inhibits
ATR (Sarkaria et al. 1999), significantly reduced γH2AX formation and spreading shortly
after the fork is stalled (Fig. 3.7B). These results are consistent with a model in which
ATR phosphorylates H2AX at a stalled fork and promotes initial spreading. At later time
points, likely after DSB formation, ATM and DNA-PKcs maintain and further propagate
the H2AX phosphorylation.
Other DNA Damaging Agents
HU  is  not  the  only  DNA  damaging  agent  that  causes  replication  stress.
Camptothecin (CPT), a Topoisomerase I poison, causes replication-dependent DSBs.
These DSBs likely arise from either cleavage of replication forks stalled by topological
strain  or  through  polymerase  run-off  at  CPT-induced  SSBs  (Pommier  2006;  Ray
Chaudhuri  et  al.  2012). Unlike HU, CPT does not  rapidly stall  every fork in the cell,
rather, in  CPT-treated cells,  replication forks proceed more slowly as they encounter
topological strain or SSBs and collapse asynchronously. 
We utilized two different experimental protocols to label and purify replication fork
associated proteins in CPT treated cells. First, we treated cells with CPT for increasing
times up to one hour and added EdU to the media for the final 15 minutes of treatment.
Using  this  methodology,  we  detected  decreasing  amounts  of  H2B  and  PCNA with
increasing CPT treatment times. This likely reflects the general slowing of replication
during CPT treatment (Regairaz et al. 2011). In this instance, however, we detected an
increase in RPA phosphorylated on S4-S8, consistent with DSB formation (Fig. 3.8A and
Sartori et al. 2007). 
Alternatively,  we  treated  cells  for  one  hour  with  CPT  and  added  EdU  for
increasing  labeling  times  at  the  end  of  CPT  treatment.  In  this  case,  we  detected
increasing H2B over time, indicating that replication forks do progress detectably in CPT
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Figure  3.8  Protein  dynamics  at  CPT-damaged  replication  forks.  (A)  Cells  were
treated with 1μM CPT for indicated times and labeled with EdU for the final 15 minutes
of CPT treatment prior to performing iPOND. (B) Cells were treated with 1μM CPT for 1
h and labeled with EdU for the indicated times at the end of CPT treatment prior to
performing iPOND.
treated cells. However, we detect only a modest increase in PCNA, suggesting that the
number of new replication forks labeled is low, consistent with a checkpoint response.
Similarly to HU treated, ATR inhibited cells, we detect a marked increase in RPA32 and
RAD51 indicative of  ssDNA on the newly synthesized DNA strand.  Furthermore,  the
RPA32 purified is largely phosphorylated on S4/S8 (Fig. 3.8B). Taken together, these
suggest that, consistent with previous reports, CPT generates DSBs at replication forks,
and iPOND can detect the changes in protein recruitment and PTMs that occur at these
forks.
Discussion
Here, we described the first investigation into the DNA damage response using
the iPOND methodology. The advantage of iPOND over similar previous methods, such
as CldU immunoprecipitation,  is  increased  resolution  and  background.  Compared  to
iPOND, which can detect replication fork proteins with only 2.5 minutes of EdU labeling,
the CldU immunoprecipitation method used a 40 minute labeling time (Petermann et al.
2010). Furthermore, iPOND is compatible with stringent wash conditions such as 1M
NaCl and 1% SDS and does not  require a denaturation step to expose an antibody
epitope.
Using iPOND, we monitored chromatin maturation by following removal of the
deposition marks H4K5ac and H4K12ac. Consistent with previous reports, H4K5ac and
H4K12ac were deacetylated at different rates. Furthermore, we demonstrated that the
difference in deacetylation rates was entirely due to reacetylation of H4K12 using the
nonspecific HAT inhibitor anacardic acid (Fig. 3.2). Our analysis provides higher spatial
and temporal resolution that previous methods and begins to elucidate the chromatin
changes that occur as chromatin is reassembled behind replication forks. We developed
the native iPOND methodology to enable future studies of chromatin PTMs (Fig. 3.3).
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iPOND  is  also  more  sensitive  than  previous  methods  of  studying
replication-associated  proteins.  Previous  studies  largely  relied  on  immunofluorescent
(IF)  imaging  to  track  protein  localization.  While  useful,  immunofluorescence  has  the
significant disadvantages of low resolution and low sensitivity. For example, proteins that
exist at only single copy levels at replication forks cannot be tracked with IF. In contrast,
iPOND technology  has  dramatically  improved  sensitivity,  allowing  us  to  detect  even
proteins  such  as  polymerases.  Furthermore,  combining  iPOND  with  pulse-chase
methods  provides  high  spatial  and  temporal  resolution  of  protein  dynamics.  Finally,
iPOND  also  facilitates  analysis  of  post-translational  modifications,  which  is  often
impossible with IF due to poor antibody quality or specificity.
We are able  to detect  molecules expected to be present  at  only  one or  two
copies  per  fork,  such  as  polymerase  subunits,  using  iPOND  (Fig  3.4).  In  lower
organisms, some DNA damaging agents cause dissociation of replisome components
(Cobb et al. 2003; Trenz et al. 2006). Therefore, we tested whether extended treatment
with HU caused replisome disassembly in mammalian cells. Our results indicate that this
does not  occur  in  response to HU; however, whether other  damaging agents cause
disassembly and whether ATR regulates this process remain open questions.
iPOND is an ensemble methodology, thus while it does not provide information
about  any  single  replication  fork,  iPOND  provides  an  average  picture  of  events  in
different  cells  at  stalled forks throughout  the genome in a population of  cells.  Using
iPOND, we detected several DDR proteins including KU80 and MRE11 prior to addition
of  any exogenous damaging agents (Fig 3.5A).  The idea that  KU80 travels with the
replication fork is not without precedent  (Shao et al. 1999), and several groups have
recently  suggested  a  function  for  the  MRN  complex  in  ATR  activation  at  stalled
replication forks (Duursma et al. 2013; Kobayashi et al. 2013; Lee and Dunphy 2013).
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The interplay between RAD51 and MRE11 at stalled replication forks has seen
several recent developments. The Costanzo group demonstrated that in  S. cerevisiae,
depletion or inhibition of RAD51 leads to increased ssDNA gaps behind the replication
fork in an MRE11-dependent process  (Hashimoto et al. 2010).  Furthermore, the Jasin
group found that in the absence of BRCA2/RAD51, the newly synthesized DNA strands
shorten during HU treatment in  an MRE11-dependent  manner. This  suggests that  at
persistently  stalled  replication  forks,  MRE11  performs  limited  resection  that  allows
BRCA2-RAD51  loading.  In  the  absence  of  BRCA2  or  RAD51,  MRE11  resection
continues  unimpeded and  produces  detectable  shortening  of  DNA fibers  using  fiber
labeling (Schlacher et al. 2011). 
Interestingly, we observed a shift  in  the DDR between 2 and 4 hours of  HU
treatment. This occurs well before evidence of DSB formation, which requires in excess
of  12  hours  of  treatment  (Petermann  et  al.  2010).  While  we  cannot  exclude  the
possibility that DSB detection methods lack sufficient sensitivity to detect breaks at these
times, another possibility is that fork regression occurs to form a Holliday junction-like
structure. To distinguish between these possibilities would require direct evidence of fork
regression in response to HU and identification of the enzymatic requirements, such as
SMARCAL1 activity. Replication stress caused by camptothecin treatment or oncogene
overexpression can induce this structure in mammalian cells (Neelsen et al. 2013; Ray
Chaudhuri et al. 2012). The extruded nascent strand duplex resembles a DSB end and
may  recruit  typical  DSB  proteins  such  as  KU70/80,  MRE11,  and  RAD51.  RAD51
assembly  at  persistently  stalled  forks  depends  on  MRE11  activity,  suggesting  a
requirement  for  end-resection  (Fig.  3.5B).  This  end-resection  is  likely  either  on  the
template DNA strand of a DSB or limited to the extruded arms of a regressed fork, since
we continued  to  capture  EdU-labeled  DNA and  associated  proteins.  In  either  case,
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resection would yield a 3’ overhang of newly synthesized DNA, which could be used in
recombination-based methods of fork repair and restart (Petermann and Helleday 2010).
Prominent  changes  in  the  response  to  replication  stress  include  protein
phosphorylation. Importantly, our data indicate that H2AX phosphorylation spreads to a
large chromatin domain early in the response to fork stalling. This early phosphorylation
is  catalyzed  by  ATR and  is  unlikely  to  be  due  to  the processing  of  the  fork  into  a
double-strand  break  intermediate.  Our  data  is  consistent  with  previous  analyses
implicating both ATR-dependent (Ward and Chen 2001) and –independent  (Brown and
Baltimore 2003; Gilad et al. 2010) H2AX phosphorylating activities in response to fork
arrest.  Most  models  of  ATR  function  suggest  it  is  only  active  when  bound  to  the
single-stranded DNA at the stalled fork through an ATRIP-RPA interaction (Cimprich and
Cortez  2008),  but  our  data  indicate  that  ATR helps  spread  the  γH2AX signal.  One
possibility  is  that  the  early  spreading  of  γH2AX  is  due  to  looping  of  the  newly
synthesized chromatin that brings it into proximity of ATR. Alternatively, ATR may have a
method  of  spreading  its  signal  beyond  the  immediate  single-stranded  DNA vicinity
similar to the ability of active ATM to spread along the double-stranded DNA away from
the DSB end (You et al. 2007). MDC1 may be involved in such a process (Ichijima et al.
2011; Wang et al. 2011). 
iPOND is also useful for studies of protein dynamics at replication forks damaged
with  other  agents.  We  demonstrated  that  iPOND  can  detect  accumulation  of  RPA,
RAD51,  and  γH2AX  at  CPT-damaged  replication  forks.  We  also  detect  RPA32
phosphorylated on S4/S8, indicative of DSB formation and DNA-PK activation. Using
iPOND,  we  conducted  a  high  resolution,  temporal  analysis  of  protein  dynamics  at
replication forks in mammalian cells. These analyses provide us with a molecular picture
of how replication stress response proteins accumulate at stalled replication forks and
some indications as to the function of ATR in this process.
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CHAPTER IV
ATR PHOSHORYLATES SMARCAL1 TO PREVENT REPLICATION FORK COLLAPSE†
Introduction
Every  cell  division  cycle,  cells  must  accurately  and completely  replicate  their
genome. Errors in replication result in mutations and chromosomal rearrangements that
contribute  to  tumorigenesis.  Replication  stress  caused  by  DNA  lesions,  insufficient
nucleotides, or even collisions of replication and transcriptional machineries increases
the chance of errors. However, replication stress also activates a DNA damage response
(DDR) that slows cell cycle progression and promotes DNA repair to ensure accurate
duplication of the genome. 
The DDR kinase Ataxia-telangiectasia and Rad3-related (ATR), a member of the
phosphoinositol  3-kinase-like  kinase  (PIKK)  family,  coordinates  much  of  the  cellular
response to replication stress (Cimprich and Cortez 2008; Nam and Cortez 2011). ATR is
activated upon replication fork stalling and uncoupling of the replicative helicase and
polymerase  (Byun  et  al.  2005).  Once  activated,  ATR  phosphorylates  hundreds  of
substrates to induce the replication checkpoint and promote fork repair. 
ATR is essential for cell viability, and hypomorphic ATR mutations cause the rare
disease Seckel syndrome characterized by growth retardation, microcephaly and other
developmental problems (O’Driscoll et al. 2003). ATR is thought to be a good drug target
for cancer therapy because its function is especially critical in replicating tumor cells,
which have elevated levels of replication stress due to activated oncogenes and frequent
loss of the G1 checkpoint (Reaper et al. 2011; Schoppy et al. 2012; Toledo et al. 2011b).
† This chapter was published in (Couch et al. 2013).
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The mechanism by which ATR selective inhibitors kill cells is unknown but is likely linked
to  the  replication  fork  stabilization  and  repair  activities  of  ATR  instead  of  its  G2
checkpoint function (Nam et al. 2011b; Toledo et al. 2011a). Defining these mechanisms
is important for the development of ATR pathway inhibitors for cancer treatment.
Replication fork repair is a complex process that can proceed through multiple
pathways depending on the cause, persistence, and genomic context of the replication
stress. These mechanisms include fork stabilization to allow completion of replication by
a converging replication fork, lesion bypass, template-switching through recombination
or fork reversal, and double-strand break (DSB)-mediated restart  (Branzei and Foiani
2010).  Many  enzymes  participate  in  these  activities  including  helicases,  DNA
translocases, nucleases, and specialized polymerases. ATR can phosphorylate many of
these enzymes; however, the mechanisms by which it promotes fork stabilization, repair,
and cell viability remain largely unknown.
One ATR substrate  that  acts  at  stalled  forks  is  SMARCAL1  (also  known  as
HARP)  (Bansbach et al. 2009; Postow et al. 2009). SMARCAL1 binds branched DNA
structures and can catalyze DNA annealing, branch migration, fork regression, and fork
restoration (Bétous et al. 2012, 2013; Ciccia et al. 2012; Yusufzai and Kadonaga 2008).
SMARCAL1 is recruited to stalled forks through an interaction with replication protein A
(RPA) (Bansbach et al. 2009; Ciccia et al. 2009; Yuan et al. 2009; Yusufzai et al. 2009),
which directs it to regress stalled forks with a leading strand gap and restore a normal
fork  structure  (Bétous  et  al.  2013).  Both  overexpression  and  siRNA-silencing  of
SMARCAL1  cause  replication-associated  DNA  damage  (Bansbach  et  al.  2009).
Furthermore,  loss  of  function  mutations  in  SMARCAL1  cause  the  human  disease
Schimke immunoosseous dysplasia that is characterized by growth defects, renal failure,
immune  deficiencies  and  predisposition  to  cancer  (Baradaran Heravi  et  al.  2012;‐
Boerkoel  et  al.  2002;  Carroll  et  al.  2013).  How ATR phosphorylation  of  SMARCAL1
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regulates  its  genome  maintenance  functions  at  a  damaged  fork  has  not  been
investigated. 
Using  a  selective  ATR inhibitor,  we  demonstrate  that  acute  inhibition  of  ATR
kinase activity perturbs the timing of replication initiation, impairs fork elongation rates,
and causes rapid lethality in S-phase cells experiencing replication stress. Stalled forks
collapse when ATR is inhibited due to SLX4-dependent endonuclease cleavage, which
yields  DSBs  and  the  CtIP-dependent  appearance  of  single-stranded  template  and
nascent  DNA  strands.  Excessive  SMARCAL1  activity  is  partly  responsible  for  this
aberrant  fork  processing.  ATR  phosphorylation  of  a  conserved  SMARCAL1  serine
regulates SMARCAL1 and is one mechanism by which ATR maintains genome integrity
during  DNA replication.  Thus,  our  results  provide  a  mechanistic  description  of  fork
collapse in mammalian cells and define a specific enzymatic pathway responsible for
this collapse. They also explain why both too much and too little SMARCAL1 causes
replication-associated  DNA damage  emphasizing  the  need  to  properly  regulate  this
replication fork repair enzyme. Finally, these data provide insights into the mechanism of
action of ATR inhibitors which are being developed to treat cancers with high levels of
dependency on this replication-stress response pathway.
Results
Acute ATR inhibition causes rapid cell death in cells experiencing replication stress
Conditional deletion of ATR in dividing mouse or human cells causes cell death
as the mRNA and protein levels decay over time (Brown and Baltimore 2000; Cortez et
al.  2001;  de Klein  et  al.  2000).  The gradual  nature of  these genetic  loss-of-function
experiments  precludes  an  analysis  of  the  immediate  effects  of  ATR  deficiency.  To
overcome  this  technical  challenge,  we  utilized  a  selective  ATR  kinase  inhibitor  to
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examine how cells respond to acute and transient ATR inhibition. In this analysis, 39% of
asynchronous cultured U2OS cells were no longer able to form colonies after a 10-hour
treatment  with a concentration  of  ATR inhibitor  sufficient  to  block  phosphorylation of
CHK1, and 71% of cells were inviable after 20 hours of treatment (Fig. 4.1A). 
Acute treatment with the combination of ATRi and replication stress induced by
the ribonucleotide reductase inhibitor hydroxyurea (HU) caused a greater reduction in
viability than either drug alone (Fig. 4.1A-B). Notably, 5 hours of treatment with HU and
ATRi caused a 55% reduction in viability. This percentage corresponds approximately to
the proportion of cells in S-phase at  the onset  of  treatment plus the cells that enter
S-phase  during  the  5-hour  treatment.  ATR  inhibition  is  synergistic  with  HU:  at  the
20-hour time point, the combination of HU+ATRi gave an experimental response (99%
decrease in viability) greater than the additive effect predicted from HU alone and ATRi
alone (89%). 
To determine how rapidly the cell lethality occurs, we treated U2OS cells with or
without HU and ATRi for up to 5 hours. While HU alone or ATRi alone had only modest
effects at earlier time points, the combination of HU and ATRi caused a 30% decrease in
colony forming ability within 45 minutes of treatment (Fig. 4.1C-D). Since HU treatment
is expected to affect primarily S-phase cells, we tested whether these cells could recover
from this treatment and complete DNA replication. By flow cytometry, at least 20% of
cells treated with HU and ATR inhibitor for 5 hours failed to complete DNA synthesis 24
hours after release into fresh growth media compared to only 7% of controls (Fig. 4.2A).
After a 16 hour HU treatment, this fraction of lagging cells increased to at least 65% of
ATR inhibited cells compared to only 15% of controls (Fig. 4.2B). Thus, ATR is required
during an acute replication stress challenge to ensure that cells can recover, complete
DNA synthesis, and retain long-term viability.
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Figure 4.1 Acute ATR inhibition causes rapid cell lethality. (A-D) U2OS cells were
treated with DMSO, 5μM ATRi, and/or 3mM HU for the indicated times and released into
fresh growth media for 10-14 days. Colonies were visualized by methylene blue staining.
Results  shown  are  mean  +/-  standard  error  of  the  mean  (SEM)  of  at  least  two
independent experiments.
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Figure 4.2 Acute ATR inhibition causes an inability to complete DNA replication
after a replication stress challenge. RPE-hTERT cells were labeled with 20μM BrdU
for  20 minutes,  treated with  3mM HU for  5 (A)  or  16 (B)  hours  in  the  presence or
absence of  5μM ATRi,  and then released into fresh growth media containing 1µg/ml
nocodazole  for  24  hours  prior  to  harvesting.  Cells  were  then  fixed,  acid  denatured,
stained with BrdU antibodies and propidium iodide,  and analyzed by flow cytometry.
Plots were made using Cyflogic software. 
ATR inhibition deregulates replication timing control and causes replication fork collapse
To understand the cause of the rapid lethality when ATR is inhibited, we utilized
fiber labeling to examine DNA replication. Cells were labeled with IdU (green) for 20
minutes then CldU (red) for 20 minutes in the presence or absence of ATRi during both
labeling  periods.  ATR  inhibition  caused  the  CldU  fiber  length  to  decrease  to
approximately  half  the  length  of  controls,  which  indicates  slower  replication  fork
elongation (Fig. 4.3A). CHK1 inhibition causes a similar slowing of fork elongation, which
was attributed to deregulation of origin firing (Seiler et al. 2007). This also appears to be
the case after ATR inhibition since we observed a large increase in the number of origins
in the ATRi sample compared to controls (Fig. 4.3B). 
Recovery of DNA synthesis after transient replication block is also dependent on
ATR function. We labeled cells with IdU, blocked replication with high concentrations of
HU in the presence or absence of ATRi, then removed the drugs and labeled with CldU.
The  CldU-labeled  replication  tracks  were  significantly  shorter  in  the  ATR  inhibited
condition compared to controls (Fig. 4.3C). Furthermore, ATR inhibition causes a large
increase  in  the  number  of  forks  that  cannot  restart  and  collapse  entirely  during the
HU-treatment with no CldU incorporation after release (Fig. 4.3D).  Origins were also
de-repressed under these conditions (Fig. 4.3E). 
Similar experiments in cells lacking BRCA2 function found that the IdU-labeled
tracks synthesized prior to HU addition undergo shortening, which indicates degradation
of the newly synthesized DNA strands after fork stalling (Schlacher et al. 2011). We did
not observe this phenotype in the ATRi samples indicating that ATR is not required in this
BRCA2-RAD51-dependent fork protection pathway (Fig. 4.3F). 
To examine what is happening to the stalled forks when ATR is inhibited, we first
examined  the  levels  of  DNA  damage  in  ATRi-treated  cells.  H2AX  phosphorylation
(γH2AX)  provides  an  indirect  marker  for  DNA damage since  it  is  phosphorylated at
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Figure  4.3  ATR  regulates  DNA replication  initiation  and  elongation. (A  and  B)
RPE-hTERT cells were labeled with IdU for 20 minutes then with CldU for 20 minutes in
the presence of DMSO (red bars) or 5μM ATRi (blue bars) during both labeling periods
before  harvesting  for  fiber  labeling.  (A)  Representative  replication  tracks  and
quantification of the length of CldU (red) tracks in dual-labeled tracks are shown. (B)
Origin initiation was scored as the percentage of red-only tracks. (C-F) RPE-hTERT cells
were labeled with IdU for 20 minutes, treated with 2mM HU for 2 hours in the presence
of DMSO (red bars) or 5μM ATRi (blue bars), then labeled with CldU for 20 minutes
before harvesting for fiber staining. Representative images and quantification of CldU
(C)  and  IdU  (F)  track  lengths  in  dual-labeled  fibers  are  shown.  (D)  Percentage  of
collapsed forks (green-only tracks) and (E) newly initiated origins (red-only tracks) were
quantitated. In all experiments data was collected from several experimental samples
with  high  quality  DNA fibers.  Error  bars  are  SEM.  Data  were  produced  by  Jessica
Luzwick.
stalled forks and at DSBs. As expected, HU treatment alone causes low but detectable
levels of γH2AX, which increase over time (Fig. 4.4A-B). In the presence of ATRi, γH2AX
is absent at the earliest time points of HU treatment indicating that ATR is required to
phosphorylate H2AX near stalled replication forks consistent with previous observations
(Sirbu et al. 2011). However, by 1 hour in HU the γH2AX in ATR inhibited cells exceeds
that in controls. At this time point a few cells display large, poorly defined γH2AX foci but
most contain a pan-nuclear staining pattern without discernable foci suggesting rapid
spreading through the chromatin. These data suggest the activation of the DSB-sensing
kinases ATM and DNA-PKcs between 30 and 60 minutes of HU treatment when ATR is
inhibited.  Indeed,  we  detected  elevated  RPA32  S4/S8  phosphorylation  (a
DNA-PK-dependent  phosphorylation  site),  and  CHK2  T68  phosphorylation  (an
ATM-dependent phosphorylation site) in ATR inhibited cells compared to controls with
similar  kinetics  to  γH2AX  (Fig.  4.4C).  Thus,  a  DSB  may  form  at  the  stalled  fork
generating the ATM and DNA-PKcs activating signal.
To provide direct evidence of DSB formation, we utilized a neutral COMET assay.
The combination of HU and ATRi treatment caused an increase in COMET tail moment
compared to controls similar to what is caused by high-dose camptothecin treatment
(Fig. 4.4D) confirming DSB formation and replication fork collapse in ATR inhibited cells.
ATR inhibition causes nascent-strand ssDNA formation
To confirm that the γH2AX and RPA32 hyper-phosphorylation that happens in
cells treated with HU and the ATRi occur at replication forks, we utilized iPOND (Sirbu et
al. 2011, 2012). iPOND uses click chemistry to conjugate biotin to a nucleoside analog
(EdU)  incorporated  in  newly  synthesized  DNA  thereby  permitting  a  single-step
purification of proteins near the replication fork. As expected, the γH2AX is associated
with the newly synthesized DNA strands (Fig. 4.5A). Additionally, we observed a striking
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Figure 4.4 Stalled replication forks collapse into double strand breaks when ATR
is acutely inhibited. (A and B) U2OS cells were treated with 3mM HU in the presence
or  absence  of  5μM  ATRi  for  the  indicated  times  before  preparation  for
immunofluorescence using anti-γH2AX antibodies. Dot-plot of mean γH2AX intensity per
nucleus is shown in (B). (C) U2OS were cells treated with 3mM HU in the presence or
absence of  5μM ATRi for  the indicated times.  Following treatment,  cell  lysates were
separated  by  SDS-PAGE  then  immunoblotted  to  detect  the  indicated  proteins  and
phosphorylation levels. (D) U2OS cells were treated for 1h with 1μM CPT or 4h with
3mM  HU  in  the  presence  or  absence  of  5μM  ATRi.  Neutral  COMET  assay  was
performed  and  at  least  100  individual  cells  were  scored  for  tail  moment  using
CometScore  software.  Representative  images  and  box-and-whisker  plot  are  shown.
Samples  were  compared  with  one-way  ANOVA (p  <  0.0001).  Bonferroni’s  Multiple
Comparison test was used as a follow up to compare untreated vs. CPT (p < 0.0001)
and HU+DMSO vs. HU+ATRi (p < 0.0001).
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Figure 4.5 ATR inhibition causes both nascent and parental ssDNA accumulation
at a stalled replication forks. (A) 293T cells were labeled with EdU for 10 minutes prior
to addition of 3mM HU and 5μM ATRi as indicated. Samples were processed for iPOND
and captured proteins were separated by SDS-PAGE then immunoblotted. (B) Model for
nascent-strand ssDNA assay. Black and red lines indicate template and nascent DNA
strands,  respectively.  Without  DNA denaturation,  BrdU antibodies  will  not  recognize
intact replication forks but will recognize the labeled, nascent DNA when single-stranded.
(C and D) The newly synthesized DNA in replicating U2OS cells was labeled for 10
minutes with 10μM BrdU before addition of 3mM HU and 5μM ATRi as indicated. “No
BrdU” sample is 4h HU+ATRi treatment without  BrdU pre-labeling.  “DMSO” samples
were labeled with BrdU and treated with 3mM HU for 4h. After the indicated treatment
times,  cells  were  fixed  and  stained  with  antibodies  against  BrdU  without  DNA
denaturation  to  selectively  detect  nascent-strand ssDNA.  Representative  images are
shown in (C) and a dot-plot of mean BrdU intensity per nucleus is shown in (D). (E)
Parental DNA in replicating U2OS cells was labeled by the addition of 10μM BrdU for 20
hours followed by a chase into normal growth media for 2 hours before addition of 3mM
HU and 5μM ATRi for the indicated times. “DMSO” samples were labeled with BrdU and
treated with 3mM HU for 4h. Cells were fixed and stained with antibodies against BrdU
without DNA denaturation to selectively detect parental-strand ssDNA. Dot-plot of mean
BrdU intensity per nucleus is shown. Data for panel A were produced by David Cortez
and Frank B. Couch.
accumulation of hyperphosphorylated RPA purified with the nascent DNA when ATR is
inhibited (Fig. 4.5A). Quantitative mass spectrometry following the iPOND purification
also  confirmed an increase in  total  RPA in  the HU+ATRi  conditions  (B Sirbu and D
Cortez,  unpublished observation).  iPOND only  purifies RPA bound to or  immediately
adjacent to the EdU-labeled nascent strand and therefore does not detect an increase in
RPA in cells treated with HU alone (Sirbu et al. 2011). Thus, the increased abundance of
RPA in the iPOND samples may suggest that the EdU-labeled nascent strand becomes
single-stranded and bound to RPA when ATR is inhibited. 
To directly test whether the nascent strand becomes single-stranded at stalled
forks  in  the  absence  of  ATR  activity,  we  developed  an  assay  to  selectively  detect
nascent-strand ssDNA using a short  (10 minute) BrdU incubation immediately before
stalling forks with HU. Under non-denaturing conditions, the BrdU antibody selectively
recognizes ssDNA (Fig. 4.5B). Treatment with HU and DMSO vehicle resulted in little
BrdU staining (Fig. 4.5C, see “4h, DMSO” image). Conversely, treatment with HU and
ATR  inhibitor  resulted  in  robust  BrdU  staining,  indicating  that  the  nascent  strand
becomes ssDNA (Fig. 4.5C-D). The nascent-strand ssDNA became detectable after 1
hour of  treatment and increased dramatically after  2 and 4 hours (Fig.  4.5C-D). The
timing  of  nascent-strand  ssDNA  formation  correlates  with  the  cellular  lethality  and
γH2AX hyper-phosphorylation caused by ATR inhibition. 
We also tested whether ATR inhibition caused the appearance of parental-strand
ssDNA at the replication fork. After labeling overnight with BrdU, we released cells into
fresh growth media for 2 hours before treating with HU with or without ATR inhibitor. As
expected, some parental-strand ssDNA forms during HU treatment alone compared to
untreated;  however,  much  more  parental-strand  ssDNA forms  in  the  ATR  inhibited
condition, indicating that ATR inhibition results in increased nascent- and parental-strand
ssDNA (Fig.  4.5E).  Thus,  fork  collapse when ATR is  inactivated is  characterized by
95
double-strand breaks and a large increase in ssDNA consisting of both the template and
newly sythesized DNA strands.
ATR prevents SLX4- and CtIP-dependent formation of DSBs and nascent-strand ssDNA
at stalled forks
We  reasoned  that  the  nascent-strand  ssDNA  could  be  generated  from
template-strand resection after DSB formation, branch migration of the stalled fork to
yield a reversed fork structure with unequal length nascent DNA strands, or both (Fig.
4.5B). The MUS81 structure-specific endonuclease generates DSBs during persistent
exposure  to  replication  stress  agents  or  in  response  to  silencing  or  inhibition  of
replication fork repair  proteins such as WRN, SMARCAL1, and CHK1  (Bétous et  al.
2012; Forment et al. 2011; Franchitto et al. 2008; Hanada et al. 2007). Therefore, we
tested whether siRNA depletion of MUS81 affects DSB formation in HU/ATRi treated
cells.  Surprisingly,  MUS81-depeleted  cells  showed  no  difference  in  γH2AX  or  DSB
formation  compared  to  controls  (data  not  shown  and  Fig.  4.6A).  We also  failed  to
observe a change in HU/ATRi-induced ssDNA formation with MUS81 knockdown or in
MUS81-deficient HCT116 cells (Fig. 4.6B-C).
Multiple other structure-specific nucleases exist in mammalian cells. SLX4 is a
molecular scaffold which functions as the structural subunit of the SLX4-SLX1 Holliday
junction resolvase and coordinates the SLX1, XPF, and MUS81 nucleases (Fekairi et al.
2009; Svendsen et al. 2009). In contrast to MUS81, silencing SLX4 by siRNA largely
abrogated  DSB formation  in  HU+ATRi  treated  cells  (Fig.  4.7A).  Furthermore,  SLX4
depletion also resulted in  a large decrease in  nascent-strand ssDNA formation (Fig.
4.7B-C).  This  result  is  not  due  to  a  change  in  the  S-phase  population  (Fig.  4.7D).
Furthermore,  the response in  the nascent-strand ssDNA assay correlates with SLX4
knockdown efficiency indicating it  is not  an off-target  effect of  the siRNA (Fig.  4.7E).
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Figure 4.6 MUS81 is not required to generate DSBs or nascent-strand ssDNA after
ATR inhibition. (A) U2OS cells were transfected with MUS81 or control siRNA prior to
treatment for 1h with 1μM CPT or 4h with 3mM HU in the presence or absence of 5μM
ATRi. A neutral COMET assay was performed. Samples were compared with one-way
ANOVA (p < 0.0001). Bonferroni’s Multiple Comparison test was used as a follow up to
compare siCTRL HU+DMSO vs siCTRL HU+ATRi (p < 0.0001), siCTRL HU+DMSO vs
siMUS81 HU+ATRi (p <  0.0001),  and siCTRL HU+ATRi  vs siMUS81 HU+ATRi (p >
0.05). (B) Two independent clones of MUS81-/- cells containing either an empty vector
or expressing a MUS81 cDNA were treated with HU and the ATRi as indicated. The cells
were then labeled with 10μM BrdU for 20 minutes and stained with BrdU antibodies in
non-denaturing conditions to visualize ssDNA. There is no significant difference among
any  of  the  ATRi-treated  samples.  (B)  U2OS  cells  were  transfected  with  control  or
MUS81-targeting siRNA. Transfected cells were labeled with 10μM BrdU for 10 minutes
before addition of 3mM HU and 5μM ATRi for 4 hours. Samples were then processed to
quantitate nascent-strand ssDNA.  Representative dot-plot of mean BrdU intensity per
nucleus is shown. 
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Figure 4.7 SLX4 is required to generate DSBs and nascent-strand ssDNA at stalled
replication forks when ATR is inhibited. (A) U2OS cells were transfected with SLX4 or
control  siRNA prior  to  treatment  for  1h  with  1μM  CPT or  4h  with  3mM  HU in  the
presence or absence of 5μM ATRi. A neutral COMET assay was performed. Samples
were compared with one-way ANOVA (p < 0.0001). Bonferroni’s Multiple Comparison
test was used as a follow up to compare siCTRL HU+DMSO vs siCTRL HU+ATRi (p <
0.0001), siCTRL HU+DMSO vs siSLX4 HU+ATRi (p > 0.05), and siCTRL HU+ATRi vs
siSLX4 HU+ATRi (p < 0.0001). (B-C) U2OS cells were transfected with non-targeting or
SLX4 siRNA then labeled with 10μM BrdU for 10 minutes before addition of 3mM HU
and 5μM ATRi for 4 hours. Samples were then processed to quantitate nascent-strand
ssDNA. (B) Representative images of nascent-strand ssDNA assay in transfected cells.
(C) Representative dot plot  of  the mean BrdU intensity per nucleus.  (D) U2OS cells
transfected with non-targeting or SLX4 siRNA were labeled for 40 minutes with 10μM
BrdU before harvesting for ethanol fixation, acid denaturation, and staining with BrdU
antibodies and propidium iodide to measure the percentage of cells in S-phase by flow
cytometry.  Values  represent  mean  +/-  SEM  of  three  replicates.  (E)  U2OS  cells
transfected with non-targeting or SLX4 siRNA were harvested and lysed. Lysates were
separated by SDS-PAGE and immunoblotted with antibodies to detect SLX4 or GAPDH.
Silencing SLX1,  XPF, MUS81,  or  the GEN1 nuclease individually  had no consistent
effect  on nascent-strand ssDNA formation (Figs.  4.6C and 4.8).  Thus it  is  likely  that
multiple  SLX4-coordinated  nucleases  function  redundantly  to  process  HU  stalled
replication forks when ATR is inhibited.
Once the fork is cleaved, ssDNA could be generated by DNA end-resection. CtIP
promotes resection at DSBs through multiple exonucleases (Paull 2010). Silencing CtIP
significantly reduced the amount of nascent-strand ssDNA with 3 of 4 siRNAs, and the
fourth  siRNA decreased  nascent-strand  ssDNA in  all  experiments  but  did  not  reach
statistical  significance  (Fig.  4.9A-B).  CtIP  protein  levels  decreased  to  nearly
undetectable  levels  with  all  four  siRNAs,  and  the  change  in  nascent-strand  ssDNA
intensity is not due to a change in the S-phase population of these cells (Fig. 4.9C-D).
These results suggest that at least some of the ssDNA that accumulates at stalled forks
when ATR function is inhibited is generated by end-resection. Knockdown of individual
exonucleases  including  EXO1  and  DNA2  alone  did  not  result  in  any  change  in
nascent-strand ssDNA consistent with redundancy in end-resection mechanisms (Fig.
4.10).
Nascent-strand ssDNA formation involves replication fork remodeling
We  next  asked  whether  any  fork  processing  steps  occur  upstream  of
SLX4-dependent cleavage. Specifically, we hypothesized that fork remodeling enzymes
may be needed to generate a reversed replication fork structure that looks like a Holliday
junction  (or  “chicken  foot”),  which  is  a  preferred  substrate  for  SLX4-dependent
endonucleases. Therefore, we tested whether nascent-strand ssDNA formation depends
on  enzymes  known  to  catalyze  replication  fork  regression.  SMARCAL1  is  a  DNA
translocase that  can anneal  DNA strands and perform replication  fork  regression  at
stalled forks with leading strand gaps (Bétous et al. 2012, 2013). Silencing SMARCAL1
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Figure 4.8  SLX1, GEN1, XPF are not required for nascent-strand ssDNA.  U2OS
cells were transfected with control or siRNA targeting SLX1, GEN1, or XPF. (A, C, E)
Transfected cells were labeled with 10μM BrdU for 10 minutes before addition of 3mM
HU and 5μM ATRi for 4 hours to measure nascent-strand ssDNA or (B, D, F) labeled
with 10μM BrdU for 40 minutes to measure percentage of cells in S-phase. Any apparent
decreases in nascent-strand ssDNA can be explained by cell cycle purturbations.
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Figure 4.9 CtIP is required to generate nascent-strand ssDNA at stalled replication
forks when ATR is inhibited.  U2OS cells were transfected with non-targeting or CtIP
siRNA.  (A-B)  Transfected cells  were labeled with 10μM BrdU for  10 minutes before
addition of 3mM HU and 5μM ATRi for 4 hours. Samples were then processed to detect
nascent-strand ssDNA. (A) Quantitation of percent of nuclei containing nascent-strand
ssDNA (mean +/- SEM of three experiments, * indicates p<0.05). (B) Dot-plot of mean
BrdU intensity per nucleus for a representative experiment is shown. (C) Transfected
cells  were  harvested  and  lysed.  Lysates  were  separated  by  SDS-PAGE  and
immunoblotted with antibodies to detect  CtIP or  GAPDH. (D) Transfected cells  were
labeled  for  40  minutes  with  10μM  BrdU before  harvesting  for  ethanol  fixation,  acid
denaturation, and staining with BrdU antibodies and propidium iodide to measure the
percentage of cells in S-phase. Values represent mean +/- SEM of four independent
replicates.
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Figure 4.10 EXO1, DNA2 are not required for nascent-strand ssDNA.  U2OS cells
were transfected with control or siRNA targeting EXO1 or DNA2. (A) Transfected cells
were labeled with 10μM BrdU for 10 minutes before addition of 3mM HU and 5μM ATRi
for 4 hours to measure nascent-strand ssDNA or (B) labeled with 10μM BrdU for 40
minutes to measure percentage of cells in S-phase. Although DNA2-4 siRNA causes a
decrease in  nascent  strand ssDNA (panel  A),  this  correlates with a decrease in  the
S-phase population.
with four siRNAs decreases nascent-strand ssDNA positive cells compared to controls
(Fig.  4.11).  Silencing  other  enzymes  capable  of  catalyzing  fork  regression  including
FANCM, HLTF, ZRANB3, and BLM did not decrease nascent-strand ssDNA (Figs. 4.12
and 4.13). 
To further confirm the requirement of SMARCAL1 in the fork collapse associated
with ATR inactivation, we examined whether a similar phenotype could be observed in
the Xenopus cell-free replication system. In this system, replication of sperm chromatin
in the presence of the DNA polymerase inhibitor aphidicolin causes ATR activation due
to  polymerase  and  helicase  uncoupling  (Byun  et  al.  2005).  Pre-labeling  the  newly
synthesized  DNA  strands  with  BrdU  allowed  us  to  observe  the  appearance  of
nascent-strand  ssDNA either  when  camptothecin  (CPT)  was  added  to  promote  fork
collapse  or  when  ATR  was  inhibited  in  the  presence  of  aphidicolin  (Fig.  4.14A-C).
Depleting  xSMARCAL1  from  the  replicating  extracts  prevented  the  nascent-strand
ssDNA generation only in the context of ATR inhibition with aphidicolin (Fig. 4.14A-C).
xSMARCAL1 depletion had no effect on CPT-induced ssDNA or the activation of the
ATR checkpoint (Fig. 4.14D). Thus, just as in mammalian cells, xSMARCAL1 is at least
partially responsible for the aberrant replication fork processing in the Xenopus cell-free
system when ATR is inactivated. 
These data suggest that when ATR is not active, SMARCAL1 remodels stalled
replication forks, and thereby provides a substrate for endonuclease cleavage and DNA
end-resection. Silencing SMARCAL1 in the mammalian system only yielded a partial
suppression  of  the  ssDNA  phenotype  indicating  other  mechanisms  may  also  be
important. 
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Figure 4.11 SMARCAL1 is required for the generation of nascent-strand ssDNA
when ATR is  inactivated in  human cells.  (A-B)  U2OS cells  were transfected with
control  or  SMARCAL1  siRNA then  labeled  with  10μM  BrdU  for  10  minutes  before
addition  of  3mM  HU and  5μM ATRi  for  4  hours.  Samples  were  then  processed  to
quantitate nascent-strand ssDNA. (A) Bars represent mean +/- SEM of percent BrdU
positive cells across at least 5 experiments. (* p<0.005, ** p<0.001) (B) Representative
dot-plots of mean BrdU intensity per nucleus. (C) U2OS cells transfected with control or
SMARCAL1 siRNA were harvested and lysed. Lysates were separated by SDS-PAGE
and immunoblotted with antibodies to detect SMARCAL1 or GAPDH. (D) Four siRNAs
against SMARCAL1 were transfected into U2OS cells. Transfected cells were labeled
with 10μM BrdU for 10 minutes before addition of 3mM HU and 5μM ATRi for 4 hours.
Samples  were  then  processed  to  quantitate  nascent-strand  ssDNA.  Bars  represent
mean and SEM of 3 replicates. (* p<0.05).
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Figure 4.12 FANCM, HLTF are not required for nascent-strand ssDNA. U2OS cells
were transfected with control or siRNA targeting FANCM or HLTF. (A) Transfected cells
were labeled with 10μM BrdU for 10 minutes before addition of 3mM HU and 5μM ATRi
for 4 hours to measure nascent-strand ssDNA or (B) labeled with 10μM BrdU for 40
minutes to measure percentage of cells in S-phase.
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Figure 4.13 ZRANB3, BLM are not required for nascent-strand ssDNA. U2OS cells
were transfected with control or siRNA targeting ZRANB3 or BLM. (A-B) Transfected
cells were labeled with 10μM BrdU for 10 minutes before addition of 3mM HU and 5μM
ATRi for 4 hours to measure nascent-strand ssDNA or (C) labeled with 10μM BrdU for
40 minutes to measure percentage of cells in S-phase. (A) Bars represent mean and
SEM of 3 replicates.
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Figure 4.14 xSMARCAL1 is required for the generation of nascent-strand ssDNA
when ATR is inactivated in  Xenopus egg extract.  Sperm chromatin (4000 nuclei/µl)
was replicated in low speed Xenopus extract containing DMSO or ATR inhibitor. After 10
minutes,  extracts  were  labeled  with  50μM BrdU for  20  minutes  prior  to  addition  of
DMSO, 50μM camptothecin (CPT), or 100μM aphidicolin (APH) as indicated. 60 minutes
after addition of chromatin, nuclei were fixed and spun down onto coverslips through a
glycerol cushion. Where indicated extracts were either mock or xSMARCAL1 depleted.
Nuclei  from  extracts  were  processed  to  quantitate  nascent-strand  ssDNA.  (A)
Representative images of BrdU staining from each sample. (B) Representative dot-plots
of BrdU intensity per nucleus measured using ImageJ. (C) Quantitation (mean +/- SEM)
of percent BrdU positive nuclei across three independent experiments. (D) Extracts were
harvested,  separated  by  SDS-PAGE  and  immunoblotted  with  antibodies  to  detect
xSMARCAL1, CHK1 pS345, or xCHK1. These data were produced by Robert Driscoll.
Replication stress induces SMARCAL1 phosphorylation after it accumulates at stalled
forks and binds DNA
One  mechanism  to  explain  these  results  is  that  ATR  prevents  aberrant  fork
processing  by  directly  regulating  SMARCAL1.  The  lack  of  effect  of  xSMARCAL1
depletion on CPT-induced ssDNA formation would be consistent with this mechanism
since  ATR  is  active  in  these  circumstances.  ATR  can  phosphorylate  SMARCAL1
(Bansbach  et  al.  2009),  but  the  functional  consequences  have  not  been  described.
Therefore,  we investigated whether  SMARCAL1 phosphorylation  is  a mechanism by
which ATR stabilizes stalled replication forks.
SMARCAL1 phosphorylation in response to replication stress can be monitored
by  a  pronounced  gel  mobility  shift  of  the  endogenous  protein  ((Bansbach  et  al.
2009) and Fig. 4.15A). GFP-SMARCAL1 protein expressed at near endogenous levels
in HEK293T cells also is phosphorylated in response to HU (Fig. 4.15A). SMARCAL1
localizes to stalled forks via an interaction between its N-terminus and RPA2 (Bansbach
et  al.  2009;  Ciccia  et  al.  2009;  Yuan  et  al.  2009;  Yusufzai  et  al.  2009).  However,
abrogation of stalled fork localization with a mutant that does not bind RPA (ΔN) caused
a  loss  of  damage-dependent  phosphorylation  indicating  SMARCAL1  must  be  in
proximity  to  the  stalled  fork  to  be  phosphorylated  (Fig.  4.15B).  Deletion  or  point
mutations in the SMARCAL1 HARP1 domain decrease but do not eliminate DNA binding
(Bétous et  al.  2012),  and  decrease  damage-dependent  SMARCAL1 phosphorylation
(Fig. 4.15B). Deletion or mutation of the HARP2 domain eliminates DNA binding (Bétous
et al. 2012) and eliminates phosphorylation (Fig. 4.15B). These HARP mutants retain the
ability to localize to stalled forks (Fig. 4.16), indicating that both localization and DNA
binding  are  required  for  damage-dependent  phosphorylation.  Thus,  phosphorylation
occurs after SMARCAL1 is positioned to catalyze fork remodeling. However, the ability
of SMARCAL1 to translocate on DNA is not a prerequisite for phosphorylation since the
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Figure 4.15 ATR phosphorylates SMARCAL1 after  SMARCAL1 binds to DNA at
stalled  forks. (A  and  B)  HEK293T  cells  were  transfected  with  small  amounts  of
GFP-SMARCAL1  wild  type  (WT)  and  mutant  expression  vectors  to  minimize
overexpression.  ΔH1  and  ΔH2  are  deletions  of  the  HARP1  and  HARP2  domains,
respectively, while H1-WF and H2-WF are point mutants in each HARP domain (Bétous
et al.  2012). Cells were treated with 2mM HU for 16h where indicated prior to lysis,
separation  by  SDS-PAGE,  and  immunoblotting  with  SMARCAL1  antibody.  (C)
SMARCAL1 was purified from untreated (unt.) or HU-treated (16h, 2mM) HEK293T cells
and used to measure ATPase activity in the presence of 5nM forked DNA substrate.
Error  bars  are  standard  deviation  from  three  experiments  (p  =  0.0007,  two-tailed
unpaired t-test). The inset is an immunoblot showing equal amounts of protein used in
each  condition.  The  purified  protein  was  treated  with  lambda  phosphatase  before
immunoblotting to eliminate the gel mobility shift and allow more accurate quantitation of
protein concentration. (D) ClustalW was used to align SMARCAL1 from the indicated
organisms.  The position  of  the  phosphorylated  SQ residues S173,  S652,  and S919
relative to protein domains is depicted. (E) SMARCAL1 was purified from HU-treated
HEK293T cells, trypsinized, and analyzed by tandem mass spectrometry. Shown is one
of several spectra that correspond to phosphorylated S652. These data were produced
by Carol Bansbach.
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Figure  4.16  SMARCAL1  mutants  that  cannot  bind  DNA  retain  their  ability  to
localize  to  sites  of  stalled  replication  forks.  U2OS  cells  transfected  with
GFP-SMARCAL1 vectors were treated with HU for five hours, fixed and stained with
antibodies to RPA2 and imaged for GFP, RPA and DAPI. Representative images are
shown. None of the mutations except the RPA binding mutant (ΔN) caused a difference
in  the  percentage  of  cells  containing  SMARCAL1  foci.  ΔHARP1  and  ΔARPH2  are
deletions of the HARP1 and HARP2 domains, respectively, while H1-WF and H2-WF are
point  mutants  in  each  HARP domain  (Bétous et  al.  2012).  R764Q is  a  catalytically
inactive mutant  (Yusufzai and Kadonaga 2008). These data were produced by Carol
Bansbach.
ATPase-deficient R764Q mutant exhibits the same mobility shift as the wild-type protein
in response to HU (Fig. 4.15B). 
S652 phosphorylation reduces SMARCAL1 activity 
To test  the functional  significance of  damage-dependent  phosphorylation we isolated
SMARCAL1 before and after exposure to HU. Phosphorylated SMARCAL1 isolated from
HU-treated  cells  retains  only  50%  activity  compared  to  SMARCAL1  isolated  from
untreated  cells  (Fig.  4.15C).  This  suggests  that  HU-dependent  post-translational
modifications inactivate SMARCAL1. This difference in activity is not due to a difference
in cell cycle stage induced by HU since the cells were synchronized and released into
S-phase prior to the experiment.
Next,  we utilized  mass-spectrometry  and  phosphopeptide  mapping  to  identify
damage-induced phosphorylation sites. Mass spectrometry of SMARCAL1 purified from
HU-treated  cells  identified  phosphorylation  of  S652,  which  lies  within  a  consensus
sequence (SQ) for the ATR kinase (Fig. 4.15E) on a linker between the two lobes of the
SMARCAL1  ATPase  domain  (Fig.  4.15D).  We  identified  two  additional  SQ
phosphorylation sites (S173 and S919) through phosphopeptide mapping (Fig.  4.17).
These phosphorylation sites are within poorly conserved, unstructured regions near the
N- and C-termini, respectively (Fig. 4.15D).
Since S652 is highly conserved, we raised phosphopeptide specific antibodies to
this phosphorylation site. These antibodies show that S652 phosphorylation is increased
in response to HU (Fig. 4.18A). Phosphorylation is largely ATR-dependent in cells (Fig.
4.18B),  and  purified  ATR can  phosphorylate  S652  in  an  in  vitro  kinase  assay  (Fig.
4.18C).
To determine whether these phosphorylation sites are functionally important, we
tested whether phosphorylation alters SMARCAL1 localization or biochemical functions.
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Figure 4.17 Mapping of SMARCAL1 phosphorylation sites. To determine and map
additional sites of phosphorylation, we utilized two-dimensional phosphopeptide
mapping on thin layer cellulose plates. (Continued on next page)
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Figure 4.17 Mapping of SMARCAL1 phosphorylation sites (cont'd).  (A) First the
phosphopeptide map of  endogenous SMARCAL1 was determined before and
after  treatment  with  HU.  Several  SMARCAL1  phosphopeptides  are  detected
when SMARCAL1 is purified from 32P-orthophosphate-labeled cells.  After HU
treatment  phosphopeptides  1  and  2  decrease  in  intensity, phosphopeptide  b
increases, and several new phosphopeptides (a, c, d, and e) appear. (B) Similar
patterns of phosphorylation are evident on GFP-SMARCAL1 with the exception
that  phosphopeptide  e  is  not  visible.  We next  examined  the  phosphopeptide
patterns  of  GFP-SMARCAL1  mutant  proteins  purified  from
orthophosphate-labeled cells.  (C)  We first  examined S172 and S173 since a
tryptic peptide containing a phosphorserine at one of these two positions was
identified in our mass spectrometry experiments. Mutation of S172 to alanine did
not change the phosphopeptide pattern; whereas, mutation of S173 to alanine
eliminated phosphopeptide d and greatly reduced posphopeptide b. Thus, S173
is a major site of phosphorylation after DNA damage. It is likely phosphorylated
by the PIKK family of kinases since it matches the consensus for ATR and ATM
phosphorylation  (SQ).  (C  and  D)  To  identify  the  other  damage-induced
phosphorylation sites, each candidate SQ or TQ in SMARCAL1 was mutated to
alanine. (C) Mutation of S919 to alanine eliminated phosphopeptide c indicating
S919 is phosphorylated in cells.  S919 is contained within a very large tryptic
peptide  that  contains  14  potential  sites  of  phosphorylation
(EGSDMELLEASESFDPGSASGTSGSSSQNMGDTLDESSLTASPQK). In the 2D
mapping,  peptides  that  have  variable  numbers  of  phosphorylated  residues
typically  yield  a  complicated  pattern  with  multiple  spots  on  a  diagonal.
Furthermore,  large  peptides  move  only  short  distances  from  the  origin  and
increasing phosphorylation retards the mobility even further. Thus, we believe
phosphopeptides 1, 2, and c are actually the same peptide with one, two, or
three  phosphates  respectively.  This  interpretation  explains  the  proportional
decrease  in  intensity  of  phosphopeptides  1  and  2  when  c  is  increased  in
HU-treated cells.  The large size of this phosphopeptide may also explain our
inability  to  observe  it  by  mass  spectrometry.  (D)  We  did  not  observe  any
consistent change in the phosphopeptide map after mutation of any of the other
SQ or TQ motifs. The lack of a change in the map when S652 is mutated to
alanine was surprising given the mass spectrometry data indicating this SQ site
is phosphorylated on endogenous SMARCAL1 in HU-treated cells. We suspect
S652  is  on  phosphopeptide  e  which  is  only  visible  on  the  endogenous
SMARCAL1 map and not on the maps from the GFP-SMARCAL1 protein. The
small size and charge of the predicted S652 tryptic peptide (SDVLSQLPAK) are
consistent with the migration of phosphopeptide e in both dimensions on the TLC
plate.  These  data  suggest  S652  is  not  efficiently  phosphorylated  on  the
exogenous  GFP-SMARCAL1  protein.  These  data  were  produced  by  Carol
Bansbach.
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Figure 4.18 SMARCAL1 S652 is phosphorylated by ATR in cells and in vitro. (A and
B) HEK293T cells were transfected with Flag-SMARCAL1 and treated with HU for the
indicated  times.  Kinase  inhibitors  were  added  as  indicated.  Flag-SMARCAL1  was
immunoprecipitated from cell lysates, separated by SDS-PAGE and immunoblotted with
either  total  SMARCAL1  antibody  or  pS652-specific  antibody.  Asterisks  indicate
non-specific bands. Images were captured and quantitated relative to total SMARCAL1
using an Odyssey imaging system. (C) Purified ATR-ATRIP complex phosphorylates a
GST-S652 peptide in vitro. ATRi was added where indicated to ensure specificity of the
kinase in the reaction. Shown are images of a coomassie stained gel to visualize the
amount of ATR and GST protein in the reactions or an autoradiogram (32P) of the gel to
visualize phosphorylation. Data for panel A were produced by Carol Bansbach. Data for
panel C were produced by David Cortez.
Phosphorylation of S173, S652, or S919 does not regulate SMARCAL1 localization to
stalled  replication  forks  since  neither  non-phosphorylatable  nor  phospho-mimetic
mutations in these residues alter their ability to co-localize with RPA foci in response to
DNA damage  (Fig.  4.19).  Mutations  of  S173  or  S919  also  did  not  affect  the  DNA
stimulated  ATPase  activity  of  SMARCAL1  (Fig.  4.20A-B).  In  contrast,  the
phospho-mimetic  S652D  mutant  is  a  much  less  active  DNA-stimulated  ATPase
compared to the wild-type (Fig.  4.20C-D),  even though it  has indistinguishable  DNA
binding  activity  (Fig  4.21).  The  extent  of  ATPase  inhibition  caused  by  the
phospho-mimetic  mutation  is  similar  to  the  inhibition  of  SMARCAL1  observed  after
HU-treatment (Fig. 4.15C), suggesting that S652 phosphorylation is a major mechanism
by  which  SMARCAL1  is  inhibited  in  cells  exposed  to  persistent  replication  stress.
Combining  the  S173D,  S652D,  S919D  mutations  did  not  further  alter  SMARCAL1
activity (data not shown), and mutation of S652 to alanine had no effect on SMARCAL1
activity indicating the serine itself is not required for function. 
Consistent  with  its  reduced  ATPase  activity,  we  also  observed  a  significant
reduction  in  the  ability  of  the  phospho-mimetic  S652D SMARCAL1  to  catalyze  fork
regression  compared  to  the  S652A or  wild-type  proteins  indicating  that  SMARCAL1
phosphorylation  at  S652 limits  its  ability  to  perform branch migration  (Fig.  4.20E-F).
Combined with the observation that SMARCAL1 must first bind DNA before it can be
phosphorylated, these data are consistent with a model in which SMARCAL1 initially is
recruited to a damaged fork, binds the DNA to perform a fork remodeling activity, and
then is phosphorylated on S652 to regulate this activity. 
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Figure 4.19 SMARCAL1 phosphorylation on S173, S652, or S919 does not alter its
ability to bind DNA or localize to stalled replication forks.  U2OS cells transfected
with  GFP-SMARCAL1  expression  vectors  encoding  non-phosphorylateable  or
phosphorylation-mimetic mutations were treated with HU for five hours, fixed and stained
with antibodies to RPA2 and imaged for GFP, RPA and DAPI. Representative images are
shown.  None  of  the  mutations  altered  the  percentage  of  cells  exhibiting
GFP-SMARCAL1 and RPA co-localization. Data were produced by Carol Bansbach.
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Figure 4.20 SMARCAL1 phosphorylation on serine 652 inhibits its ATP-dependent
fork remodeling activity. (A-D) The indicated Flag-SMARCAL1 proteins were purified
from HEK293T cells  (A-C) or  baculovirus infected insect  cells  (D),  and their  ATPase
activity  measured in  the presence of  increasing concentrations  of  splayed arm DNA
substrate. The insets in (A-C) are representative immunoblots, and the inset in (D) is a
coomassie  stained  gel  showing  equal  amount  of  wild-type  and  mutant  SMARCAL1
proteins used. Error bars in all panels represent SEM (n=3) and in many cases were
smaller than the symbol. *p < 0.0002, **p < 0.002, ***p < 0.05. (E-F) The fork regression
activity  of  purified  SMARCAL1  proteins  was  assayed  on  a  model  replication  fork
substrate schematized on the far left. (See Table 4.1 for details). (E) A representative
DNA gel and (F) quantitation of three independent experiments (mean and SEM) are
shown. Inset  is a representative immunoblot  showing equal  amount of  wild-type and
mutant SMARCAL1 proteins. Data for panels A-D were produced by Carol Bansbach.
Proteins used in panels E-F were purified by Clint Carroll. Lead-gap substrate used in
panels E-F was purified by Rémy Bétous.
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Figure 4.21 Mutation of S652 does not alter the DNA binding ability of SMARCAL1.
Increasing amounts of wild-type, S652A, or S652D mutant SMARCAL1 proteins were
incubated with a radio-labeled splayed arm DNA substrate. Complexes were separated
by  electrophoresis  on  a  polyacrylamide  gel  and  imaged  by  autoradiography.
WB=western blot showing that equal levels of the proteins were used in the assay. Data
were produced by Clint Carroll.
Too much SMARCAL1 activity in cells phenocopies the effect of ATR inhibition on fork
collapse
To  confirm  that  ATR-dependent  SMARCAL1  phosphorylation  also  inhibits
SMARCAL1 activity in cells at stalled replication forks, we used an assay that measures
the  consequences  of  uncontrolled  SMARCAL1  activity.  Expression  of  wild  type
SMARCAL1  from a  strong  promoter  causes  the  induction  of  γH2AX throughout  the
nucleus in a pan-nuclear pattern (Fig. 4.22A-C, and  Bansbach et al.  2009) similar to
what  is  observed when ATR is  inhibited in  HU-treated cells  (Fig.  4.4A)  supporting a
functional link between ATR and SMARCAL1. The induction of pan-nuclear γH2AX by
overexpressed SMARCAL1 is dependent on DNA replication, the ability of SMARCAL1
to localize to stalled forks, and its enzymatic activity  (Bansbach et al. 2009). Like ATR
inhibition,  overexpression  of  SMARCAL1 causes  increased  levels  of  single-stranded
DNA at  replication  forks  (Fig.  4.22D-E).  Furthermore,  just  as  is  the  case  with  ATR
inhibition,  knockdown  of  SLX4,  but  not  MUS81,  resulted  in  a  decrease  in  ssDNA
formation  in  cells  expressing  SMARCAL1  (Fig.  4.22E).  Taken  together,  these  data
indicate that the phenotype of cells overexpressing SMARCAL1 is similar to that induced
when ATR is inhibited as predicted if ATR phosphorylates SMARCAL1 as a mechanism
of limiting its activity and preventing fork collapse. 
If ATR-catalyzed S652 phosphorylation decreases SMARCAL1 activity to prevent
aberrant  fork  processing  then  the  S652D  phospho-mimetic  mutation  should  yield  a
protein  that  is  less  capable  of  inducing  the  pan-nuclear  γH2AX phenotype.  Indeed,
overexpression of GFP-SMARCAL1 S652D induces significantly less pan-nuclear H2AX
phosphorylation compared to the wild type protein (Fig. 4.22A-B). We did observe some
cells  with  pan-nuclear  γH2AX  when  S652D  is  overexpressed;  however,  those  cells
contained on average twice the amount of S652D protein overexpression compared to
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Figure 4.22 Phosphorylation of SMARCAL1 at S652 decreases its activity at DNA
replication forks in cells. (A-C) GFP-SMARCAL1 wild type and mutant proteins were
over-expressed in U2OS cells. Cells were stained with DAPI to mark the nucleus and
antibodies  to  γH2AX.  Images  were  acquired  using  an  Opera  automated  confocal
microscope and the levels of GFP-SMARCAL1 and γH2AX levels were quantitated in
each nucleus using Columbus software. (A) Representative images. (B) Data represent
the  percent  of  cells  expressing  between  500-2500  arbitrary  units  (a.u.)  of
GFP-SMARCAL1 that contain a mean γH2AX intensity of greater than 1000 a.u. Error
bars represent SEM from three independent experiments; *p = 0.0007, **p = 0.023. (C)
The expression level of GFP-SMARCAL1 (as measured by GFP intensity) in each cell
that  had  γH2AX intensity  of  greater  than  1000  arbitrary  units  is  plotted  in  box  and
whisker format; Significantly higher GFP-SMARCAL1 S652D protein levels were needed
to  induce  γH2AX  than  either  wild-type  or  S652A  protein  (p  <  0.0001).  (D)
GFP-SMARCAL1 proteins with the indicated mutations were expressed in U2OS cells.
BrdU was added to the culture media 16h prior fixation and staining in non-denaturing
conditions  to  measure  the  total  level  of  ssDNA.  The  mean  intensity  (a.u.)  of  BrdU
staining per GFP-SMARCAL1 expressing cell is graphed. The line indicates the mean
value  in  each  population  (Mann-Whitney  test  S652A  vs.  S652D,  p  =  0.013).  (E)
GFP-SMARCAL1 proteins were expressed in U2OS. These cells were then transfected
with control, MUS81 or SLX4 siRNA. BrdU was added to the culture media 16h prior
fixation and staining in non-denaturing conditions to measure the total level of ssDNA.
The mean intensity (a.u.) of BrdU staining per cell  is graphed. The line indicates the
mean value in  each  population  (Mann-Whitney  test  siCTRL vs  siSLX4,  p  =  0.0012;
siSLX4  vs  siMUS81,  p  <  0.0001).  Data  for  panels  A-C  were  produced  by  Carol
Bansbach. Data for panels D-E were produced by Gloria Glick.
the level of the wild type or S652A proteins needed to induce pan-nuclear γH2AX (Fig.
4.22C). 
Finally,  consistent  with  our  model,  we  also  found  that  overexpression  of  the
S652D SMARCAL1 protein yielded less single-stranded DNA than the S652A mutant
although it does remain slightly more active than a SMARCAL1-ΔN protein that cannot
localize to stalled forks because it lacks an RPA binding domain (Fig. 4.22D). These data
suggest that S652 of SMARCAL1 is one of the ATR phosphorylation targets necessary
to prevent fork collapse and emphasize the need for properly regulating SMARCAL1 to
achieve successful stalled fork stabilization and repair.
Discussion
Our data is consistent with a specific model of how ATR prevents fork collapse in
the context of replication stress (Fig. 4.23). ATR maintains the integrity of the replication
fork through regulation of several proteins including direct phosphorylation of S652 of
SMARCAL1. If properly regulated, SMARCAL1 participates in maintaining fork stability
and promoting fork restart.  However, in  the absence of  ATR regulation,  SMARCAL1
catalyzes excessive replication fork reversal or other DNA remodeling that generates a
substrate  for  the  SLX4-dependent  Holliday  junction  endonucleases.  These  enzymes
cleave  the  reversed  replication  fork  into  a  one-ended  DSB  which  CtIP-dependent
endonucleases further process into ssDNA of both the parental and nascent strands.
Consistent with this model, fork reversal is observed in replication checkpoint-deficient
S.  cerevisiae cells  in  response to replication stress  (Lopes et  al.  2001) although no
responsible yeast enzymes have been identified. In addition, nucleases process stalled
forks in checkpoint defective yeast cells (Cotta-Ramusino et al. 2005). This model also
explains why both too little and too much SMARCAL1 in a cell causes replication fork
collapse  (Bansbach  et  al.  2009).  Finally,  the  activity  of  unregulated  SMARCAL1  in
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Figure 4.23 Model for nascent-strand ssDNA generation at stalled forks. Black and
red lines represent template and nascent strands, respectively. HU causes uncoupling of
the replicative  helicase  and  polymerases,  resulting  in  template-strand  ssDNA at  the
replication fork. ATR prevents aberrant fork remodeling by the SMARCAL1 enzyme. In
the absence of ATR-dependent SMARCAL1 S652 phosphorylation, a Holliday-junction
like  structure  may persist  at  the  fork  and  is  cleaved by  SLX4-dependent  nucleases
generating  a  double-strand  break.  CtIP-dependent  nucleases  then  resect  the  break
yielding nascent-strand ssDNA. CtIP may also process a reversed fork structure prior to
SLX4 cleavage which could contribute to the nascent-strand ssDNA formation.
causing fork collapse is not limited to mammalian cells since we also observed it in a
Xenopus cell-free replication system when ATR is inhibited. 
ATR as a drug target
The essential function of ATR to maintain cell viability is linked to its requirement
to complete DNA replication and separable from its G2 checkpoint activity  (Nam et al.
2011b). Defining how ATR promotes the completion of DNA replication is essential to
understand the major pathway that controls genome integrity in S-phase and to identify
the  mechanism  of  action  of  ATR-directed  drugs.  Our  data  indicate  that  acute  ATR
inhibition results in  a rapid decrease in  the rate of  fork elongation.  This  effect  likely
results from loss of checkpoint control of origin firing leading to a decrease in elongation
rates due to depletion of essential replication factors such as nucleotides or replication
proteins. The deregulation of origin timing is unlikely to be cell lethal by itself since it
happens within 20 minutes of adding the ATRi but loss of cell viability requires several
hours without additional genotoxic agents. Furthermore, suppression of origin firing by
the addition of CDK2 or CDC7 inhibitors did not improve the viability of ATRi-treated cells
(Fig.  4.24).  More likely  the  essential  function  of  ATR is  to  stabilize  or  repair  stalled
replication forks, which collapse when ATR is inhibited. Deregulated origin firing would
exacerbate  this  problem  by  creating  additional  stalled  forks.  Consistent  with  this
interpretation, viability is lost within 45 minutes in cells treated with both ATRi and HU.
The increase in irreversible replication fork collapse, concomitant formation of  DSBs,
and excess ssDNA when ATR is inactivated suggests improper enzymatic processing of
the  stalled  fork  DNA.  These  fork-processing  events  may  be  largely  unsuccessful
attempts to repair the damaged fork. 
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Figure 4.24  CDK2 and CDC7 kinase inhibitors do not rescue ATRi toxicity. (A-C)
U2OS cells were treated with DMSO, 5μM ATRi, 5μM CDC7i (PHA 767491, Sigma), or
ATRi + CDC7i in the absence (A) or presence (B) of 3mM HU for the indicated times. (C)
U2OS cells were treated with DMSO, 5μM ATRi, 30μM Roscovitine (Sigma), or ATRi +
Roscovitine in the presence of 3mM HU for the indicated times. (A-C) After treatment,
cells were released into fresh growth media for 10-14 days. Colonies were visualized by
methylene blue staining. Results shown are mean +/- SEM of at least two independent
experiments.
Aberrant stalled fork processing when ATR is inactivated
Previous  studies  implicated  the  MUS81  endonuclease  as  an  enzyme  that
cleaves persistently stalled replication forks after several hours of HU treatment leading
to the appearance of  high levels  of  γH2AX  (Hanada et  al.  2007).  MUS81 was also
reported to generate DNA damage in cells treated with a CHK1 inhibitor (Forment et al.
2011). However, we found no effect of MUS81 on the generation of DSBs in cells treated
with the ATRi. Instead, we observed a strong dependency on SLX4. Furthermore, we
found that SLX4 is required for nascent-strand ssDNA formation. SLX4 is a scaffolding
protein for several endonucleases including MUS81, SLX1, and XPF (Fekairi et al. 2009;
Svendsen et al. 2009). Since we did not observe a significant effect of silencing any of
these nucleases individually, our data suggests that more than one of them may function
redundantly to cleave stalled forks when ATR is inhibited. CtIP-dependent exonucleases
then process the cleaved fork to generate nascent-strand ssDNA. SLX4 depletion yields
a  complete  loss  of  DSBs  as  measured  by  the  COMET  assay,  but  only  a  partial
suppression of the nascent-strand ssDNA. Therefore, it is possible that CtIP also directs
resection of  a stalled,  regressed fork when ATR is  inhibited prior  to  DSB formation,
thereby generating a nascent-strand ssDNA overhang with or without SLX4-dependent
cleavage.
A preferred substrate of SLX4-dependent endonucleases resembles a Holliday
junction,  which can form at  a stalled fork either due to torsional stress or  enzymatic
processing.  Our  data  are  consistent  with  enzymatic  processing  of  the  fork  by  the
SMARCAL1  fork  regressing  enzyme  to  generate  a  preferred  substrate  for
SLX4-dependent cleavage when ATR is inhibited. ATR phosphorylates SMARCAL1, and
previous  studies  indicate  that  excess  SMARCAL1  activity  causes  replication  fork
problems  (Bansbach et al.  2009). Thus,  the fork remodeling activities of SMARCAL1
promotes fork repair in some cases, but can threaten genome stability if  not properly
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regulated. SMARCAL1 is not needed for fork collapse in all circumstances. For example,
our  data  indicate  that  CPT  treatment  induces  fork  collapse  and  ssDNA  formation
independently  of  xSMARCAL1.  Since  ATR  would  be  active  in  CPT-treated  cells,
SMARCAL1 would be appropriately regulated. 
Consistent with our model we find that phosphorylated SMARCAL1 purified from
cells treated with HU is significantly less active than SMARCAL1 purified from untreated
cells.  We  identified  three  damage  induced  phosphorylation  sites  on  SMARCAL1
including S652, which is phosphorylated by ATR. Phospho-mimetic mutations in S652
yield  a  protein  that  is  significantly  less  active  in  catalyzing  ATP hydrolysis  and  fork
reversal in vitro and also less active in cells. S652 lies within the linker between the two
RecA lobes of the ATPase domain. Flexibility of this linker is needed for conformational
changes required for catalysis (Dürr et al. 2005; Lewis et al. 2008; Sprouse et al. 2006).
Since S652 phosphorylation does not impair SMARCAL1 localization or DNA binding
activity, we suspect that phosphorylation of the linker reduces the ability of SMARCAL1
to  undergo  this  conformational  change  and  thereby  inhibits  its  translocase  activity.
SMARCAL1 phosphorylation requires it to first localize to the stalled fork and bind DNA.
Thus, SMARCAL1 likely acts at damaged forks prior to ATR-dependent phosphorylation,
which serves as a mechanism of limiting its activity. 
Overexpression of active SMARCAL1 causes pan-nuclear γH2AX staining. This
effect requires localization of SMARCAL1 to replication forks and its enzymatic activity.
The exact source of this staining pattern is not clear although it forms well before there is
any evidence of  apoptosis,  it  is  chromatin-associated (data not  shown),  and is  also
observed in cells treated with ATRi and HU. Thus, our data suggest that it is linked to the
aberrant  fork  processing  and  collapse  that  occurs  when  ATR  cannot  regulate
SMARCAL1.  Consistent  with  this  interpretation,  the  phospho-mimetic  S652D
SMARCAL1 protein is less capable of inducing this phenotype and is less active as a
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fork regression enzyme. Furthermore, like ATR inhibition, SMARCAL1 overexpression
also induces SLX4-dependent excess ssDNA formation at stalled forks and this effect is
alleviated by a phosphomimetic mutation in S652. 
Another prediction of our model is that the S652A mutant should retain too much
activity in HU-treated cells perhaps generating some fork collapse events even when
ATR is not inhibited (assuming S652 phosphorylation is not completely redundant with
other mechanisms). Unfortunately, since SMARCAL1 overexpression causes significant
perturbations to DNA replication on its own and the S652 site does not appear to be
regulated properly  on the exogenously expressed SMARCAL1 wild-type protein (Fig.
4.17),  we have been unable to do effective genetic complementation experiments to
examine the effect of the S652A mutant on fork collapse and ssDNA generation. Future
experiments  either  knocking  in  the  mutation  into  the  genome  or  using  expression
systems with native promoter and gene structures will be needed.
Neither  SMARCAL1  nor  SLX4  silencing  completely  prevents  nascent-strand
ssDNA  formation  caused  by  ATR  inhibition  suggesting  additional  aberrant  fork
processing  events  remain  to  be  identified.  The  lack  of  complete  suppression  by
SMARCAL1 silencing may also be due to the competing increase in ssDNA generated
due to the need for some properly regulated SMARCAL1 protein to protect stalled forks.
In  addition,  it  seems  likely  that  additional  mechanisms  regulate  the  activity  of
SMARCAL1. Our phosphopeptide maps indicate that S652, S173, and S919 are the
major HU-induced phosphorylation sites on SMARCAL1; however mutation of all three
serines to alanines does not eliminate the HU-induced mobility shift of the protein on
SDS-PAGE  gels  (data  not  shown).  Thus,  there  must  be  additional  regulatory
post-translational  modifications  that  could  also  contribute  to  SMARCAL1  regulation.
Finally,  the  ATR  inhibitor  may  not  completely  block  all  ATR  activity  so  the  results
observed may not be equivalent to a complete loss of ATR function.
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Conclusions
ATR signaling has long been known to regulate DNA replication and prevent fork
collapse based largely on studies in yeast. However, the molecular mechanisms of what
ATR does to prevent fork collapse and even what fork collapse is in mammalian cells are
not  well  understood.  Our  data  define  an  ATR-dependent  replication  fork  protection
mechanism in human cells  that  is  critical  for  genome maintenance and cell  viability.
These studies also help define the mechanism of action of  ATR-targeted therapeutic
agents. Specifically, combinations of selective ATR pathway inhibitors with either intrinsic
or added replication stress provides a rapid mechanism of cancer cell killing due at least
in part to aberrant processing of stalled replication forks.
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Table 4.1 Oligonucleotides for substrate construction.
CHAPTER V
BIOCHEMICAL MECHANISM OF SMARCAL1 TRANSLOCATION ON DNA
Introduction
During  DNA  replication,  replication  forks  frequently  encounter  DNA  damage
which causes replication stress. One potential repair intermediate is the regressed fork
in  which  the  two  nascent  strands  pair  as  the  branch  point  migrates  in  the  reverse
direction  of  replication  fork  movement.  This  four  way  junction  resembles  a  Holliday
junction and may serve as an intermediate in several repair pathways.
SMARCAL1  is  a  DNA-stimulated  ATPase  capable  of  rewinding  RPA-coated
bubbles  and  performing  both  fork  regression  and  restoration  in  vitro. Depletion  of
SMARCAL1 causes DNA damage and sensitivity to replication stress  (Bansbach et al.
2009; Ciccia et al. 2009; Postow et al. 2009; Yuan et al. 2009), and over-expression of
SMARCAL1  also  causes  DNA damage  (Bansbach  et  al.  2009;  Couch  et  al.  2013).
SMARCAL1 belongs to the SWI/SNF family of the helicase-like protein superfamily 2
(SF2), which includes several other enzymes capable of in vitro fork regression including
UvsW, ZRANB3, and RecG (Atkinson and McGlynn 2009; Singleton et al. 2007). While
we have characterized several genetic phenotypes of SMARCAL1, we still do not fully
understand the biochemistry of the enzyme. Therefore, we will compare SMARCAL1 to
the more well characterized UvsW and RecG and the related human annealing helicase,
ZRANB3.
To better understand how annealing helicases help preserve genome integrity,
we conducted a biochemical study of how leading and lagging template strand lesions
affect SMARCAL1 activity, and we compared the activities of UvsW, RecG, and ZRANB3
in these assays. Two lines of evidence suggest a translocation polarity for SMARCAL1.
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First, nuclease footprinting assays demonstrated that SMARCAL1 binds the dsDNA of
the  parental  duplex  primarily  on  the  leading  template  strand  (Bétous  et  al.  2013).
Second, our collaborator Maria Manosas determined that in a single molecule assay
using a DNA hairpin controlled by magnetic tweezers, a region of reversed polarity on
the  parental  leading  strand  more  strongly  inhibited  SMARCAL1 activity  than  on  the
parental  lagging  strand,  suggesting  that  SMARCAL1  binds  the  leading  strand  (M.
Manosas, personal communication – similar  to experiments in  Manosas et al.  2013).
Therefore,  we  hypothesized  that  SMARCAL1 binds  and  tracks  the leading  template
strand of DNA during fork regression.
To test this hypothesis, we created model replication fork substrates containing
modifications on the leading or lagging template strands. These modifications included
nicks, gaps, and biotinylation. Using substrates containing biotinylated deoxyuridine in
either  the  leading,  lagging,  or  both  tempate  strands,  we  compared  SMARCAL1,
ZRANB3, UvsW, and RecG. We determined that these enzymes were similarly inhibited
by avidin bound to the leading template strand. This suggests that while this assay likely
does not measure translocation polarity, these enzymes use a common mechanism for
fork regression.
Results
The  biochemical  properties  of  other  dsDNA translocases  have  been  defined
using gapped dsDNA to determine the polarity and step-size of these enzymes (Deindl
et al. 2013; Stanley et al. 2006; Whitehouse and Stockdale 2003). While SMARCAL1 is
not known to translocate on dsDNA alone, we reasoned that constructing fork regression
substrates containing template-strand gaps would provide insight into how this enzyme
functions and what lesions SMARCAL1 can and cannot tolerate in the cell.
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First, we constructed substrates containing a nick or 1 nucleotide gap on either
the leading or  lagging template strand.  None of  these substrates had any effect  on
SMARCAL1 activity (Fig. 5.1). This suggests that the step size of SMARCAL1 is greater
than 1 nucleotide.  Next,  we constructed substrates with 5 or  10 nucleotide gaps on
either template strand. In both cases, a gap on the leading strand inhibited SMARCAL1
activity  approximately  2-fold,  which  suggests  a  step-size  less  than  or  equal  to  5
nucleotides (Fig. 5.2). 
Next, we tested UvsW and RecG in this assay. While SMARCAL1 and UvsW are
structurally  similar  enzymes  (Aaron  Mason  and  Brandt  Eichman,  unpublished
observations), UvsW was unaffected by the leading strand lesion. Instead, the lagging
strand gap inhibited UvsW activity, consistent with the reported 3' → 5' polarity of UvsW
(Nelson et al. 2009).  On the other hand, lesions on either strand inhibited RecG to some
extent,  though the extent  of  inhibition was greater when the gap was placed on the
leading template strand (Fig. 5.3).
Both RecG and UvsW have strand-switching capability  (Manosas et al. 2013).
Template strand gaps did not inhibit SMARCAL1 activity completely in either orientation.
Although our results suggest a 5' → 3' polarity, one alternative explanation for this limited
inhibition is that SMARCAL1 may switch strands after encountering the lesion. Once the
fork junction is  migrated to the gap,  this  intermediate resembles the fork restoration
substrates used previously. In fork restoration assays, SMARCAL1 prefers substrates
where the leading nascent strand is longer than the lagging nascent strand (Bétous et al.
2013). The leading template strand gap substrate used here resembles a fork restoration
substrate  with  a  longer  lagging  nascent  strand,  and  vice  versa  (Fig.  5.4A).  Once
SMARCAL1 migrates these substrates to the template strand gap,  SMARCAL1 may
complete the reaction through translocation on a different strand (Fig. 5.4B).
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Figure 5.1 Nicks and 1nt Gaps Have No Effect on SMARCAL1 Fork Regression
Activity.  (A-B)  Leading gap substrates  (3nM) containing no modification  (“None”),  a
leading  strand  nick  (“Lead”),  or  a  lagging  strand  nick  (“Lag”)  were  incubated  with
SMARCAL1 (3nM) at 30°C for 5, 10, or 20 minutes. DNA products were analyzed by
native gel electrophoresis (A) and phosphorimager quantitation (B). (C-D) Leading gap
substrates (3nM) containing a 1nt gap on the leading (“Lead”) or lagging (“Lag”) template
strand were incubated with SMARCAL1 (3nM) at 30°C for 5, 10, or 20 minutes. DNA
products  were  analyzed  by  native  gel  electrophoresis  (C)  and  phosphorimager
quantitation (D). Graphs are from a single experiment (n=1). Oligos: (No mod) LeadP122
+ LagP122 + LeadD52 + LagG82;  (Lead nick/gap)  LeadP84/LeadP83 + LeadP38 +
LagP122 + LeadD52 + LagG82; (Lag nick/gap) LeadP122 + LagP38 + LagP84/LagP83
+ LeadD52 + LagG82.
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Figure 5.2 5nt and 10nt Gaps on the Leading Template Strand Inhibit SMARCAL1
Fork Regression Activity. (A-B) Leading gap substrates (3nM) containing a 5nt gap on
the leading (“Lead”) or lagging (“Lag”) template strand were incubated with SMARCAL1
(3nM) at  30°C for  5,  10,  or  20 minutes.  DNA products were analyzed by native gel
electrophoresis (A) and phosphorimager quantitation (B). (C-D) Leading gap substrates
(3nM) containing a 10nt gap on the leading (“Lead”) or lagging (“Lag”) template strand or
unmodified substrate (“None”) were incubated with SMARCAL1 (3nM) at 30°C for 5, 10,
or  20  minutes.  DNA products  were  analyzed  by  native  gel  electrophoresis  (C)  and
phosphorimager quantitation (D). (A, C) Arrow indicates alternative product that likely
lacks leading nascent strand and the smaller leading template fragment. (B, D) Graphs
represent mean and standard deviation of 3 replicates. (* p < 0.05). Oligos: (No mod)
LeadP122  +  LagP122  +  LeadD52  +  LagG82;  (Lead   5/10nt  gap)  LeadP79  +
LeadP38/LeadP33  +  LagP122  +  LeadD52  +  LagG82;  (Lag  nick/gap)  LeadP122  +
LagP38/LagP33 + LagP79 + LeadD52 + LagG82.
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Figure  5.3 Effects  of  10nt  Template  Strand  Gaps  on  UvsW  and  RecG  Fork
Regression  Activity.  Leading  gap  substrates  (3nM)  containing  a  10nt  gap  on  the
leading (“Lead”)  or  lagging (“Lag”)  template  strand  or  unmodified  substrate  (“None”)
were incubated with UvsW (3nM; A-B) or RecG (50pM; C-D) at 30°C for 5, 10, or 20
minutes.  DNA  products  were  analyzed  by  native  gel  electrophoresis  (A,  C)  and
phosphorimager  quantitation  (B,  D).  (B,  D)  Graphs  represent  mean  and  standard
deviation  of  3  replicates.  (*  p  <  0.05).  Oligos:  (No  mod)  LeadP122  +  LagP122  +
LeadD52 + LagG82; (Lead  5/10nt gap) LeadP79 + LeadP38/LeadP33 + LagP122 +
LeadD52 + LagG82; (Lag nick/gap) LeadP122 + LagP38/LagP33 + LagP79 + LeadD52
+ LagG82.
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Figure  5.4 Gapped  fork  regression  intermediate  resembles  fork  restoration
substrate and SMARCAL1 strand switching.  (A) A stalled fork regression substrate
with a leading-strand template gap can be regressed until the gap on the template strand
reaches the fork junction by SMARCAL1 applying force in the direction of the blue arrow.
Continued movement in this direction results in product formation by fork regression.
However, by rotating this intermediate 90° clockwise and splaying the arms, we can see
that  this  intermediate  resembles  the  stalled  fork  restoration  substrate  (Bétous et  al.
2013). If SMARCAL1 applies force in the direction of the blue arrow, translocating on the
nascent  duplex,  the  same products  are  formed from a fork  restoration  reaction.  (B)
SMARCAL1 may change strands during regression of  these substrates.  SMARCAL1
translocation in either orientation shown will produce the same products. As in panel A,
blue arrows indicate direction of force exerted on DNA.
Development of a Biotin-Streptavidin Block Assay
Another  method  used  to  determine  translocation  polarity  is  using  a
biotin-streptavidin block (Fu et al. 2011; Nelson et al. 2009). Therefore, we constructed
substrates containing biotinylated nucleotides. First, we removed the ssDNA at the fork
junction  to  eliminate ssDNA position  as a variable.  SMARCAL1 binds poorly  to  fork
junctions without ssDNA  (Bétous et al.  2012). Therefore, we reduced the size of the
substrates from 122 to 62 nucleotides; thus, annealing of only 42 nucleotides, rather
than  82  nucleotides,  is  required  to  form  the  products.  To add  biotin  moieties,  we
constructed substrates containing a nick on either template strand and biotin on either
the 5' or 3' end of these nicks.
We tested SMARCAL1 activity on these substrates and found that the nick alone
inhibited SMARCAL1 activity, and in no case did addition of streptavidin to the substrate
further inhibit SMARCAL1 activity (Fig. 5.5). We reasoned that this inhibition may arise
due to the lower affinity of SMARCAL1 for three-way junctions lacking ssDNA combined
with some affinity of SMARCAL1 to bind directly to the nick itself instead of the junction
(Bétous et  al.  2012).  To test  this  hypothesis,  we added nicked dsDNA to a reaction
containing the unmodified substrate. Indeed, the nicked dsDNA inhibited the reaction
(Fig.  5.6),  suggesting  that  the  presence  of  a  nick  titrates  SMARCAL1  away  from
productive binding to the fork junction.
To  eliminate  these  nicks,  we  constructed  substrates  that  contain
biotin-11-deoxyuridine  in  the  leading,  lagging,  or  both  template  strands.  We  tested
SMARCAL1 activity on these substrates in the presence and absence of streptavidin.
We observed that biotin placed on either the leading or lagging strand was sufficient to
inhibit  SMARCAL1 activity approximately two-fold, and placing biotin on both strands
further  inhibited  SMARCAL1  another  two-fold  (Fig.  5.7B-C).  This  suggests  that
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Figure 5.5 Substrates Containing Biotinylated Nicks Inhibit SMARCAL1 Activity.
(A-C) Small, no-gap (sNG) substrates (3nM) containing no modification (“-”), a leading
strand nick (“Lead nick, -”), a 5'-biotinylated leading strand nick (“Lead nick, 5'”), or a
3'-biotinylated leading strand nick (“Lead nick, 3'”) were incubated in the presence or
absence of streptavidin (12nM) for 10 minutes at room temperature. SMARCAL1 (12nM)
was added to the reaction and further incubated for 1 hour at 37°C. DNA products were
analyzed by native gel electrophoresis (C) and phosphorimager quantitated (A-B).  %
Fork Regression is the ratio of product formed to total radioactivity in the lane (A), % Alt.
Product is the ratio of intermediate sized products to the total radioactivity in the lane (B).
(C) Lanes 1-4 contain markers that correspond to the reaction product (nascent-nascent
duplex) and several possible alternative products that retain the labelled DNA strand.
(D-F) The same as (A-C) except that the substrates used contained no modification (“-”),
a lagging strand nick (“Lag nick, -”), a 5'-biotinylated lagging strand nick (“Lag nick, 5'”),
or a 3'-biotinylated lagging strand nick (“Lag nick, 3'”). Data shown are representative of
2  independent  experiments  (each  n=1).  Oligos:  (No  mod)  LeadP62  +  LagP62  +
LeadN42 +  LagN42;  (Leading  nick)  LeadP42/LeadP42-3b  +  LeadP20/LeadP20-5b +
LeadN42  +  LagN42;  (Lagging  nick)  LeadP62  +  LagP42/LagP42-5b  +
LagP20/LagP20-3b + LeadN42 + LagN42.
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Figure  5.6  Nicked  Duplex  DNA  Inhibits  SMARCAL1  activity  on  No  Gap  Fork
Regression Substrates.  No gap substrates (3nM) were incubated in the presence or
absence of nicked duplex DNA (“nick”) (3nM) with increasing amounts of SMARCAL1ΔN
(0,  3,  9,  30nM)  for  1  hour  at  37°C.  DNA  products  were  analyzed  by  native  gel
electrophoresis  (A)  and  phosphorimager  quantitation  (B).  Data  shown  is  a  single
experiment (n=1). Oligos: (No gap substrate) LeadP62 + LagP62 + LeadN42 + LagN42;
(nicked duplex) LeadP42 + LeadP20 + LagP62.
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Figure  5.7  Substrates  Containing  Biotin-dU  Bound  to  Streptavidin  Inhibit
SMARCAL1 Fork  Regression Activity.  (A)  Chemical  structure  of  Biotin-11-dU.  “11”
indicates  the  linker  size  between  uridine  and  biotin.  (B-D)  No-gap  substrates  (3nM)
containing  no  modification  (“-”),  leading  strand  biotin-dU  (“Lead”),  lagging  strand
biotin-dU (“Lag”), or both (“Lead+Lag”) were incubated in the absence (C) or presence
(D) of streptavidin (12nM) for 10 minutes at room temperature. Increasing amounts of
SMARCAL1ΔN (0, 3, 9, 30) were added to the reaction and further incubated for 1 hour
at  37°C.  DNA  products  were  analyzed  by  native  gel  electrophoresis  (B)  and
phosphorimager quantitation (C-D). Graphs represent mean and standard deviation of 3
replicates. Oligos: LeadP62/LeadP62-ib + LagP62/LagP62-ib + LeadN42 + LagN42.
SMARCAL1 may be generally sensitive to base modifications in the major groove of
DNA.
When we bound streptavidin to these substrates, SMARCAL1 activity was further
inhibited  by  biotin-streptavidin  on  the  leading  template  strand,  but  the  addition  of
streptavidin relieved the inhibitory effect of biotin on the lagging template strand. I don't
know why this  occurs.  Perhaps streptavidin  binding causes the base to flip  out  into
solution and no longer occludes the major groove. The presence of biotin-streptavidin on
both strands resulted in nearly complete inhibition of SMARCAL1 (Fig. 5.7B and 5.7D).
However, this substrate has increased electrophoretic mobility compared to the singly
biotinylated  substrates  bound  to  streptavidin.  Likely,  streptavidin  cross-links  the  two
strands – a single streptavidin tetramer binds both biotin moieties – and SMARCAL1
cannot break the streptavidin intramolecular interactions to generate products.
To test  for  streptavidin-specific  effects,  we repeated  these  experiments  using
avidin. Using a time course, we obtained similar results. In this case, avidin bound to
both strands inhibited SMARCAL1 only slightly more than avidin bound to the leading
strand alone. This suggests that this effect is an artifact of streptavidin (Fig. 5.8). The
multiple avidin-bound substrate bands likely  reflects either  avidin tetramers bound to
multiple  substrates  or  multiple  oligomerization  states  of  avidin  (monomer,  dimer,
tetramer).  As with streptavidin,  avidin binding relieved the inhibitory  effect  of  lagging
strand biotin on SMARCAL1 activity.
Next, we tested ZRANB3 in this assay. Like SMARCAL1, biotin-avidin bound to
the  leading  strand  or  both  strands  strongly  inhibited  ZRANB3  activity.  However,
biotin-avidin bound to the lagging strand had an intermediate effect on ZRANB3 (Fig.
5.9).  As  with  SMARCAL1  and  ZRANB3,  biotin-avidin  bound  to  both  strands  nearly
completely  inhibited  RecG  activity  in  this  assay.  However,  unlike  SMARCAL1  and
ZRANB3, RecG was only modestly inhibited by biotin-avidin on either strand alone (Fig.
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Figure 5.8 Substrates Containing Biotin-dU Bound to Avidin Inhibit  SMARCAL1
Fork Regression Activity.  No-gap substrates (3nM) containing no modification (“-”),
leading strand biotin-dU (“Lead”), lagging strand biotin-dU (“Lag”), or both (“Lead+Lag”)
were incubated in the absence (B) or presence (C) of avidin (12nM) for 10 minutes at
room temperature as indicated. SMARCAL1ΔN was added to 9nM to the reaction and
further incubated for 15 or 30 minutes at 37°C. DNA products were analyzed by native
gel  electrophoresis  and  phosphorimager  quantitation.  Bars  represent  mean  and
standard deviation of 3 replicates. Oligos: LeadP62/LeadP62-ib + LagP62/LagP62-ib +
LeadN42 + LagN42.
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Figure 5.9 Substrates Containing Biotin-dU Bound to Avidin Inhibit ZRANB3 Fork
Regression Activity. No-gap substrates (3nM) containing no modification (“-”), leading
strand biotin-dU (“Lead”), lagging strand biotin-dU (“Lag”),  or both (“Lead+Lag”) were
incubated in the absence (B) or presence (C) of avidin (12nM) for 10 minutes at room
temperature  as  indicated.  ZRANB3  was  added  to  3nM  to  the  reaction  and  further
incubated for  15 or  30 minutes at  37°C. DNA products were analyzed by native gel
electrophoresis and phosphorimager quantitation. Bars represent mean and standard
deviation of 3 replicates. Oligos: LeadP62/LeadP62-ib + LagP62/LagP62-ib + LeadN42
+ LagN42.
5.10).  Finally,  we  tested  UvsW.  As  with  SMARCAL1  and  ZRANB3,  leading  strand
biotin-avidin strongly inhibited UvsW, while biotin-avidin on the lagging strand had an
intermediate  effect.  Again,  biotin-avidin  bound  to  both  strands  resulted  in  nearly
complete inhibition (Fig. 5.11). The common pattern of these results is that biotin-avidin
bound to the leading strand has a stronger effect than biotin-avidin bound to the lagging
strand, and SMARCAL1, ZRANB3, and UvsW are more sensitive to these modifications
than RecG.
Discussion
Previous studies suggested that RecG and UvsW bind and translocate along the
dsDNA  backbone  and  make  contact  with  both  template  DNA  strands  during  fork
regression. Nuclease protection assays and reversed polarity experiments suggest that
RecG may bind and track along both strands (Manosas et al. 2013; Tanaka and Masai
2006), though perhaps with a preference for 3' → 5' translocation (Whitby et al. 1994).
UvsW likely also contacts both strands, though mechanical force may only be applied to
the 3' → 5' (lagging) strand (Manosas et al. 2013; Nelson et al. 2009). Our results with
fork  regression  substrates  containing  a  10  nucleotide  gap  on  either  the  leading  or
lagging template strand are consistent with such a model: RecG is inhibited by a gap
placed on either template strand, and UvsW is only inhibited when the gap is on the
lagging (3' → 5') template strand (Fig. 5.3).
Our previous report demonstrated that SMARCAL1 protects the leading strand in
nuclease protection assays  (Bétous et al. 2013). Reversed polarity experiments were
consistent with SMARCAL1 binding to the leading strand upstream of the fork junction
(Maria  Manosas,  unpublished  observations).  Consistent  with  a  5'  → 3'  translocation
polarity for SMARCAL1, both 5-10 nucleotide gaps inhibit SMARCAL1 when placed on
the leading (5' → 3') template strand (Fig. 5.2).
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Figure 5.10 Substrates Containing Biotin-dU Bound to Avidin Inhibit RecG Fork
Regression Activity. No-gap substrates (3nM) containing no modification (“-”), leading
strand biotin-dU (“Lead”), lagging strand biotin-dU (“Lag”),  or both (“Lead+Lag”) were
incubated in the absence (B) or presence (C) of avidin (12nM) for 10 minutes at room
temperature  as  indicated.  RecG  was  added  to  15pM  to  the  reaction  and  further
incubated for  15 or  30 minutes at  37°C. DNA products were analyzed by native gel
electrophoresis and phosphorimager quantitation. Bars represent mean and standard
deviation of 3 replicates. Oligos: LeadP62/LeadP62-ib + LagP62/LagP62-ib + LeadN42
+ LagN42.
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Figure 5.11 Substrates Containing Biotin-dU Bound to Avidin Inhibit UvsW Fork
Regression Activity. No-gap substrates (3nM) containing no modification (“-”), leading
strand biotin-dU (“Lead”), lagging strand biotin-dU (“Lag”),  or both (“Lead+Lag”) were
incubated in the absence (B) or presence (C) of avidin (12nM) for 10 minutes at room
temperature  as  indicated.  UvsW  was  added  to  0.5nM  to  the  reaction  and  further
incubated for  15 or  30 minutes at  37°C. DNA products were analyzed by native gel
electrophoresis and phosphorimager quantitation. Bars represent mean and standard
deviation of 3 replicates. Oligos: LeadP62/LeadP62-ib + LagP62/LagP62-ib + LeadN42
+ LagN42.
A Helicase Activity for SMARCAL1?
When tested on no-gap substrates containing a nick on the leading template
strand,  SMARCAL1 activity  produced an “alternative”  product  with an electrophoretic
mobility similar to the substrate without the leading nascent strand. How this product
forms is a mystery; however, one possibility is that SMARCAL1 changes strands during
branch  migration  across  a  nick.  For  example,  SMARCAL1  may  translocate  on  the
template strands until reaching the nick, then switch to the nascent strands to continue
the same annealing reaction. Maria Manosas recently demonstrated in single molecule
assays that UvsW and RecG switch strands during translocation (Manosas et al. 2013).
It is possible that SMARCAL1 can perform similar strand switching (Fig. 5.4B).
Switching to one of the template-nascent duplex arms may yield the 'alternative'
product, but this does not fully explain the appearance of this product. SMARCAL1 has
no reported helicase activity, and formation of this product requires unwinding of a short
sequence. There is some independent indication that on partial-X junction substrates,
SMARCAL1 may perform limited unwinding of the parental duplex (Aaron Mason and
Brandt Eichman, unpublished observations). This suggests that SMARCAL1 may have
cryptic helicase activity on complex substrates such as partial-X junctions.
Avidin bound substrates reveal commonalities between fork regression enzymes
Our results with avidin blocks showed that  all  four enzymes tested are more
sensitive to a block on the leading strand compared to the lagging strand (Figs. 5.8, 5.9,
5.10, 5.11).  Because this result  does not match the reported translocation polarity of
UvsW and RecG, this suggests that this assay does not, in fact, measure translocation
polarity. This is not too surprising, since unlike nicks, gaps, and 5' or 3' biotinylation, the
internal biotin modifications reside in the major groove of DNA, not on the backbone.
Instead,  this  assay  may  tell  us  something  about  a  common  mechanism  of  fork
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regression for these enzymes. Perhaps the substrate specificity domains make more
extensive contacts with the leading strand than the lagging strand.  In any case,  the
SWI/SNF family members SMARCAL1, ZRANB3, and UvsW have very similar activities
in this assay, while the non-SWI/SNF RecG is less sensitive overall to modifications.
It will be interesting to follow up this study with DNA footprinting assays using
hydroxyl-radical cleavage to map both dsDNA and ssDNA protection by these enzymes.
If the internal biotin-avidin assay is really measuring something about how the substrate
specificity domains bind, we would anticipate greater protection of leading strand ssDNA
compared to lagging strand ssDNA. Since we lack any footprinting data for ZRANB3,
this would give us an indication for whether ZRANB3 protects the leading or lagging
template strand. This is especially interesting given that that on naked DNA substrates,
SMARCAL1  and  ZRANB3  have  similar  substrate  preferences  with  respect  to  the
orientation of ssDNA at a replication fork-like junction (Bétous et al. 2013).
Function of Annealing Helicases in Replication
On  naked  DNA substrates,  RecG  and  SMARCAL1  have  opposite  substrate
preferences with respect to the ssDNA. However, SSB and RPA stimulate RecG and
SMARCAL1  activity,  respectively,  when  bound  to  the  leading  strand.  Furthermore,
SSB/RPA inhibit RecG and SMARCAL1 when bound to the lagging strand (Bétous et al.
2013).  This reinforces the preference of RecG for leading strand ssDNA, and flips the
preference for SMARCAL1 to match RecG. As such,  one hypothesis is that in cells,
SMARCAL1 and RecG perform fork regression at stalled forks that have ssDNA on the
leading strand.
While such careful analysis has not been carried out for UvsW, recent reports
suggest that UvsW can perform fork regression to allow lesion bypass in a model T4
replication system (Manosas et al. 2012), and that UvsW may be stimulated by the T4
148
SSB, gp32, at least in some instances (Perumal et al. 2013). It is possible then, that the
function  of  these divergent  SF2 rewinding enzymes is  conserved:  to  regress stalled
replication forks to allow tolerance of template DNA damage.
Interestingly, ZRANB3 shares a similar SWI/SNF ATPase core with SMARCAL1
and has a similar substrate preference to SMARCAL1, but ZRANB3 fork regression is
inhibited  by  RPA  (Bétous  et  al.  2013).  This  suggests  that  while  SMARCAL1  and
ZRANB3 share a similar mode of translocation, they perform different functions in the
cell.  ZRANB3  localizes  to  stalled  replication  forks  via  an  interaction  with
polyubiquitinated PCNA (Ciccia et al. 2012; Weston et al. 2012; Yuan et al. 2012), which
is associated with damage tolerance pathways  (Blastyák et al.  2007; Lin et al.  2011;
Ulrich and Walden 2010; Unk et al. 2010). Further experiments may demonstrate that
ZRANB3 also has a protein activator such as PCNA.
One possible model for the function of SMARCAL1 and ZRANB3 is the following:
Leading strand template damage stalls the leading strand polymerase, exposing ssDNA
on the leading strand. SMARCAL1 is recruited and stimulated by RPA to regress the
stalled  fork  and  allow  lesion  bypass  by  template  switching.  SMARCAL1  can  also
catalyze the reverse reaction and restore a fork that has bypassed the lesion. However,
if  damage occurs  on the lagging strand,  this  will  only  reveal  limited ssDNA,  as  the
replication  fork  will  likely  continue  after  unwinding  and  priming  another  Okazaki
fragment. Poly-ubiquitination of PCNA at the stalled polymerase recruits ZRANB3. Thus,
ZRANB3 may assist in some step of template switching to ensure replication across the
damaged  area  (see  Fig.  6.4).  ZRANB3  also  contains  an  ATP-dependent  3'-flap
endonuclease activity of unclear significance in cells (Weston et al. 2012).
Another  open  question  is  whether  SMARCAL1  and  ZRANB3  prefer  fork
regression or fork restoration, since previous analyses relied upon substrates which can
only migrate in one direction (Bétous et al. 2013). To address this question, substrates
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that resemble partially regressed forks could be used that can migrate in either direction
(Fig. 5.12). 
Conclusions
From our experiments with gapped substrates,  we conclude that  SMARCAL1
likely translocates 5' → 3' on the leading template strand, while UvsW uses the 3' → 5'
lagging  template  strand.  RecG  likely  uses  both  strands,  though  it  may  have  some
preference for 5' → 3' translocation in these assays, in distinction to previous reports.
Our experiments with avidin blocks suggest similarities between the enzymes: leading
strand biotin-avidin  inhibited  SMARCAL1,  ZRANB3,  RecG,  and UvsW more strongly
than lagging strand biotin-avidin.
Perhaps just as interesting as the substrates that block SMARCAL1 activity is
those that do not: neither a nick nor a 1 nucleotide gap affected SMARCAL1 activity on a
stalled  fork  substrate.  Furthermore,  while  SMARCAL1  binding  to  nicks  titrated  the
enzyme away from the fork junction in the no-gap assay (Fig. 5.6), the presence of biotin
or  streptavidin  at  these  nicks  had  no  effect  on  SMARCAL1  activity  (Fig.  5.5).  This
suggests that  SMARCAL1 could tolerate both naked single strand breaks and those
covalently attached to a protein, such as a Topoisomerase I cleavage complex induced
by  camptothecin.  Therefore,  SMARCAL1  is  a  robust  annealing  helicase,  capable  of
performing fork regression in a number of circumstances to promote genome stability.
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Figure  5.12  Dual  Regression/Restoration  Substrate  Design.  A  substrate  that
resembles the fork restoration substrates from  (Bétous et al. 2013) with the exception
that the sequences are entirely homologous except for a few mismatches that can be
strategically  placed  to  prevent  spontaneous  branch  migration.  In  this  way,  DNA
movement along the red arrows will result in fork restoration (annealing of the ssDNA
arm to the parental  duplex),  and movement along the blue arrows will  result  in fork
regression (annealing of the parental-parental and nascent-nascent duplexes). Products
can be distinguished by labelling both of the top strands (one parental and one nascent),
thus  fork  restoration  will  result  in  a  single  band  containing  both  labels,  while  fork
regression results in two bands.
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Table 5.1 Construction of Fork Regression Substrates. Lead gap substrates were constructed
as previously (Bétous et al. 2013) with nicks and gaps added by substitution of LagP84/83/78 +
LagP38/33 for LagP122 or LeadP84/83/78 + LeadP38/33 for LeadP122. Small no-gap substrates
were  prepared  similarly,  substituting  LagP42  +  LagP20/P20-3b  for  LagP62  and  LeadP42  +
LeadP20 for LeadP62. Biotin modifications were introduced by substituting biotinylated oligos
where appropriate.
CHAPTER VI
DISCUSSION and FUTURE DIRECTIONS†
Summary
Human cells  must  faithfully  duplicate billions of  base pairs  of  DNA every cell
division cycle. Insufficient precursors, template DNA damage, and difficult to replicate
sequences cause replication fork stalling. Even in the best of circumstances hundreds of
forks may stall during each S-phase in a human cell and the frequency increases in cells
exposed to genotoxic or oncogenic stresses. Cells must resolve these stalled replication
forks to complete DNA synthesis, as failure to do so leads to mutations or cell death.
Given  its  importance,  multiple  pathways  exist  to  recover  stalled  replication  forks
including  stabilization  and  restart,  repriming  and  post-replicative  repair,  template
switching,  and  double-strand  break  (DSB)-mediated  recovery  (Yeeles  et  al.  2013).
However,  much  remains  to  be  learned  about  these  mechanisms  and  how  they
coordinate to successfully replicate the genome trillions of times during a human lifetime.
The most important regulator of replication stress responses is the ATR kinase,
which phosphorylates hundreds of substrates and is essential for every round of cell
division.  Many cancer  cells  have an elevated survival  requirement  for  ATR function,
making ATR a good drug target for cancer therapy (Toledo et al. 2011a). In addition, ATR
inhibition hypersensitizes cells to many chemotherapeutic agents that work by damaging
DNA or interfering with DNA replication.
While I have worked on three very different projects during my dissertation, the
overarching theme is to understand how cells protect stalled replication forks. In chapter
† Portions of this chapter will be published in (Couch and Cortez 2014).
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III,  I  collaborated with Bianca Sirbu to conduct  time-dependent analyses of the DNA
damage response at stalled replication forks. In chapter IV, I collaborated with a number
of other scientists to elucidate one mechanism by which ATR stabilizes stalled replication
forks: phosphorylation of SMARCAL1. In chapter V, I  explored further how annealing
helicases, especially SMARCAL1, perform fork regression.
iPOND and the DNA Damage Response
iPOND is a useful tool to study protein dynamics at stalled replication forks
Bianca developed iPOND to study proteins that accumulate at replication forks.
Using iPOND, we found that a switch occurs in the replication stress response after 2-4
hours  of  HU treatment.  This  switch  results  in  accumulation  of  the  KU heterodimer,
MRE11,  and  RAD51.  Furthermore,  RAD51  accumulation  is  dependent  on  MRE11
nuclease activity. 
The function of RAD51 at replication forks is an interesting topic. RAD51 likely
performs multiple, temporally distinct functions at stalled forks (Petermann et al. 2010).
In the absence of RAD51, transiently stalled replication forks are more likely to collapse,
unable to resume synthesis (Petermann et al. 2010). RAD51 deficient cells accumulate
MRE11-dependent gaps behind replication forks  (Hashimoto et al. 2010), and MRE11
degrades the newly synthesized DNA strands in the absence of RAD51 (Schlacher et al.
2011). However, recent reports also suggest that MRE11 is required for full activation of
ATR, at least in some circumstances (Duursma et al. 2013; Lee and Dunphy 2013). 
The  key  to  understanding  this  paradox  may  be  our  observation  that  RAD51
recruitment  to  persistently  stalled  replication  forks  is  MRE11-dependent  (Sirbu  et  al.
2011). MRE11 has both endonuclease and 3' → 5' exonuclease activities (D’Amours and
Jackson  2002).  RAD51  is  required  for  fork  restart  during  short  HU  treatments
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(Petermann  et  al.  2010),  and  RAD51  recruitment  to  these  forks  appears  to  be
MRE11-independent  (Sirbu  et  al.  2011).  However,  after  2-4  hours  of  HU treatment,
RAD51 accumulates to a greater degree in an MRE11-dependent  manner. This may
reflect a change in the underlying DNA structure, such as fork regression, where some
amount of  MRE11-dependent  processing is  required to load RAD51. RAD51 loading
prevents excess degradation of the nascent strands by MRE11 (Hashimoto et al. 2010;
Schlacher et al. 2012). Finally, HU treatments in excess of 18 hours produce DSBs, and
while  RAD51  accumulates  at  these  stalled  forks,  the  forks  are  unable  to  resume
synthesis  (Petermann  et  al.  2010).  This  suggests  that  RAD51  may  mediate  strand
invasion to await rescue of the stalled fork from a nearby origin without re-replicating the
region behind the stalled fork (Fig. 6.1).
We also demonstrated that γH2AX spreads away from the site of replication fork
stalling to encompass a large chromatin domain, likely tens of thousands of base pairs in
size.  We  determined  that  ATR  catalyzes  the  initial  H2AX  phosphorylation  at  the
replication fork and the early spreading into the surrounding chromatin, and that at later
timepoints,  ATM/DNA-PK activity are critical  for  γH2AX spreading in  the surrounding
chromatin. ATR inhibition results in hyper-phosphorylation of H2AX and a pan-nuclear
γH2AX  phenotype.  Kamakoti  Bhat,  another  graduate  student  in  the  lab,  and  I
demonstrated that this pan-nuclear γH2AX phenotype is dependent on DNA-PK but not
ATM. Some γH2AX foci remain after inhibiton of ATR, ATM, and DNA-PK; thus, there
may be another kinase capable of catalyzing phosphorylation of H2AX-S139 (Fig. 6.2).
Building on the success of  iPOND, Bianca set  out  to identify  new replication
proteins.  Using  iPOND  coupled  to  mass  spectrometry,  she  identified  290  proteins
enriched at replication forks. Of those identified, only a minority had annotated functions
in replication or DNA damage (Sirbu et al. 2013). Huzefa Dungrawala, a post-doctoral
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Figure  6.1  MRE11  and  RAD51  interplay  at  stalled  replication  forks.  At  early
timepoints  (0-2h)  in  HU,  MRE11 activity  may  have  some  function  to  promote  ATR
activity, while RAD51 prevents excess MRE11 degradation of the nascent strands and
promotes fork restart.  At intermediate times in HU (4-8h),  some fork remodeling may
occur that requires some MRE11 activity for RAD51 recruitment. At later times in HU
(>18h), MUS81-dependent DSBs occur. RAD51 likely promotes strand invasion to await
rescue from a nearby origin.
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Figure  6.2  ATRi-induced  pan-nuclear  γH2AX  is  DNA-PK-dependent.  U2OS  cells
were treated for 4h with 3mM HU in the presence or absence of 5μM ATRi (VE-812
Reaper et al. 2011), 2μM ATMi (KU55933 Hickson et al. 2004), 2μM DNA-PKi (NU7441
Leahy  et  al.  2004),  or  all  three  together  (DDRi  =  ATRi  +  ATMi  +  DNA-PKi)  before
preparation  for  immunofluorescence  using  anti-γH2AX  antibodies.  Dot-plot  of  mean
γH2AX intensity per nucleus is shown in (B).
fellow in our laboratory, is now working to improve the specificity of iPOND and further
characterize the protein composition at normal, stalled, and collapsed replication forks.
The  post-translational  modification  landscape  at  replication  forks  remains
somewhat mysterious. I developed the native iPOND protocol to address this question,
and  the  protocol  was  since  improved  (Leung  et  al.  2013).  In  theory, native  iPOND
coupled to mass spectrometry can identify the histone marks at replication forks and
how these change over time and distance from the fork and under various conditions of
DNA damage. Many of Huzefa's improvements to the iPOND protocol will apply to native
iPOND and should futher improve the signal-to-noise ratio of n-iPOND.
ATR Regulation of Stalled Replication Forks
ATR activity is critical to prevent replication fork collapse, a situation in which a
fork is no longer competent to support DNA synthesis. But what is fork collapse at the
molecular  level,  and how does fork collapse contribute to cell  death in ATR deficient
cells? These questions have been difficult to answer especially in mammalian systems
since deletion of the ATR gene is cell lethal (Brown and Baltimore 2000; de Klein et al.
2000).  The development  of  selective ATR kinase inhibitors  has now allowed us and
others to begin to answer these questions (Reaper et al. 2011).
As  expected,  stalled  replication  forks  in  ATR  inhibited  cells  rapidly  undergo
collapse into DSBs (Couch et al. 2013). In addition to DSBs, ATR inhibition results in the
formation of excess single-stranded DNA (ssDNA) at the fork including both the template
and newly-synthesized strands (Couch et al. 2013). Origin firing is de-repressed in ATR
inhibited cells, which exacerbates the aberrant DNA phenotype as these new forks likely
undergo similar stalling and degradation (Fig. 6.3A). Importantly, fork collapse into DSBs
and  excess  ssDNA  is  an  active  process  mediated  by  SLX4-  and  CtIP-dependent
nucleases (Couch et al. 2013; Ragland et al. 2013).
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Figure 6.3 SMARCAL1 activity is a balance between too much and too little. (A) A
replication fork encounters leading strand template damage (green star) which stalls the
polymerase and generates ssDNA. ATR senses this ssDNA, supresses origin firing, and
prevents aberrant processing of the stalled fork. (B) ATR maintains a balance between
too much and too little SMARCAL1 activity by phosphorylating SMARCAL1 on S652.
Tipping the balance by either inhibiting ATR or overexpressing SMARCAL1 results in
fork  collapse  through  an  SLX4-dependent  cleavage.  Conversely,  fork  collapse  is
MUS81-dependent  when  there  is  too  little  SMARCAL1  activity.  The  actual  DNA
structures that these nucleases cleave in these conditions remain to be experimentally
verified.
The DNA structure at the stalled replication fork that is cleaved to create breaks
is  not  known;  however,  one  clue  comes  from our  observation  that  the  SMARCAL1
protein is also involved in the aberrant fork processing that happens in ATR-deficient
cells (Couch et al. 2013). SMARCAL1 is a SWI/SNF family DNA-dependent ATPase that
catalyzes  branch  migration  of  fork  junctions  (Bétous  et  al.  2012).  In  particular,
SMARCAL1 is recruited to and active at stalled replication forks that contain ssDNA on
the leading  template  strand  (Bétous  et  al.  2013).  On  these  substrates,  SMARCAL1
catalyzes reversal  of  the replication  fork into a  chicken-foot  structure,  potentially  the
substrate  for  SLX4-dependent  nucleases.  SMARCAL1  is  also  able  to  catalyze  the
reverse reaction (fork restoration) when the nascent leading strand is longer than the
nascent lagging strand so other models could be envisioned (Bétous et al. 2013).
Importantly,  fork  reversal  is  a  common  event  in  human  cells  and  is  an
evolutionarily  conserved  mechanism  of  fork  stabilization  or  repair  at  least  in  some
circumstances (Atkinson and McGlynn 2009; Neelsen et al. 2013; Ray Chaudhuri et al.
2012). Furthermore, SMARCAL1 has fork repair functions important to promote restart in
normal cells that have an intact ATR pathway (Bansbach et al. 2009; Ciccia et al. 2009;
Yuan et al. 2009). Thus, in ATR-deficient cells, SMARCAL1 catalyzed fork remodeling
leads to fork collapse, but in ATR proficient cells, SMARCAL1 maintains fork stability.
This paradox is further illustrated by the observation that either too little or too much
SMARCAL1 activity in cells leads to replication-associated DSBs (Bansbach et al. 2009).
The solution  to  this  conundrum is  that  ATR directly  regulates  SMARCAL1 to
maintain the balance between too much and too little SMARCAL1 activity (Fig. 6.3B).
Specifically, ATR phosphorylates SMARCAL1 on S652 in a linker region between the two
lobes of its ATPase domain. S652 phosphorylation happens after SMARCAL1 binds to
DNA at the replication fork and inhibits its fork remodeling activities. Thus, an attractive
model  is  that  ATR  ensures  the  right  level  of  SMARCAL1  activity  at  the  damaged
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replication fork. Treating cells with an ATR inhibitor causes fork collapse in part because
it interferes with SMARCAL1 regulation, sending stalled forks through a pathway that
includes SLX4-dependent cleavage. Were this infrequent, recombination could repair the
break and restart replication, but the deregulation of origin timing when ATR is inhibited
multiplies  the  number  of  collapsed  forks.  This  leads  to  genome-wide  problems,
evidenced by pan-nuclear γH2AX staining. Furthermore, addition of replication stress to
the system in the presence of an ATR inhibitor for more than 30-45 minutes ensures the
cells will be unable to complete replication and die (Couch et al. 2013).
ATR and Fork Repair Pathways
The ATR-SMARCAL1 pathway is certainly not the only mechanism by which ATR
prevents fork collapse and cell death. For example, ATR signaling likely regulates the
integrity of the replisome proteins themselves, and both RNF4 (RING finger protein 4)
and PLK1 (Polo-like kinase 1) have been implicated in this pathway  (Ragland et  al.
2013). Given the large number of ATR substrates and mechanisms of fork repair, ATR
inactivation likely disrupts multiple pathways of fork repair and maintenance, and much
remains to be understood about this critical genome maintenance activity.
One possibility is that ATR activity helps to enforce an order of events at stalled
replication forks. For example, ATR may stabilize the replisome for some amount of time
to  allow direct  restart  or  bypass.  However, after  some time has  passed,  some fork
remodeling may occur, such as fork regression or template switching. In the absence of
nucleotides,  these repair  pathways will  also  fail.  As  a  backup,  ATR may then allow
controlled MUS81-dependent collapse of the replication fork into a DSB. Forks could
then recover by break-induced replication, or this may simply re-form the replication fork
to await rescue from a nearby origin (Fig. 6.1).
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In  the  absence  of  ATR  activity,  lack  of  ordered  control  of  these  pathways
produces  chaos:  RNF4-PLK1-dependent  degradation  of  replisome  components  and
SMARCAL1-SLX4-dependent collapse of the replication fork into a DSB (Couch et al.
2013; Ragland et al. 2013). Since these would also occur at any newly fired origins as
well in the absence of ATR activity, there is no way to rescue these collapsed forks.
Firing excess origins also depletes cellular reserves of RPA, which may also contribute
to the lethality of ATR inhibition  (Toledo et al. 2013). Thus, cells are unable to recover
after HU treatment in the presence of the ATR inhibitor.
Future Directions
Further investigations will likely uncover additional modes of ATR regulation of
stalled replication forks.  Two post-doctoral  fellows in  our  laboratory have undertaken
screens that may prove informative. First, Gina Kavanaugh conducted a high-throughput
immunofluorescence screen for ATR-like genes, which she defined as those genes that
cause  γH2AX  persistence  and  decreased  DNA  synthesis  after  release  from
hydroxyurea. Second, Kareem Mohni has conducted screens for ATR inhibitor sensitivity.
This methodology appears to be especially good at identifying ATR-pathway proteins
(Kareem Mohni, personal communication).
Even within the identified SMARCAL1- and SLX4-dependent pathway of ATR fork
protection,  open  questions  remain.  For  example,  does  ATR  phosphorylate  SLX4
normally to prevent degradation of the replication forks? Is SLX4-dependent cleavage of
the replication fork only a pathogenic process or is there a physiological function for this
pathway?
Frustratingly,  we  have  been  unable  to  easily  complement  SMARCAL1
phenotypes, despite publication of an assay for SMARCAL1 complementation by our lab
and  others  (Bansbach  et  al.  2009;  Ghosal  et  al.  2011).  This  likely  stems  from  the
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limitations of siRNA technology and exogenous protein expression. The CRISPR-Cas
system  has  enabled  efficient  genome  editing  in  mammalian  cells  and  can  create
knockout and knock-in mutants with high efficiency (Cong et al. 2013; Mali et al. 2013;
Wang  et  al.  2013a).  Thus,  to  overcome  the  technical  limitations  of  siRNA
complementation,  we  should  develop  a  SMARCAL1  knockout  cell  line  and  several
knock-in mutants including R764Q, S652A, and S652D. These cell lines should give us
definitive evidence that S652 phosphorylation is biologically relevant and not an artifact
of over-expression.
Knockout cell lines have another advantage: a genetically clean system in which
to study genetic interactions with other proteins in the cell. For example, SMARCAL1
and ZRANB3, when co-depleted, give a stronger phenotype than either gene depleted
alone  (Ciccia  et  al.  2012;  Weston  et  al.  2012).  However,  because  siRNA depletion
reduces but does not eliminate function, we cannot say whether these proteins exist in
the same or different pathways. A double knockout developed using CRISPR-Cas would
answer this question definitively. Comparing these genetic knockouts could help identify
overlapping and specialized functions of these proteins.
We  have  primarily  limited  our  studies  to  a  single  DNA  damaging  agent,
hydroxyurea. While hydroxyurea is valuable because it rapidly stalls replication forks, it
may bias our discoveries of fork protection pathways. Thus, another step will be to use
other drugs such as UV, MMS, and CPT, and test for replication fork stability, replisome
stability, DSB formation, and of course, find the genetic and biochemical requirements
for each of these.
Finally, I  believe an important  experiment  is  a  genome-wide  siRNA or  cDNA
screen for suppressors of ATR inhibitor sensitivity. This could reveal which pathways are
deleterious or beneficial using siRNA and cDNA, respectively. Following up on hits from
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such a screen will require exclusion of any genes that prevent cell cycle progression, as
this is the most obvious mechanism of protection.
The utility of selective inhibitors to ATR and other DDR kinases is not limited to
basic scientific discoveries. ATR inhibition sensitizes cells to replication stress, which is a
hallmark of cancer cells. As such, several CHK1 inhibitors have entered clinical trials,
and as ATR inhibitors become available, they will likely find their way into clinical trials as
well (Bartucci et al. 2011; Fokas et al. 2014; Toledo et al. 2011a).
Biochemistry of Annealing Helicases
Rémy Bétous demonstrated that SMARCAL1 activity on model replication fork
substrates is regulated by RPA. Namely, he determined that RPA stimulated SMARCAL1
fork  regression  activity  on  substrates  that  resemble  stalled  replication  forks
(leading-strand ssDNA) and inhibited SMARCAL1 activity on normal  replication forks
(lagging-strand ssDNA). Finally, Rémy determined that SMARCAL1 can also perform the
reverse reaction, called fork restoration, by re-annealing the template-nascent duplexes
of the replication fork. Moreover, RPA stimulated SMARCAL1 restoration of normal forks
and inhibited SMARCAL1 restoration of stalled forks (Bétous et al. 2013).
To  build  on  this  story,  I  wanted  to  answer  a  biochemical  question  about
SMARCAL1: how it translocates on DNA. Helicases and DNA translocases often track
one strand of DNA with a defined directionality: 5' → 3' or 3' → 5'. For example, the
related UvsW protein from T4 bacteriophage tracks ssDNA 3' → 5' (Nelson et al. 2009).
SMARCAL1 requires the presence of both dsDNA and ssDNA to bind its substrates, thus
answering  this  question  is  more  difficult  than  for  traditional  helicases  or  dsDNA
translocases.
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Development of an assay for fork regression polarity
To develop an assay for fork regression polarity, I first modified the stalled fork
substrate  to  contain  nicks  or  gaps  in  either  the  leading  or  lagging  template  strand.
SMARCAL1 was able to accommodate substrates containing a nick or 1nt gap without
any trouble. When I extended the gap to 5 or 10 nucleotides, however, I observed that
SMARCAL1 was less active when the gap was placed on the leading template strand.
This suggests a step-size for SMARCAL1 of greater than 1, but less than or equal to 5
nucleotides.
Unfortunately, these substrates come with an important caveat: SMARCAL1 can
bind to dsDNA with a gap, and once the gap migrates to the fork junction, SMARCAL1
can bind these substrates differently. Furthermore, it  is possible, in principle, that the
orientation  of  ssDNA  at  the  fork  junction  could  affect  SMARCAL1  translocation.
Therefore, I constructed substrates without ssDNA at the fork junction that contained a
nick on either the leading or lagging template strand. I also incorporated biotin moieties
on either the 5' or 3' end of those nicks. Unfortunately, a nick on these substrates inhibits
SMARCAL1 by titrating the enzyme away from the fork junction. It is interesting to note,
however,  that  in  no  case  did  addition  of  streptavidin  to  these  substrates  inhibit
SMARCAL1  activity.  Therefore  SMARCAL1  can  tolerate  large  modifications  to  the
backbone, perhaps even Top1 cleavage complexes.
Next,  I  constructed  substrates  containing  biotin-11-dU  in  either  the  leading,
lagging or both template strands. Using these substrates, a biotin-avidin block on the
leading strand, but not the lagging strand, inhibited SMARCAL1 activity. This suggests
that  SMARCAL1 translocates on the leading template strand,  5'  → 3'.  Unfortunately,
while these data are consistent with a leading strand, 5' → 3' ssDNA translocase activity
for  SMARCAL1,  considerations  below  suggest  that  this  assay  may  not  measure
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translocation polarity. Likely, nothing short of crystal structures that capture ATPase cycle
intermediates such as for NS3 (Gu and Rice 2010) will provide conclusive answers.
Comparison of SMARCAL1 and other annealing helicases
These data are not convincing or particularly useful in a vacuum. Therefore, I
also tested other fork regression enzymes in this assay. ZRANB3, the closest human
relative  of  SMARCAL1,  and UvsW, a  SWI/SNF family  member  from T4 phage,  had
similar preferences to SMARCAL1: they were blocked by a lesion on the leading, but not
the lagging strand. RecG, an E. coli SF2 helicase, was less inhibited by avidin bound to
only one strand, consistent with the literature which suggests that RecG can use both
strands for translocation  (Manosas et al. 2013; McGlynn and Lloyd 2001; Tanaka and
Masai 2006). Still,  RecG was inhibited more by avidin bound to the leading template
strand than the lagging template strand.
This  is  an  interesting  result.  It  suggests  that  this  assay  does  not  measure
translocation polarity. UvsW, which functions similarly to SMARCAL1 in this assay, is a 3'
→  5'  translocase  (Nelson  et  al.  2009) –  in  other  words,  if  this  assay  measured
translocation,  then a lagging strand lesion should  inhibit  UvsW more than a leading
strand lesion.  I  suspect  that  this  assay instead measures  something about  how the
substrate specificity domains of these enzymes contact the daughter strands.
RecG has been crystallized with a replication fork junction. In that structure, the
wedge domain is inserted between the two daughter strands at the fork junction and
makes  contacts  with  both  daughter  template  strands  (Singleton  et  al.  2001).  One
explanation for the results of the biotin-avidin blocks is that RecG makes contacts with
both daughter strands and is thus sensitive to bulky adducts that may not pass over the
wedge domain properly.
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Since we lack crystal  structures of  UvsW, SMARCAL1,  or  ZRANB3 with fork
DNA, we can only hypothesize that the substrate specificity domains of these enzymes
also make contacts  with  the daughter  strands.  Perhaps these make more extensive
contacts with the leading strand than the lagging strand, and thus are more sensitive to
avidin bound to the leading strand. The HARP2 domain of SMARCAL1 is required for
binding to forked DNA and can replace the MotA-like domain of UvsW (Aaron Mason
and Brandt  Eichman,  unpublished observations).  This  suggests that  the SMARCAL1
HARP2 domain and UvsW MotA-like domain function similarly as substrate specificity
domains.
The Normal Function of Annealing Helicases
In these studies, SMARCAL1 fork regression has proved quite robust, able to
tolerate  small  modifications  to  the  backbone.  This  suggests  that  SMARCAL1  can
perform annealing activity on a wide variety of structures in vivo. One limitation of these
experiments is that these all used fork regression substrates. While useful because of
the  relative  simplicity  of  the  substrate  and  amenability  to  modification,  it  is  unclear
whether SMARCAL1 uses such a substrate in the cell. 
At  first  blush,  SMARCAL1  would  seem  to  prefer  fork  regression  to  fork
restoration. However, this fails to account for two important facts: (1) the fork restoration
substrates  tested  contain  6  mismatches,  compared  to  the  2  mismatches  in  fork
regression  substrates,  which  provides  a  higher  barrier  to  fork  regression;  (2)  RPA
stimulates  “normal”  fork  restoration  to  a  much  greater  extent  than  “stalled”  fork
regression. Further experiments will be required to solve this mystery. One possibility is
that  the  model  put  forth  by  Rémy Bétous  is  correct:  at  a  stalled  fork,  SMARCAL1
performs fork regression,  then after  repair  and processing,  SMARCAL1 restores the
repaired replication fork (Bétous et al. 2013).
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It is also possible that SMARCAL1 only performs one or the other of these steps.
Further insight into the function of SMARCAL1 in cells could be gained through analysis
of replication intermediates in the presence and absence of SMARCAL1. This analysis
could  be  performed  using  either  electron  microscopy  or  using  density  gradient
centrifugation to identify nascent-nascent hybrids. It will prove interesting as well to test
whether phosphorylation of SMARCAL1 on S652 alters the preference of SMARCAL1
for fork regression or restoration, given that this damage inducible phosphorylation site
reduces  SMARCAL1  activity  in  cells  and  SMARCAL1  phosphorylation  requires
DNA-binding activity of the protein (Couch et al. 2013).
A Model for SMARCAL1 and ZRANB3 Function
While ZRANB3 and SMARCAL1 are biochemically similar enzymes, it remains
unclear whether these two proteins function in the same or different pathways in cells.
Moreover, while the HARP domains of SMARCAL1 function as a substrate specificity
domain  to  the  point  that  chimaeras  of  the  SMARCAL1  HARP  domains  and  other
SWI/SNF motor domains can perform annealing helicase activity (Ghosal et al. 2011), it
is unclear what domain of ZRANB3 confers substrate specificity to the SWI/SNF motor.
In cells, SMARCAL1 and ZRANB3 localize to replication foci and sites of laser
microirradiation  (Bansbach et al.  2009; Ciccia et al.  2009, 2012; Weston et al.  2012;
Yuan et al. 2009, 2012). Depletion of either protein results in γH2AX foci formation and
sensitivity to replication stress agents including HU, CPT, and MMC  (Bansbach et al.
2009; Ciccia et al. 2009, 2012; Yuan et al. 2009, 2012). Interestingly, there are conflicting
reports  of  the  damage  sensitivity  of  ZRANB3-depleted  cells:  one  report  found
ZRANB3-depleted cells sensitive to MMS, but not HU or CPT (compare  Weston et al.
2012 to Ciccia et al. 2012; Yuan et al. 2012).
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In  cells,  these  two  proteins  likely  function  at  different  places:  SMARCAL1  is
recruited  to  stalled  forks  via  an  interaction  with  RPA32,  which  places  SMARCAL1
potentially  at  the replication  fork junction  (Bansbach et  al.  2009;  Ciccia  et  al.  2009;
Yusufzai  et  al.  2009).  On  the  other  hand,  ZRANB3  requires  PCNA-Ub,  which  is
associated with template switching and likely occurs behind the replication fork (Ciccia et
al. 2012; Weston et al. 2012; Yuan et al. 2012; Zeman and Cimprich 2012). The simplest
model, then, is that SMARCAL1 and ZRANB3 operate in different pathways. One such
case is that SMARCAL1, but not ZRANB3,  is required for the nascent-strand ssDNA
that  occurs  in  ATR inhibited  cells  (Couch  et  al.  2013).  Thus,  there  is  at  least  one
separable function of SMARCAL1 and ZRANB3.
One model  is  as  follows:  SMARCAL1 is  recruited to stalled  forks through its
interaction with RPA. SMARCAL1 fork regression protects these forks from nucleolytic
degradation by MUS81. After repair, SMARCAL1 can restore the functional replication
fork,  and  some  unknown  mechanism  may  reload  the  MCM  helicase  (Fig.  6.4A).
Alternatively, a stalled fork may be reprimed, especially if  the damage occurs on the
lagging strand, allowing the replisome to continue away from the site of damage. In this
case,  the  PCNA at  the  lesion  may  become poly-ubiquitinated  by  HLTF  or  SHPRH.
Poly-ubiquitinated PCNA then recruits ZRANB3 to aid in some step of  the error-free
template switching mechanism of repair. What step this may be remains unclear, though
ZRANB3  contains  an  HNH  ATP-dependent  endonuclease  activity.  Coupled  with  the
observation that  ZRANB3-deficient  cells  exhibit  increased sister-chromatid  exchange,
this suggests that ZRANB3 aids in dissolution of the junction molecule between the two
sister chromatids that forms during template switching (Fig. 6.4B). Of course, this is only
a model and will require further experimentation.
How can we test this model? One obvious place to start is to test SMARCAL1 in
the sister chromatid exchange assay. This will either indicate that SMARCAL1 deficiency
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Figure  6.4  Differential  functions  of  SMARCAL1  and  ZRANB3.  (A)  RPA recruits
SMARCAL1 to stalled forks, such as a polymerase blocking lesion on the leading strand.
SMARCAL1  fork  regression  and  restoration  activities  can  allow  lesion  bypass  by
template  switching.  (B)  A  lagging  strand  lesion  is  unlikely  to  stall  the  replisome.
Poly-ubiquitinated PCNA marks a lesion for  error-free template switching.  HLTF may
begin this process. After synthesis, both the annealing helicase and nuclease activities
of ZRANB3 are required to dissolve the sister chromatid junction. This model awaits
experimental verification.
also results in increased sister chromatid exchanges, or that this is a distinct function of
ZRANB3. In either case, this is an interesting result. Next, it would be elegant to show
that  HLTF  or  SHPRH  and  ZRANB3  are  in  the  same  pathway  genetically,  while
SMARCAL1 and ZRANB3 are in separate pathways.
Regulation of ZRANB3
We demonstrated that SMARCAL1 is a phospho-regulated protein (Carroll et al.
2014; Couch et al. 2013). Notably, the linker region of SMARCAL1 containing S652 is
highly conserved in ZRANB3 (Fig. 6.5). One testable hypothesis is that like SMARCAL1,
ATR regulates ZRANB3 activity by phosphorylation of this linker region, especially T264.
Another question is whether over-expression of ZRANB3 produces similar pan-nuclear
and ssDNA phenotypes as SMARCAL1.
Conclusions
This  dissertation  makes  several  important  contributions  to  the  field  of  DNA
damage repair, and provides a foundation from which we can continue to pull back the
curtain on regulation of replication fork repair. In Chapter III, Bianca and I characterized
the differences in protein recruitment at early vs late timepoints in HU. In Chapter IV,
Carol and I demonstrated that one mechanism by which ATR stabilizes replication forks
is through regulation of SMARCAL1. In Chapter V, I demonstrated common themes in
the biochemical mechanism of annealing helicases.
I believe that future studies of the replication stress response should “zoom out”
and take a systems biology approach to understand the interplay between the different
fork repair pathways. To do this, changes in the transcriptome, phospho-proteome, and
replication  fork  associated  proteins  should  be  compared  over  time  in  HU and  with
different  damaging  agents.  Integrating  all  this  information  should  reveal  regulatory
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Figure 6.5 ZRANB3 contains similar linker sequence to SMARCAL1 including T264
in the same position as SMARCAL1 S652. Domain maps of SMARCAL1 and ZRANB3
include RPA binding domain (RPA), HARP1 (H1), HARP2 (H2), ATPaseN, ATPaseC, PIP
box (PIP), Zinc finger (NZF), HNH nuclease (HNH), and APIM motif (APIM). Alignment
was performed with NCBI BLASTp. Asterisk and underline mark SMARCAL1 S652, an
ATR-dependent phosphorylation site. The equivalent residues in ZRANB3 are aligned as
shown.
pathways and feedback loops that allow time- and damage-dependent regulation of fork
repair. One simple example of such a time-dependent regulatory mechanism is likely
ATR phosphorylation of SMARCAL1 on S652: at early times in HU, most SMARCAL1 is
unphosphorylated on  S652  and this  prevents  MUS81 cleavage  of  stalled  replication
forks.  However,  at  later  times  in  HU,  S652  may  be  highly  phosphorylated,  and  the
decreased  SMARCAL1 activity  may no longer  be  sufficient  to  prevent  MUS81 from
cleaving stalled forks (Fig. 6.3B). This is also consistent with the differential requirements
for RAD51 at early and late timepoints in HU.
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